10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 001-34292

ORRSTOWN FINANCIAL SERVICES, INC.

(Exact Name of Registrant as Specified in its Charter)

Pennsylvania				23-2530374
(State or Other Jurisdiction of Incorporation or Organization)				(I.R.S. Employer Identification No.)
	77 East King Street	P. O. Box 250	Shippensburg	Pennsylvania	17257
	(Address of Principal Executive Offices)				(Zip Code)
	Registrant’s Telephone Number, Including Area Code:		(717)	532-6114

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, no par value	ORRF	Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	☒
Non-accelerated filer	¨	Smaller reporting company	☒
		Emerging growth company	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.			o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.).    Yes  ☐    No  x

Number of shares outstanding of the registrant’s Common Stock as of November 1, 2021: 11,206,452.

ORRSTOWN FINANCIAL SERVICES, INC.

INDEX

 

		Page
Part I – FINANCIAL INFORMATION
	Glossary	3
Item 1.	Financial Statements	4
	Consolidated Balance Sheets (Unaudited)	4
	Consolidated Statements of Income (Unaudited)	5
	Consolidated Statements of Comprehensive Income (Unaudited)	7
	Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)	8
	Consolidated Statements of Cash Flows (Unaudited)	10
	Notes to Consolidated Financial Statements (Unaudited)	12
Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	46
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	68
Item 4.	Controls and Procedures	69
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	70
Item 1A.	Risk Factors	70
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	70
Item 3.	Defaults upon Senior Securities	70
Item 4.	Mine Safety Disclosures	70
Item 5.	Other Information	70
Item 6.	Exhibits	71
SIGNATURES		72

2

Glossary of Defined Terms

The following terms may be used throughout this Report, including the unaudited condensed consolidated financial statements and related notes.

Term	Definition
ALL	Allowance for loan losses
AFS	Available for sale
AOCI	Accumulated other comprehensive income
ASC	Accounting Standards Codification
ASU	Accounting Standards Update
Bank	Orrstown Bank, the commercial banking subsidiary of Orrstown Financial Services, Inc.
CDI	Core deposit intangible
CET1	Common Equity Tier 1
CMO	Collateralized mortgage obligation
CRE	Commercial real estate
EPS	Earnings per common share
ERM	Enterprise risk management
Exchange Act	Securities Exchange Act of 1934, as amended
FASB	Financial Accounting Standards Board
FDIC	Federal Deposit Insurance Corporation
FHLB	Federal Home Loan Bank
FRB	Board of Governors of the Federal Reserve System
GAAP	Accounting principles generally accepted in the United States of America
GDP	Gross Domestic Deposit
GSE	U.S. government-sponsored enterprise
Hamilton	Hamilton Bancorp, Inc., and its wholly-owned banking subsidiary, Hamilton Bank, acquired May 1, 2019
IRC	Internal Revenue Code of 1986, as amended
LHFS	Loans held for sale
LIBOR	London Interbank Offered Rate
MBS	Mortgage-backed securities
MPF Program	Mortgage Partnership Finance Program
MSR	Mortgage servicing right
NIM	Net interest margin
OCI	Other comprehensive income
OREO	Other real estate owned
OTTI	Other-than-temporary impairment
2011 Plan	2011 Orrstown Financial Services, Inc. Incentive Stock Plan
PCI loans	Purchased credit impaired loans
PPP	Paycheck Protection Program
Repurchase Agreements	Securities sold under agreements to repurchase
ROU	Right of use (leases)
SBA	U.S. Small Business Administration
SEC	Securities and Exchange Commission
Securities Act	Securities Act of 1933, as amended
SOFR	Secured Overnight Financing Rate
TDR	Troubled debt restructuring
Unless the context otherwise requires, the terms “Orrstown,” “we,” “us,” “our,” and “Company” refer to Orrstown Financial Services, Inc. and its subsidiaries.

3

PART I – FINANCIAL INFORMATION

Item 1.     Financial Statements

Condensed Consolidated Balance Sheets (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

(Dollars in thousands, except per share amounts)	September 30, 2021		December 31, 2020
Assets
Cash and due from banks	$	36,920	$	26,203
Interest-bearing deposits with banks	274,495		99,055
Cash and cash equivalents	311,415		125,258
Restricted investments in bank stocks	7,051		10,563
Securities available for sale (amortized cost of $437,852 and $460,999 at September 30, 2021 and December 31, 2020, respectively)	445,018		466,465
Loans held for sale, at fair value	6,412		11,734
Loans	1,939,764		1,979,690
Less: Allowance for loan losses	(19,965)		(20,151)
Net loans	1,919,799		1,959,539
Premises and equipment, net	34,279		35,149
Cash surrender value of life insurance	69,792		68,554
Goodwill	18,724		18,724
Other intangible assets, net	4,486		5,458
Accrued interest receivable	8,015		8,927
Other assets	45,191		40,201
Total assets	$	2,870,182	$	2,750,572
Liabilities
Deposits:
Noninterest-bearing	$	545,323	$	456,778
Interest-bearing	1,956,785		1,900,102
Total deposits	2,502,108		2,356,880
Securities sold under agreements to repurchase	27,595		19,466
FHLB advances and other borrowings	2,003		58,045
Subordinated notes	31,948		31,903
Other liabilities	37,959		38,029
Total liabilities	2,601,613		2,504,323
Commitments and contingencies
Shareholders’ Equity
Preferred stock, $1.25 par value per share; 500,000 shares authorized; no shares issued or outstanding	—		—
Common stock, no par value—$0.05205 stated value per share 50,000,000 shares authorized; 11,248,917 shares issued and 11,205,052 outstanding at September 30, 2021; 11,257,046 shares issued and 11,201,317 outstanding at December 31, 2020	586		586
Additional paid - in capital	189,168		189,066
Retained earnings	74,122		54,099
Accumulated other comprehensive income	5,661		3,346
Treasury stock— 43,865 and 55,729 shares, at cost at September 30, 2021 and December 31, 2020, respectively	(968)		(848)
Total shareholders’ equity	268,569		246,249
Total liabilities and shareholders’ equity	$	2,870,182	$	2,750,572

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

4

Condensed Consolidated Statements of Income (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

	Three Months Ended				Nine Months Ended
(Dollars in thousands, except per share amounts)	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Interest income
Loans	$	19,890	$	21,645	$	62,724	$	63,605
Investment securities - taxable	1,514		2,145		5,007		8,378
Investment securities - tax-exempt	652		417		1,790		1,121
Short-term investments	135		9		255		101
Total interest income	22,191		24,216		69,776		73,205
Interest expense
Deposits	937		2,483		3,410		10,147
Securities sold under agreements to repurchase	8		20		25		72
FHLB advances and other borrowings	123		394		458		1,604
Subordinated notes	503		501		1,507		1,504
Total interest expense	1,571		3,398		5,400		13,327
Net interest income	20,620		20,818		64,376		59,878
Provision for loan losses	365		2,200		(10)		5,025
Net interest income after provision for loan losses	20,255		18,618		64,386		54,853
Noninterest income
Service charges on deposit accounts	796		684		2,231		2,085
Interchange income	1,030		900		3,049		2,507
Other service charges and fees	197		168		527		473
Swap fee income	67		95		135		527
Trust and investment management income	1,930		1,713		5,862		5,049
Brokerage income	987		751		2,708		2,069
Mortgage banking activities	1,333		1,985		4,684		3,926
Gains on sale of portfolio loans	—		—		—		2,803
Income from life insurance	569		543		1,690		1,615
Investment securities gains (losses)	479		(13)		635		(44)
Other income	263		35		338		118
Total noninterest income	7,651		6,861		21,859		21,128
Noninterest expenses
Salaries and employee benefits	11,498		10,695		31,907		32,352
Occupancy	1,154		1,231		3,492		3,480
Furniture and equipment	1,220		1,203		3,800		3,569
Data processing	990		958		3,041		2,620
Automated teller and interchange fees	294		278		862		778
Advertising and bank promotions	735		197		1,434		1,153
FDIC insurance	218		230		570		491
Professional services	562		603		1,862		2,340
Directors' compensation	155		214		624		679
Taxes other than income	16		453		929		904
Intangible asset amortization	314		357		972		1,224
Branch consolidation expenses	—		1,310		—		1,310
Insurance claim receivable recovery	—		—		—		(486)
Other operating expenses	1,879		1,536		4,358		5,586
Total noninterest expenses	19,035		19,265		53,851		56,000
Income before income tax expense	8,871		6,214		32,394		19,981
Income tax expense	1,679		1,237		6,219		3,577
Net income	$	7,192	$	4,977	$	26,175	$	16,404

5

Per share information:
Basic earnings per share	$	0.66	$	0.45	$	2.38	$	1.50
Diluted earnings per share	0.65		0.45		2.36		1.49
Dividends paid per share	0.19		0.17		0.55		0.51

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

6

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

 

	Three Months Ended				Nine Months Ended
(Dollars in thousands)	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Net income	$	7,192	$	4,977	$	26,175	$	16,404
Other comprehensive income (loss), net of tax:
Unrealized (losses) gains on securities available for sale arising during the period	(2,346)		4,296		2,335		375
Reclassification adjustment for (gains) losses realized in net income	(479)		13		(635)		44
Net unrealized (losses) gains on securities available for sale	(2,825)		4,309		1,700		419
Tax effect	593		(904)		(357)		(87)
Total other comprehensive (loss) income, net of tax and reclassification adjustments on securities available for sale	(2,232)		3,405		1,343		332
Unrealized (losses) gains on interest rate swaps used in cash flow hedges	(183)		208		473		(1,893)
Reclassification adjustment for losses realized in net income	581		114		757		239
Net unrealized gains (losses) on interest rate swaps used in cash flow hedges	398		322		1,230		(1,654)
Tax effect	(83)		(68)		(258)		347
Total other comprehensive gains (losses), net of tax and reclassification adjustments on interest rate swaps used in cash flow hedges	315		254		972		(1,307)
Total other comprehensive (loss) income, net of tax and reclassification adjustments	(1,917)		3,659		2,315		(975)
Total comprehensive income	$	5,275	$	8,636	$	28,490	$	15,429

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

7

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

	Three Months Ended September 30, 2021
(Dollars in thousands, except per share amounts)	Common Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Income		Treasury Stock		Total Shareholders’ Equity
Balance, July 1, 2021	$	586	$	188,772	$	69,052	$	7,578	$	(50)	$	265,938
Net income	—		—		7,192		—		—		7,192
Total other comprehensive loss, net of taxes	—		—		—		(1,917)		—		(1,917)
Cash dividends ($0.19 per share)	—		—		(2,122)		—		—		(2,122)
Share-based compensation plans:
16,593 net common shares acquired and 41,106 net treasury shares acquired, including compensation expense totaling $483	—		396		—		—		(918)		(522)
Balance, September 30, 2021	$	586	$	189,168	$	74,122	$	5,661	$	(968)	$	268,569
	Nine Months Ended September 30, 2021
(Dollars in thousands, except per share amounts)	Common Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Income		Treasury Stock		Total Shareholders’ Equity
Balance, January 1, 2021	$	586	$	189,066	$	54,099	$	3,346	$	(848)	$	246,249
Net income	—		—		26,175		—		—		26,175
Total other comprehensive income, net of taxes	—		—		—		2,315		—		2,315
Cash dividends ($0.55 per share)	—		—		(6,152)		—		—		(6,152)
Share-based compensation plans:
8,129 net common shares acquired and 11,864 net treasury shares issued, including compensation expense totaling $1,428	—		102		—		—		(120)		(18)
Balance, September 30, 2021	$	586	$	189,168	$	74,122	$	5,661	$	(968)	$	268,569

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

8

 

	Three Months Ended September 30, 2020
(Dollars in thousands, except per share amounts)	Common Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Total Shareholders’ Equity
Balance, July 1, 2020	$	586	$	188,226	$	42,862	$	(5,114)	$	(922)	$	225,638
Net income	—		—		4,977		—		—		4,977
Total other comprehensive income, net of taxes	—		—		—		3,659		—		3,659
Cash dividends ($0.17 per share)	—		—		(1,901)		—		—		(1,901)
Share-based compensation plans:
11,383 net common shares forfeited and 5,634 net treasury shares issued, including compensation expense totaling $437	—		362		—		—		112		474
Balance, September 30, 2020	$	586	$	188,588	$	45,938	$	(1,455)	$	(810)	$	232,847
	Nine Months Ended September 30, 2020
(Dollars in thousands, except per share amounts)	Common Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Stock		Total Shareholders’ Equity
Balance, January 1, 2020	$	584	$	188,365	$	35,246	$	(480)	$	(466)	$	223,249
Net income	—		—		16,404		—		—		16,404
Total other comprehensive loss, net of taxes	—		—		—		(975)		—		(975)
Cash dividends ($0.51 per share)	—		—		(5,712)		—		—		(5,712)
Share-based compensation plans:
36,442 net common shares issued and 32,804 net treasury shares acquired, including compensation expense totaling $1,613	2		223		—		—		(344)		(119)
Balance, September 30, 2020	$	586	$	188,588	$	45,938	$	(1,455)	$	(810)	$	232,847

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

9

Condensed Consolidated Statements of Cash Flows (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

	Nine Months Ended
(Dollars in thousands)	September 30, 2021		September 30, 2020
Cash flows from operating activities
Net income	$	26,175	$	16,404
Adjustments to reconcile net income to net cash provided by operating activities:
Net discount accretion	(690)		(2,898)
Depreciation and amortization expense	4,014		4,980
Impairment of intangibles	—		153
Provision for loan losses	(10)		5,025
Share-based compensation	1,428		1,613
Gains on sales of loans originated for sale	(3,980)		(4,028)
Mortgage loans originated for sale	(150,652)		(147,647)
Proceeds from sales of loans originated for sale	159,425		146,890
Gains on sale of portfolio loans	—		(2,803)
Net gain on disposal of OREO	—		164
Writedown of OREO	—		544
Deferred income taxes	(267)		(672)
Investment securities (gains) losses	(635)		44
Loss on derivative terminations	514		—
Income from life insurance	(1,690)		(1,615)
Decrease (increase) in accrued interest receivable	912		(2,772)
Increase in accrued interest payable and other liabilities	(221)		(504)
Other, net	(4,108)		3,460
Net cash provided by operating activities	30,215		16,338
Cash flows from investing activities
Proceeds from sales of AFS securities	149,038		—
Maturities, repayments and calls of AFS securities	30,525		38,970
Purchases of AFS securities	(156,912)		(26,691)
Net redemptions of restricted investments in bank stocks	3,512		3,538
Net decrease in loans	41,504		65,605
Proceeds from sales of portfolio loans	—		22,665
Purchases of bank premises and equipment	(891)		(914)
Proceeds from disposal of OREO	—		3,734
Proceeds from disposal of bank premises and equipment	—		59
Purchases of bank owned life insurance	—		(3,636)
Net cash provided by investing activities	66,776		103,330
Cash flows from financing activities
Net increase (decrease) in deposits	145,203		(63,761)
Net increase (decrease) in borrowings with original maturities less than 90 days	8,129		(137,424)
Proceeds from FHLB advances and other borrowings	—		180,955
Payments on FHLB advances and other borrowings	(56,042)		(60,649)
Settlement of terminated derivatives	(525)		—
Dividends paid	(6,152)		(5,712)
Acquisition of treasury stock	(1,069)		(1,170)
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting	(514)		(679)
Proceeds from issuance of employee stock purchase plan shares	136		116
Net cash provided by (used in) financing activities	89,166		(88,324)
Net increase in cash and cash equivalents	186,157		31,344
Cash and cash equivalents at beginning of period	125,258		55,963
Cash and cash equivalents at end of period	$	311,415	$	87,307

10

Supplemental disclosures of cash flow information:
Cash paid during the period for:
Interest	$	5,007	$	13,387
Income taxes	4,100		—

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

11

Notes to Condensed Consolidated Financial Statements (Unaudited)

(All dollar amounts presented in the tables, except per share amounts, are in thousands)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

See the Glossary of Defined Terms at the beginning of this Report for terms used throughout the unaudited condensed consolidated financial statements and related notes of this Form 10-Q.

Nature of Operations – Orrstown Financial Services, Inc. is a financial holding company that operates Orrstown Bank, a commercial bank providing banking and financial advisory services in Berks, Cumberland, Dauphin, Franklin, Lancaster, Perry and York Counties, Pennsylvania, and in Anne Arundel, Baltimore, Howard and Washington Counties, Maryland, as well as Baltimore City, Maryland. The Company operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services, including checking, savings, time, and money market deposits. The Company also provides fiduciary services, investment advisory, insurance and brokerage services. The Company and the Bank are subject to regulation by certain federal and state agencies and undergo periodic examinations by such regulatory authorities.

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements include the accounts of Orrstown Financial Services, Inc. and its wholly owned subsidiary, the Bank. The Company has prepared these unaudited condensed consolidated financial statements in accordance with GAAP for interim financial information, SEC rules that permit reduced disclosure for interim periods, and Article 10 of Regulation S-X. In the opinion of management, all adjustments (all of which are of a normal recurring nature) that are necessary for a fair statement are reflected in the unaudited condensed consolidated financial statements. The December 31, 2020 consolidated balance sheet information contained in this Quarterly Report on Form 10-Q was derived from the Company's 2020 audited consolidated financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. All significant intercompany transactions and accounts have been eliminated.

The Company's management has evaluated all activity of the Company and concluded that subsequent events are properly reflected in the Company's unaudited condensed consolidated financial statements and notes as required by GAAP.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. The effects of the COVID-19 pandemic may impact material estimates. Material estimates that are particularly susceptible to significant change include the determination of the ALL and those used in valuation methodologies in areas with no observable market, such as loans, deposits, borrowings, goodwill, core deposit and other intangible assets, mortgage servicing rights, other assets and liabilities obtained or assumed in business combinations. Certain prior-year amounts have been reclassified to conform to the current year presentation. These reclassifications did not have a material impact on the Company's consolidated financial condition or results of operations.

Derivatives - FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge.

12

The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company's objectives in using interest rate derivatives are to add stability to interest income and to manage its exposure to interest rate movements. To accomplish this objective, the Company uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of fixed amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount.

Changes to the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income and are subsequently reclassified into earnings in the period that the hedged transaction affects earnings. The Company discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in accumulated other comprehensive income (loss) are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. Such derivatives were used to hedge the variable cash flows associated with overnight borrowings. During the three and nine months ended September 30, 2021, the Company terminated its interest rate derivative designated as a cash flow hedge.

Derivatives not designated as hedges are not speculative and result from a service the Company provides to certain customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting derivatives that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate derivatives associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer derivatives and the offsetting derivatives are recognized directly in earnings.

Leases - The Company evaluates its contracts at inception to determine if an arrangement either is a lease or contains one. Operating lease ROU assets are included in other assets and operating lease liabilities in accrued interest payable and other liabilities in the unaudited condensed consolidated balance sheets. The Company had no finance leases at September 30, 2021.

ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company's leases do not provide an implicit rate, so the Company's incremental borrowing rate is used, which approximates its fully collateralized borrowing rate, based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is reevaluated upon lease modification. The operating lease ROU asset also includes any initial direct costs and prepaid lease payments made less any lease incentives. In calculating the present value of lease payments, the Company may include options to extend the lease when it is reasonably certain that it will exercise that option.

In accordance with ASU 2016-02, “Leases (Topic 842)” (“ASU 2016-02”), the Company keeps leases with an initial term of 12 months or less off of the balance sheet. The Company recognizes these lease payments in the unaudited condensed consolidated statements of income on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components and has elected the practical expedient to account for them as a single lease component.

Recent Accounting Pronouncements - ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The amendments in this update require an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Organizations will continue to use judgment to determine which loss estimation method is appropriate for their circumstances. Additionally, the amendments in this update amend the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For certain public companies, this update was effective for interim and annual periods beginning after December 15, 2019. The Company delayed the adoption of ASU 2016-13 as noted below.

ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates ("ASU 2019-10"), extended the implementation deadline of ASU 2016-13 for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company meets the requirements to be considered a smaller reporting company under SEC Regulation S-K and SEC Rule 405, and did not adopt ASU 2016-13 on January 1, 2020. The Company is evaluating the impact of the delay for adoption of ASU 2016-13, and is working with a third-party vendor solution to assist with the application of ASU 2016-13 and finalizing the loss estimation models to be used. Once management determines which methods will be utilized, a third party will be contracted to perform a model validation prior to adoption. While the Company anticipates the allowance for loan losses will increase under its current

13

assumptions, it expects the impact of adopting ASU 2016-13 will be influenced by the composition, characteristics and quality of its loan and securities portfolios, as well as general economic conditions and forecasts at the adoption date. The other provisions of ASU 2019-10 were not applicable to the Company.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). ASU 2020-04 contains optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The optional expedients apply consistently to all contracts or transactions within the scope of this topic, while the optional expedients for hedging relationships can be elected on an individual basis. The Company has formed a cross-functional working group to lead the transition from LIBOR to a planned adoption of an alternate index. The Company currently plans to replace LIBOR with the 30-Day Average SOFR in its loan agreements. The Company is in the process of implementing fallback language for loans that will mature after 2021. The Company expects to adopt the LIBOR transition relief allowed under this standard, and is currently evaluating the potential impact of this guidance on its financial statements.

NOTE 2. INVESTMENT SECURITIES

At September 30, 2021 and December 31, 2020, all investment securities were classified as AFS. The following table summarizes amortized cost and fair value of investment securities, and the corresponding amounts of gross unrealized gains and losses recognized in AOCI, at September 30, 2021 and December 31, 2020:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
September 30, 2021
U.S. Treasury securities	$	20,087	$	—	$	256	$	19,831
States and political subdivisions	174,239		8,072		790		181,521
GSE residential MBSs	20,552		80		114		20,518
GSE residential CMOs	69,922		921		656		70,187
Non-agency CMOs	25,929		1		273		25,657
Asset-backed	126,726		457		276		126,907
Other	397		—		—		397
Totals	$	437,852	$	9,531	$	2,365	$	445,018
December 31, 2020
States and political subdivisions	$	104,704	$	9,091	$	1,125	$	112,670
GSE residential MBSs	4,197		96		—		4,293
GSE residential CMOs	56,856		2,226		1,071		58,011
Non-agency CMOs	16,505		413		—		16,918
Private label commercial CMOs	63,941		57		1,762		62,236
Asset-backed	214,425		171		2,630		211,966
Other	371		—		—		371
Totals	$	460,999	$	12,054	$	6,588	$	466,465

14

The following table summarizes investment securities with unrealized losses at September 30, 2021 and December 31, 2020, aggregated by major investment security type and the length of time in a continuous unrealized loss position.

	Less Than 12 Months					12 Months or More					Total
	# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses
September 30, 2021
U.S. Treasury securities	3	$	19,831	$	256	—	$	—	$	—	3	$	19,831	$	256
States and political subdivisions	11	40,666		790		—	—		—		11	40,666		790
GSE residential MBSs	5	17,354		114		—	—		—		5	17,354		114
GSE residential CMOs	7	43,267		656		—	—		—		7	43,267		656
Non-agency CMOs	1	13,257		273		—	—		—		1	13,257		273
Asset-backed	2	19,084		14		3	36,067		262		5	55,151		276
Totals	29	$	153,459	$	2,103	3	$	36,067	$	262	32	$	189,526	$	2,365
December 31, 2020
States and political subdivisions	1	$	9,079	$	1,125	—	$	—	$	—	1	$	9,079	$	1,125
GSE residential CMOs	3	23,954		1,071		—	—		—		3	23,954		1,071
Private label commercial CMOs	1	4,314		685		10	42,403		1,077		11	46,717		1,762
Asset-backed	2	16,921		12		15	183,161		2,618		17	200,082		2,630
Totals	7	$	54,268	$	2,893	25	$	225,564	$	3,695	32	$	279,832	$	6,588

The Company determines whether unrealized losses are temporary in nature in accordance with FASB ASC 320-10, Investments - Overall, (“FASB ASC 320-10”) and FASB ASC 325-40, Investments – Beneficial Interests in Securitized Financial Assets, when applicable. The evaluation is based upon factors such as the creditworthiness of the underlying borrowers, performance of the underlying collateral, if applicable, and the level of credit support in the security structure. Management also evaluates other factors and circumstances that may be indicative of an OTTI condition. This includes, but is not limited to, an evaluation of the type of security, length of time and extent to which the fair value has been less than cost and near-term prospects of the issuer.

FASB ASC 320-10 requires the Company to assess if an OTTI exists by considering whether the Company has the intent to sell the security or it is more likely than not that it will be required to sell the security before recovery. If either of these situations applies, the guidance requires the Company to record an OTTI charge to earnings on debt securities for the difference between the amortized cost basis of the security and the fair value of the security. If neither of these situations applies, the Company is required to assess whether it is expected to recover the entire amortized cost basis of the security. If the Company is not expected to recover the entire amortized cost basis of the security, the guidance requires the Company to bifurcate the identified OTTI into a credit loss component and a component representing loss related to other factors. A discount rate is applied which equals the effective yield of the security. The difference between the present value of the expected flows and the amortized book value is considered a credit loss, which would be recorded through earnings as an OTTI charge. When a market price is not readily available, the market value of the security is determined using the same expected cash flows; the discount rate is a rate the Company determines from the open market and other sources as appropriate for the security. The difference between the market value and the present value of cash flows expected to be collected is recognized in accumulated other comprehensive loss on the unaudited condensed consolidated statements of financial condition.

As of September 30, 2021, the Company had no cumulative OTTI. There were no OTTI charges recognized in earnings as a result of credit losses on investments in the three and nine months ended September 30, 2021 and 2020. During 2020, unrealized losses were substantially higher due to market uncertainty brought about by the COVID-19 pandemic. The sudden and desperate need for liquidity from many institutional pools of capital, combined with the global economic implications of the COVID-19 pandemic, caused significant widening of spreads. Market conditions improved in the second half of 2020 and into 2021 as the uncertainty dissipated with economies re-opening and the distribution of vaccines.

U.S. Treasury Securities. The unrealized losses presented in the table above have been caused by an increase in rates from the time these securities were purchased. Management considers the full faith and credit of the U.S. government in determining whether a security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021.

States and Political Subdivisions. The unrealized losses presented in the table above have been caused by a widening of spreads from the time these securities were purchased. Management considers the investment rating, the state of the issuer of

15

the security and other credit support in determining whether the security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021 or December 31, 2020.

GSE Residential CMOs and GSE Residential MBS. The unrealized losses presented in the table above have been caused by a widening of spreads from the time these securities were purchased. The contractual terms of these securities do not permit the issuer to settle the securities at a price less than its par value basis. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021 or December 31, 2020.

Non-Agency CMOs. The unrealized losses presented in the table above were caused by a widening of spreads and/or a rise in interest rates from the time the securities were purchased. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021.

Asset-backed. The unrealized losses presented in the table above were caused by a widening of spreads from the time the securities were purchased. Management considers the investment rating and other credit support in determining whether a security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021 or December 31, 2020.

The following table summarizes amortized cost and fair value of investment securities by contractual maturity at September 30, 2021. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date are shown separately.

	Amortized Cost		Fair Value
Due in one year or less	$	—	$	—
Due after one year through five years	249		249
Due after five years through ten years	69,999		71,976
Due after ten years	124,475		129,524
CMOs and MBSs	116,403		116,362
Asset-backed	126,726		126,907
Totals	$	437,852	$	445,018

The following table summarizes proceeds from sales of investment securities and gross gains and gross losses for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Proceeds from sale of investment securities	$	73,319	$	—	$	149,038	$	—
Gross gains	482		—		1,844		—
Gross losses	3		13		1,209		44

During the three and nine months ended September 30, 2021, net investment security gains of $479 thousand and $635 thousand were recorded, respectively, compared to a net loss of $13 thousand and $44 thousand recorded to adjust an equity security to market value for the three and nine months ended September 30, 2020, respectively. During the nine months ended September 30, 2021, 18 securities with a principal balance of $148.4 million were sold for proceeds of $149.0 million compared to none during the nine months ended September 30, 2020. There were four investment securities with a principal balance of $72.8 million sold for proceeds of $73.3 million during the three months ended September 30, 2021, compared to none during the three months ended September 30, 2020. Investment securities with a fair value of $316.0 million and $398.7 million at September 30, 2021 and December 31, 2020, respectively, were pledged to secure public funds and for other purposes as required or permitted by law.

16

NOTE 3. LOANS AND ALLOWANCE FOR LOAN LOSSES

Consistent with ASU 2010-20, Disclosures about the Credit Quality of Financing Receivables and the Allowance for Loan Losses, the Company’s loan portfolio is grouped into segments which are further broken down into classes to allow management to monitor the performance by the borrower and to monitor the yield on the portfolio.

The risks associated with lending activities differ among the various loan classes and are subject to the impact of changes in interest rates, market conditions of collateral securing the loans, and general economic conditions. All of these factors may adversely impact both the borrower’s ability to repay its loans and associated collateral.

The Company has various types of commercial real estate loans, which have differing levels of credit risk. Owner occupied commercial real estate loans are generally dependent upon the successful operation of the borrower’s business, with the cash flows generated from the business being the primary source of repayment of the loan. If the business suffers a downturn in sales or profitability, the borrower’s ability to repay the loan could be in jeopardy.

Non-owner occupied and multi-family commercial real estate loans and non-owner occupied residential loans present a different credit risk to the Company than owner occupied commercial real estate loans, as the repayment of the loan is dependent upon the borrower’s ability to generate a sufficient level of occupancy to produce rental income that exceeds debt service requirements and operating expenses. Lower occupancy or lease rates may result in a reduction in cash flows, which hinders the ability of the borrower to meet debt service requirements, and may result in lower collateral values. The Company generally recognizes that greater risk is inherent in these credit relationships compared to owner occupied loans mentioned above.

Acquisition and development loans consist of 1-4 family residential construction and commercial and land development loans. The risk of loss on these loans is largely dependent on the Company’s ability to assess the property’s value at the completion of the project, which should exceed the property’s construction costs. During the construction phase, a number of factors could potentially negatively impact the collateral value, including cost overruns, delays in completing the project, competition, and real estate market conditions, which may change based on the supply of similar properties in the area. In the event the collateral value at the completion of the project is not sufficient to cover the outstanding loan balance, the Company must rely upon other repayment sources, if any, including the guarantors of the project or other collateral securing the loan.

Commercial and industrial loans include advances to local and regional businesses for general commercial purposes and include permanent and short-term working capital, machinery and equipment financing, and may be either in the form of lines of credit or term loans. Although commercial and industrial loans may be unsecured to our highest-rated borrowers, the majority of these loans are secured by the borrower’s accounts receivable, inventory and machinery and equipment. In a significant number of these loans, the collateral also includes the business real estate or the business owner’s personal real estate or assets. Commercial and industrial loans present credit exposure to the Company, as they are more susceptible to risk of loss during a downturn in the economy as borrowers may have greater difficulty in meeting their debt service requirements and the value of the collateral may decline. The Company attempts to mitigate this risk through its underwriting standards, including evaluating the creditworthiness of the borrower and, to the extent available, credit ratings on the business. Additionally, monitoring of the loans through annual renewals and meetings with the borrowers are typical. However, these procedures cannot eliminate the risk of loss associated with commercial and industrial lending. At September 30, 2021 and December 31, 2020, commercial and industrial loans include $259.9 million and $403.3 million, respectively, of loans, net of deferred fees and costs, originated through the SBA PPP.

Municipal loans consist of extensions of credit to municipalities and school districts within the Company’s market area. These loans generally present a lower risk than commercial and industrial loans, as they are generally secured by the municipality’s full taxing authority, by revenue obligations, or by its ability to raise assessments on its customers for a specific utility.

The Company originates loans to its retail customers, including fixed-rate and adjustable first lien mortgage loans, with the underlying 1-4 family owner occupied residential property securing the loan. The Company’s risk exposure is minimized in these types of loans through the evaluation of the creditworthiness of the borrower, including credit scores and debt-to-income ratios, and underwriting standards, which limit the loan-to-value ratio to generally no more than 80% upon loan origination, unless the borrower obtains private mortgage insurance.

Home equity loans, including term loans and lines of credit, present a slightly higher risk to the Company than 1-4 family first liens, as these loans can be first or second liens on 1-4 family owner occupied residential property, but can have loan-to-value ratios of no greater than 90% of the value of the real estate taken as collateral. The creditworthiness of the borrower is also considered, including credit scores and debt-to-income ratios.

17

Installment and other loans’ credit risk is mitigated through prudent underwriting standards, including evaluation of the creditworthiness of the borrower through credit scores and debt-to-income ratios and, if secured, the collateral value of the assets. These loans can be unsecured or secured by assets the value of which may depreciate quickly or may fluctuate, and may present a greater risk to the Company than 1-4 family residential loans.

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was enacted. The CARES Act established the SBA PPP. The SBA PPP is intended to provide economic relief to small businesses nationwide adversely impacted under the COVID-19 Emergency Declaration issued on March 13, 2020. The SBA PPP, which began on April 3, 2020, provided small businesses with funds to cover up to 24 weeks of payroll costs and other expenses, including benefits. It also provides for forgiveness of up to the full principal amount of qualifying loans. Through December 31, 2020, the Bank closed and funded almost 3,200 loans for a total gross loan amount of $467.7 million. These loans resulted in net processing fees of $13.5 million to be recognized through net interest income over the life of the loans, which is between two and five years. For the nine months ended September 30, 2021, the Bank closed and funded almost 3,300 PPP loans for a total loan amount of $231.7 million. In total, the Bank closed and funded almost 6,500 PPP loans for a total gross loan amount of $699.4 million. The loans originated in 2021 resulted in net processing fees of $12.3 million. At September 30, 2021, the Bank has $8.6 million of net deferred SBA PPP fees remaining to be recognized through net interest income over the life of the loans. The timing of the recognition of these fees is dependent upon the loan forgiveness process established by the SBA. As these loans are 100% guaranteed by the SBA, there is no associated allowance for loan losses at September 30, 2021.

In an effort to assist clients that were negatively impacted by the COVID-19 pandemic, the Bank offered various mitigation options, including a loan payment deferral program. Under this program, most commercial deferrals were for a 90-day period, while most consumer deferrals were for a 180-day period. Commercial and consumer deferrals totaled zero and $317 thousand, respectively, at September 30, 2021 and $15.7 million and $2.5 million, respectively, at December 31, 2020. In accordance with the revised Interagency Statement on Loan Modifications by Financial Institutions Working with Customers Affected by the Coronavirus issued by the federal bank regulatory agencies on April 7, 2020, these deferrals are exempt from TDR status as they meet the specified requirements.

The following table presents the loan portfolio by segment and class, excluding residential mortgage LHFS, at September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
Commercial real estate:
Owner occupied	$	196,585	$	174,908
Non-owner occupied	509,703		409,567
Multi-family	112,002		113,635
Non-owner occupied residential	100,088		114,505
Acquisition and development:
1-4 family residential construction	12,246		9,486
Commercial and land development	71,784		51,826
Commercial and industrial (1)	540,205		647,368
Municipal	13,631		20,523
Residential mortgage:
First lien	203,360		244,321
Home equity - term	7,079		10,169
Home equity - lines of credit	154,004		157,021
Installment and other loans	19,077		26,361
Total loans	$	1,939,764	$	1,979,690

(1) This balance includes $259.9 million and $403.3 million of SBA PPP loans, net of deferred fees and costs, at September 30, 2021 and December 31, 2020, respectively.

In order to monitor ongoing risk associated with its loan portfolio and specific loans within the segments, management uses an internal grading system. The first several rating categories, representing the lowest risk to the Bank, are combined and given a “Pass” rating. Management generally follows regulatory definitions in assigning criticized ratings to loans, including "Special Mention," "Substandard," "Doubtful" or "Loss." The Special Mention category includes loans that have potential

18

weaknesses that may, if not monitored or corrected, weaken the asset or inadequately protect the Bank's position at some future date. These assets pose elevated risk, but their weakness does not yet justify a more severe, or classified rating. Substandard loans are classified as they have a well-defined weakness, or weaknesses that jeopardize liquidation of the debt. These loans are characterized by the distinct possibility that the Bank will sustain some loss if the deficiencies are not corrected. Substandard loans include loans that management has determined not to be impaired, as well as loans considered to be impaired. A Doubtful loan has a high probability of total or substantial loss, but because of specific pending events that may strengthen the asset, its classification as Loss is deferred. Loss loans are considered uncollectible, as the borrowers are often in bankruptcy, have suspended debt repayments, or have ceased business operations. Once a loan is classified as Loss, there is little prospect of collecting the loan’s principal or interest and it is charged-off.

The Company has a loan review policy and program which is designed to identify and monitor risk in the lending function. The Management ERM Committee, comprised of executive officers and loan department personnel, is charged with the oversight of overall credit quality and risk exposure of the Company's loan portfolio. This includes the monitoring of the lending activities of all Company personnel with respect to underwriting and processing new loans and the timely follow-up and corrective action for loans showing signs of deterioration in quality. A loan review program provides the Company with an independent review of the commercial loan portfolio on an ongoing basis. Generally, consumer and residential mortgage loans are included in the Pass categories unless a specific action, such as extended delinquencies, bankruptcy, repossession or death of the borrower occurs, which heightens awareness as to a possible credit event.

Internal loan reviews are completed annually on all commercial relationships with a committed loan balance in excess of $1.0 million, which includes confirmation of risk rating by an independent credit officer. In addition, all commercial relationships greater than $500 thousand rated Substandard, Doubtful or Loss are reviewed quarterly and corresponding risk ratings are reaffirmed by the Company's Problem Loan Committee, with subsequent reporting to the Management ERM Committee and the Board of Directors.

19

The following table summarizes the Company’s loan portfolio ratings based on its internal risk rating system at September 30, 2021 and December 31, 2020:

	Pass		Special Mention		Non-Impaired Substandard		Impaired - Substandard		Doubtful		PCI Loans		Total
September 30, 2021
Commercial real estate:
Owner occupied	$	176,029	$	8,219	$	6,147	$	3,832	$	—	$	2,358	$	196,585
Non-owner occupied	476,947		32,272		168		—		—		316		509,703
Multi-family	91,726		19,662		614		—		—		—		112,002
Non-owner occupied residential	95,338		2,028		1,344		171		—		1,207		100,088
Acquisition and development:
1-4 family residential construction	12,246		—		—		—		—		—		12,246
Commercial and land development	70,648		636		500		—		—		—		71,784
Commercial and industrial	521,530		7,939		5,505		2,941		—		2,290		540,205
Municipal	13,631		—		—		—		—		—		13,631
Residential mortgage:
First lien	195,717		—		240		2,472		—		4,931		203,360
Home equity - term	7,056		—		—		7		—		16		7,079
Home equity - lines of credit	153,436		21		52		495		—		—		154,004
Installment and other loans	19,002		—		—		37		—		38		19,077
	$	1,833,306	$	70,777	$	14,570	$	9,955	$	—	$	11,156	$	1,939,764
December 31, 2020
Commercial real estate:
Owner occupied	$	148,846	$	12,491	$	7,855	$	3,260	$	—	$	2,456	$	174,908
Non-owner occupied	351,860		57,378		—		—		—		329		409,567
Multi-family	92,769		20,224		642		—		—		—		113,635
Non-owner occupied residential	107,557		3,948		1,422		268		—		1,310		114,505
Acquisition and development:
1-4 family residential construction	9,101		385		—		—		—		—		9,486
Commercial and land development	49,832		655		525		814		—		—		51,826
Commercial and industrial	617,213		17,561		6,118		3,639		—		2,837		647,368
Municipal	20,523		—		—		—		—		—		20,523
Residential mortgage:
First lien	236,381		—		—		2,628		—		5,312		244,321
Home equity - term	10,076		—		64		10		—		19		10,169
Home equity - lines of credit	156,264		95		54		608		—		—		157,021
Installment and other loans	26,283		—		—		17		—		61		26,361
	$	1,826,705	$	112,737	$	16,680	$	11,244	$	—	$	12,324	$	1,979,690

For commercial real estate, acquisition and development and commercial and industrial loans, a loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by

20

management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays and payment shortfalls generally are not classified as impaired. Generally, loans that are more than 90 days past due are deemed impaired. Management determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed to determine if the loan should be placed on nonaccrual status. Nonaccrual loans in the commercial and commercial real estate portfolios and any TDRs are, by definition, deemed to be impaired. Impairment is measured on a loan-by-loan basis for commercial, construction and restructured loans by either the present value of the expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price, or the fair value of the collateral if the loan is collateral dependent. A loan is collateral dependent if the repayment of the loan is expected to be provided solely by the underlying collateral. For loans that are deemed to be impaired for extended periods of time, periodic updates on fair values are obtained, which may include updated appraisals. Updated fair values are incorporated into the impairment analysis in the next reporting period.

Loan charge-offs, which may include partial charge-offs, are taken on an impaired loan that is collateral dependent if the loan’s carrying balance exceeds its collateral’s appraised value, the loan has been identified as uncollectible, and it is deemed to be a confirmed loss. Typically, impaired loans with a charge-off or partial charge-off will continue to be considered impaired, unless the note is split into two, and management expects the performing note to continue to perform and is adequately secured. The second, or non-performing note, would be charged-off. Generally, an impaired loan with a partial charge-off may continue to have an impairment reserve on it after the partial charge-off, if factors warrant.

At September 30, 2021 and December 31, 2020, nearly all of the Company’s loan impairments were measured based on the estimated fair value of the collateral securing the loan, except for TDRs. By definition, TDRs are considered impaired. All TDR impairment analyses are initially based on discounted cash flows for those loans. For real estate loans, collateral generally consists of commercial real estate, but in the case of commercial and industrial loans, it could also consist of accounts receivable, inventory, equipment or other business assets. Commercial and industrial loans may also have real estate collateral.

Updated appraisals are generally required every 18 months for classified commercial loans in excess of $250 thousand. The “as is" value provided in the appraisal is often used as the fair value of the collateral in determining impairment, unless circumstances, such as subsequent improvements, approvals, or other circumstances, dictate that another value than that provided by the appraiser is more appropriate.

Generally, impaired commercial loans secured by real estate, other than performing TDRs, are measured at fair value using certified real estate appraisals that had been completed within the last 18 months. Appraised values are discounted for estimated costs to sell the property and other selling considerations to arrive at the property’s fair value. In those situations in which it is determined an updated appraisal is not required for loans individually evaluated for impairment, fair values are based on either an existing appraisal or a discounted cash flow analysis as determined by management. The approaches are discussed below:

•Existing appraisal – if the existing appraisal provides a strong loan-to-value ratio (generally 70% or lower) and, after consideration of market conditions and knowledge of the property and area, it is determined by the Credit Administration staff that there has not been a significant deterioration in the collateral value, the existing certified appraised value may be used. Discounts to the appraised value, as deemed appropriate for selling costs, are factored into the fair value.

•Discounted cash flows – in limited cases, discounted cash flows may be used on projects in which the collateral is liquidated to reduce the borrowings outstanding, and is used to validate collateral values derived from other approaches.

Collateral on certain impaired loans is not limited to real estate, and may consist of accounts receivable, inventory, equipment or other business assets. Estimated fair values are determined based on borrowers’ financial statements, inventory ledgers, accounts receivable aging or appraisals from individuals with knowledge in the business. Stated balances are generally discounted for the age of the financial information or the quality of the assets. In determining fair value, liquidation discounts are applied to this collateral based on existing loan evaluation policies.

The Company distinguishes substandard loans on both an impaired and non-impaired basis, as it places less emphasis on a loan’s classification, and increased reliance on whether the loan was performing in accordance with the contractual terms. A substandard classification does not automatically meet the definition of impaired. Loss potential, while existing in the aggregate amount of substandard loans, does not have to exist in individual extensions of credit classified as substandard. As a result, the Company’s methodology includes an evaluation of certain accruing commercial real estate, acquisition and development, and commercial and industrial loans rated substandard to be collectively evaluated for impairment. Although the Company believes

21

these loans meet the definition of substandard, they are generally performing and management has concluded that it is likely the Company will be able to collect the scheduled payments of principal and interest when due according to the contractual terms of the loan agreement.

Larger groups of smaller balance homogeneous loans are collectively evaluated for impairment. Generally, the Company does not separately identify individual consumer and residential loans for impairment disclosures, unless such loans are the subject of a restructuring agreement due to financial difficulties of the borrower.

The following table, which excludes accruing PCI loans, summarizes impaired loans by segment and class, segregated by those for which a specific allowance was required and those for which a specific allowance was not required at September 30, 2021 and December 31, 2020. The recorded investment in loans excludes accrued interest receivable due to insignificance. Related allowances established generally pertain to those loans in which loan forbearance agreements were in the process of being negotiated or updated appraisals were pending, and any partial charge-off will be recorded when final information is received.

	Impaired Loans with a Specific Allowance						Impaired Loans with No Specific Allowance
	Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)		Related Allowance		Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)
September 30, 2021
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,832	$	4,923
Non-owner occupied residential	—		—		—		171		383
Commercial and industrial	—		—		—		2,941		3,592
Residential mortgage:
First lien	469		469		29		2,003		3,161
Home equity—term	—		—		—		7		10
Home equity—lines of credit	—		—		—		495		733
Installment and other loans	—		—		—		37		37
	$	469	$	469	$	29	$	9,486	$	12,839
December 31, 2020
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,260	$	4,091
Non-owner occupied residential	—		—		—		268		393
Acquisition and development:
Commercial and land development	—		—		—		814		875
Commercial and industrial	—		—		—		3,639		4,269
Residential mortgage:
First lien	424		508		33		2,204		3,264
Home equity—term	—		—		—		10		13
Home equity—lines of credit	—		—		—		608		832
Installment and other loans	—		—		—		17		18
	$	424	$	508	$	33	$	10,820	$	13,755

22

The following table, which excludes accruing PCI loans, summarizes the average recorded investment in impaired loans and related recognized interest income for the three and nine months ended September 30, 2021 and 2020:

	2021				2020
	Average Impaired Balance		Interest Income Recognized		Average Impaired Balance		Interest Income Recognized
Three Months Ended September 30,
Commercial real estate:
Owner-occupied	$	4,179	$	—	$	4,424	$	—
Non-owner occupied	—		—		102		—
Multi-family	—		—		141		—
Non-owner occupied residential	232		—		433		—
Acquisition and development:
Commercial and land development	—		—		837		—
Commercial and industrial	3,073		—		1,044		—
Residential mortgage:
First lien	2,541		11		3,209		12
Home equity – term	10		—		12		—
Home equity - lines of credit	463		—		645		—
Installment and other loans	24		—		17		—
	$	10,522	$	11	$	10,864	$	12
Nine Months Ended September 30,
Commercial real estate:
Owner occupied	$	3,848	$	1	$	5,033	$	1
Non-owner occupied	—		—		108		—
Multi-family	7		—		259		—
Non-owner occupied residential	252		—		422		—
Acquisition and development:
Commercial and land development	246		—		586		—
Commercial and industrial	3,046		—		1,316		—
Residential mortgage:
First lien	2,575		32		3,050		36
Home equity - term	12		—		12		—
Home equity - lines of credit	547		—		699		1
Installment and other loans	17		—		29		—
	$	10,550	$	33	$	11,514	$	38

23

The following table presents impaired loans that are TDRs, with the recorded investment at September 30, 2021 and December 31, 2020:

	September 30, 2021			December 31, 2020
	Number of Contracts	Recorded Investment		Number of Contracts	Recorded Investment
Accruing:
Commercial real estate:
Owner occupied	1	$	26	1	$	28
Residential mortgage:
First lien	8	813		9	898
Home equity - lines of credit	—	—		1	8
	9	839		11	934
Nonaccruing:
Residential mortgage:
First lien	5	291		5	320
	5	291		5	320
	14	$	1,130	16	$	1,254

There were no new TDR's for the three and nine months ended September 30, 2021 or 2020.

24

Management further monitors the performance and credit quality of the loan portfolio by analyzing the length of time a portfolio is past due, by aggregating loans based on its delinquencies. The following table presents the classes of loan portfolio summarized by aging categories of performing loans and nonaccrual loans at September 30, 2021 and December 31, 2020:

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
September 30, 2021
Commercial real estate:
Owner occupied	$	190,183	$	238	$	—	$	—	$	238	$	3,806	$	194,227
Non-owner occupied	509,387		—		—		—		—		—		509,387
Multi-family	112,002		—		—		—		—		—		112,002
Non-owner occupied residential	98,459		—		251		—		251		171		98,881
Acquisition and development:
1-4 family residential construction	12,246		—		—		—		—		—		12,246
Commercial and land development	71,774		10		—		—		10		—		71,784
Commercial and industrial	534,967		7		—		—		7		2,941		537,915
Municipal	13,631		—		—		—		—		—		13,631
Residential mortgage:
First lien	196,076		341		318		35		694		1,659		198,429
Home equity - term	7,041		15		—		—		15		7		7,063
Home equity - lines of credit	153,266		208		35		—		243		495		154,004
Installment and other loans	18,891		70		41		—		111		37		19,039
Subtotal	1,917,923		889		645		35		1,569		9,116		1,928,608
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,358		—		—		—		—		—		2,358
Non-owner occupied	316		—		—		—		—		—		316
Non-owner occupied residential	1,081		—		—		126		126		—		1,207
Commercial and industrial	2,290		—		—		—		—		—		2,290
Residential mortgage:
First lien	4,730		—		—		201		201		—		4,931
Home equity - term	16		—		—		—		—		—		16
Installment and other loans	38		—		—		—		—		—		38
Subtotal	10,829		—		—		327		327		—		11,156
	$	1,928,752	$	889	$	645	$	362	$	1,896	$	9,116	$	1,939,764

25

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
December 31, 2020
Commercial real estate:
Owner occupied	$	168,262	$	958	$	—	$	—	$	958	$	3,232	$	172,452
Non-owner occupied	409,130		108		—		—		108		—		409,238
Multi-family	113,635		—		—		—		—		—		113,635
Non-owner occupied residential	112,443		484		—		—		484		268		113,195
Acquisition and development:
1-4 family residential construction	9,486		—		—		—		—		—		9,486
Commercial and land development	50,922		32		58		—		90		814		51,826
Commercial and industrial	640,573		9		310		—		319		3,639		644,531
Municipal	19,677		846		—		—		846		—		20,523
Residential mortgage:
First lien	230,903		5,758		535		83		6,376		1,730		239,009
Home equity - term	10,099		40		—		1		41		10		10,150
Home equity - lines of credit	156,153		268		—		—		268		600		157,021
Installment and other loans	26,052		168		49		14		231		17		26,300
Subtotal	1,947,335		8,671		952		98		9,721		10,310		1,967,366
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,456		—		—		—		—		—		2,456
Non-owner occupied	329		—		—		—		—		—		329
Non-owner occupied residential	1,161		—		—		149		149		—		1,310
Commercial and industrial	2,837		—		—		—		—		—		2,837
Residential mortgage:
First lien	4,341		655		9		307		971		—		5,312
Home equity - term	19		—		—		—		—		—		19
Installment and other loans	57		4		—		—		4		—		61
Subtotal	11,200		659		9		456		1,124		—		12,324
	$	1,958,535	$	9,330	$	961	$	554	$	10,845	$	10,310	$	1,979,690

The Company maintains its ALL at a level management believes adequate for probable incurred credit losses. The ALL is established and maintained through a provision for loan losses charged to earnings. On a quarterly basis, management assesses the adequacy of the ALL utilizing a defined methodology, which considers specific credit evaluation of impaired loans as discussed above, historical loan loss experience, and qualitative factors. Management believes its approach properly addresses relevant accounting guidance for loans individually identified as impaired and for loans collectively evaluated for impairment, and other bank regulatory guidance.

In connection with its quarterly evaluation of the adequacy of the ALL, management reviews its methodology to determine if it properly addresses the current risk in the loan portfolio. For each loan class, general allowances based on quantitative factors, principally historical loss trends, are provided for loans that are collectively evaluated for impairment. An

26

adjustment to historical loss factors may be incorporated for delinquency and other potential risk not elsewhere defined within the ALL methodology.

In addition to this quantitative analysis, adjustments to the ALL requirements are allocated on loans collectively evaluated for impairment based on additional qualitative factors, including:

Nature and Volume of Loans – including loan growth in the current and subsequent quarters based on the Company’s targeted growth and strategic plan, coupled with the types of loans booked based on risk management and credit culture; the number of exceptions to loan policy; and supervisory loan to value exceptions.

Concentrations of Credit and Changes within Credit Concentrations – including the composition of the Company’s overall portfolio makeup and management's evaluation related to concentration risk management and the inherent risk associated with the concentrations identified.

Underwriting Standards and Recovery Practices – including changes to underwriting standards and perceived impact on anticipated losses; trends in the number of exceptions to loan policy; supervisory loan to value exceptions; and administration of loan recovery practices.

Delinquency Trends – including delinquency percentages noted in the portfolio relative to economic conditions; severity of the delinquencies; and whether the ratios are trending upwards or downwards.

Classified Loans Trends – including internal loan ratings of the portfolio; severity of the ratings; whether the loan segment’s ratings show a more favorable or less favorable trend; and underlying market conditions and impact on the collateral values securing the loans.

Experience, Ability and Depth of Management/Lending staff – including the years’ experience of senior and middle management and the lending staff; turnover of the staff; and instances of repeat criticisms of ratings.

Quality of Loan Review – including the years of experience of the loan review staff; in-house versus outsourced provider of review; turnover of staff and the perceived quality of their work in relation to other external information.

National and Local Economic Conditions – including trends in the consumer price index, unemployment rates, the housing price index, housing statistics compared to the prior year, bankruptcy rates, regulatory and legal environment risks and competition.

All factors noted above were evaluated and remained unchanged for the nine months ended September 30, 2021, except for a reduction in the National and Local Economic Conditions qualitative factor during the three months ended March 31, 2021.

COVID-19 – during the nine months ended September 30, 2020, a qualitative allocation was implemented associated with the potential impact of the COVID-19 pandemic on the Company's commercial loan portfolio. The factor assumes downgrades of loans which were granted deferrals or forbearances based upon identified hardships resulting from the economic shutdown driven by the pandemic. The qualitative reserve on these loans was reduced over time as sustained performance was demonstrated after the loans were removed from deferral status or the forbearance period ended. During the three and nine months ended September 30, 2021, this qualitative reserve was reduced by $1.0 million and $2.7 million, respectively. This reserve is zero at September 30, 2021.

27

The following table presents the activity in the ALL for the three and nine months ended September 30, 2021 and 2020:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
Three Months Ended
September 30, 2021
Balance, beginning of period	$	11,315	$	1,243	$	3,495	$	29	$	16,082	$	2,863	$	227	$	3,090	$	209	$	19,381
Provision for loan losses	(179)		290		386		(2)		495		(147)		18		(129)		(1)		365
Charge-offs	(89)		—		(55)		—		(144)		—		(20)		(20)		—		(164)
Recoveries	305		8		60		—		373		5		5		10		—		383
Balance, end of period	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
September 30, 2020
Balance, beginning of period	$	9,347	$	1,069	$	2,916	$	75	$	13,407	$	3,552	$	386	$	3,938	$	172	$	17,517
Provision for loan losses	1,520		(219)		963		(19)		2,245		(71)		18		(53)		8		2,200
Charge-offs	(3)		—		(193)		—		(196)		—		(31)		(31)		—		(227)
Recoveries	171		—		45		—		216		6		13		19		—		235
Balance, end of period	$	11,035	$	850	$	3,731	$	56	$	15,672	$	3,487	$	386	$	3,873	$	180	$	19,725
Nine Months Ended
September 30, 2021
Balance, beginning of period	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151
Provision for loan losses	133		418		109		(13)		647		(578)		(69)		(647)		(10)		(10)
Charge-offs	(270)		—		(621)		—		(891)		(92)		(49)		(141)		—		(1,032)
Recoveries	338		9		456		—		803		29		24		53		—		856
Balance, end of period	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
September 30, 2020
Balance, beginning of period	$	7,634	$	959	$	2,356	$	100	$	11,049	$	3,147	$	319	$	3,466	$	140	$	14,655
Provision for loan losses	2,780		(117)		1,875		(44)		4,494		329		162		491		40		5,025
Charge-offs	(3)		—		(689)		—		(692)		(109)		(117)		(226)		—		(918)
Recoveries	624		8		189		—		821		120		22		142		—		963
Balance, end of period	$	11,035	$	850	$	3,731	$	56	$	15,672	$	3,487	$	386	$	3,873	$	180	$	19,725

28

The following table summarizes the ending loan balance individually evaluated for impairment based upon loan segment, as well as the related ALL loss allocation for each at September 30, 2021 and December 31, 2020. Accruing PCI loans are excluded from loans individually evaluated for impairment.

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
September 30, 2021
Loans allocated by:
Individually evaluated for impairment	$	4,003	$	—	$	2,941	$	—	$	6,944	$	2,974	$	37	$	3,011	$	—	$	9,955
Collectively evaluated for impairment	914,375		84,030		537,264		13,631		1,549,300		361,469		19,040		380,509		—		1,929,809
	$	918,378	$	84,030	$	540,205	$	13,631	$	1,556,244	$	364,443	$	19,077	$	383,520	$	—	$	1,939,764
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	29	$	—	$	29	$	—	$	29
Collectively evaluated for impairment	11,352		1,541		3,886		27		16,806		2,692		230		2,922		208		19,936
	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
December 31, 2020
Loans allocated by:
Individually evaluated for impairment	$	3,528	$	814	$	3,639	$	—	$	7,981	$	3,246	$	17	$	3,263	$	—	$	11,244
Collectively evaluated for impairment	809,087		60,498		643,729		20,523		1,533,837		408,265		26,344		434,609		—		1,968,446
	$	812,615	$	61,312	$	647,368	$	20,523	$	1,541,818	$	411,511	$	26,361	$	437,872	$	—	$	1,979,690
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	33	$	—	$	33	$	—	$	33
Collectively evaluated for impairment	11,151		1,114		3,942		40		16,247		3,329		324		3,653		218		20,118
	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151

The following table provides activity for the accretable yield of PCI loans for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Accretable yield, beginning of period	$	3,016	$	4,182	$	3,438	$	6,950
Additions (1)	—		—		—		570
Accretion of income	(203)		(546)		(878)		(2,459)
Reclassifications from nonaccretable difference due to improvement in expected cash flows	11		139		128		1,260
Other changes, net (2)	(12)		(231)		124		(2,777)
Accretable yield, end of period	$	2,812	$	3,544	$	2,812	$	3,544

(1) The amount for the nine months ended September 30, 2020 reflects a measurement period adjustment for Hamilton loans that should have been in the PCI pool at the acquisition date.

(2) The amount for the nine months ended September 30, 2020 represents the impact of PCI loans sold during that period.

NOTE 4. LEASES

A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. The Company has primarily entered into operating leases for branches and office space. Most of the Company's

29

leases contain renewal options, which the Company is reasonably certain to exercise. Including renewal options, the Company's leases range from seven to 32 years. Operating lease right-of-use assets and lease liabilities are included in other assets and accrued interest and other liabilities on the Company's unaudited condensed consolidated balance sheets.

The Company uses its incremental borrowing rate to determine the present value of the lease payments, as the rate implicit in the Company's leases is not readily determinable. Lease agreements that contain non-lease components are generally accounted for as a single lease component, while variable costs, such as common area maintenance expenses and property taxes, are expensed as incurred.

The following table summarizes the Company's operating leases at September 30, 2021 and December 31, 2020:

	September 30, 2021			December 31, 2020
Operating lease ROU assets	$	9,301		$	8,686
Operating lease ROU liabilities	9,832			9,143
Weighted-average remaining lease term (in years)	16.0			16.8
Weighted-average discount rate	4.2		%	4.3		%

The following table presents information related to the Company's operating leases for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Cash paid for operating lease liabilities	$	331	$	210	$	947	$	847
Operating lease expense	388		421		1,179		1,171

The following table presents expected future maturities of the Company's lease liabilities as of September 30, 2021:

Remainder of 2021	$	296
2022	926
2023	951
2024	974
2025	991
Thereafter	10,387
	14,525
Less: imputed interest	4,693
Total lease liabilities	$	9,832

NOTE 5. GOODWILL AND OTHER INTANGIBLE ASSETS

The following table presents changes in goodwill for the nine months ended September 30, 2021 and 2020:

	September 30, 2021		September 30, 2020
Balance, beginning of year	$	18,724	$	19,925
Adjustments to acquired goodwill (1)	—		(1,201)
Balance, end of period	$	18,724	$	18,724

(1) The Company finalized its purchase accounting adjustments associated with Hamilton as of May 1, 2020.

Goodwill is not amortized but is reviewed for potential impairment on at least an annual basis, with testing between annual tests if an event occurs or circumstances change that could potentially reduce the fair value of a reporting unit.

The Company typically completes its annual goodwill impairment assessment as of November 30. Due to the severe economic impact of COVID-19 and a resulting sustained decline in the Company's market value below book value, management performed a quantitative Step 1 impairment analysis of its goodwill to determine whether the Company's goodwill was impaired as of August 31, 2020. This analysis, which was performed in accordance with ASU 2017-04, Intangibles-Goodwill and Other, considered several factors, such as future cash flow projections and estimated market acquisition

30

premiums in its analysis. In performing the analysis, management made several assumptions with respect to future operating performance, economic and market conditions and various others, many of which required significant judgment. The analysis performed and the related assumptions reflected the best currently available estimates and judgements regarding future performance of the Company. It was concluded that no impairment existed at August 31, 2020 as the calculated fair value of the reporting unit exceeded its book value. No changes have occurred that would impact the results of that analysis through September 30, 2021.

The following table presents changes in other intangible assets for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Beginning of period	$	4,800	$	6,160	$	5,458	$	7,180
Amortization expense	(314)		(357)		(972)		(1,224)
Impairment	—		—		—		(153)
Balance, end of period	$	4,486	$	5,803	$	4,486	$	5,803

No impairment charges were recorded in the three and nine months ended September 30, 2021. During the nine months ended September 30, 2020, the Company recorded an impairment charge of $153 thousand for the full remaining balance attributable to a customer list intangible asset due to the dissolution of Wheatland Advisors, Inc.

The following table presents the components of other identifiable intangible assets at September 30, 2021 and December 31, 2020:

	September 30, 2021				December 31, 2020
	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
Amortized intangible assets:
Core deposit intangibles	$	8,390	$	3,906	$	8,390	$	2,935
Other customer relationship intangibles	25		23		25		22
Total	$	8,415	$	3,929	$	8,415	$	2,957

The following table presents future estimated aggregate amortization expense for intangible assets remaining at September 30, 2021:

Remainder of 2021	$	303
2022	1,105
2023	935
2024	766
2025	596
Thereafter	781
	$	4,486

NOTE 6. SHARE-BASED COMPENSATION PLANS

The Company maintains share-based compensation plans under the shareholder-approved 2011 Plan. The purpose of the share-based compensation plans is to provide officers, employees, and non-employee members of the Board of Directors of the Company with additional incentive to further the success of the Company. 881,920 shares of the common stock of the Company were originally reserved, of which 258,020 shares are available to be issued as of September 30, 2021.

The 2011 Plan incentive awards may consist of grants of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units and performance shares. All employees and members of the Board of Directors of the Company are eligible to participate in the 2011 Plan. The 2011 Plan allows for the Compensation Committee of

31

the Board of Directors to determine the type of incentive to be awarded, its term, manner of exercise, vesting and restrictions on shares. Generally, awards are nonqualified under the IRC, unless the awards are deemed to be incentive awards to employees at the Compensation Committee’s discretion.

The table below presents a summary of nonvested restricted shares activity for the nine months ended September 30, 2021:

	Shares	Weighted Average Grant Date Fair Value
Nonvested shares, beginning of year	245,576	$	21.45
Granted	127,847	19.21
Forfeited	(29,388)	19.69
Vested	(78,588)	23.52
Nonvested shares, at period end	265,447	$	19.92

The following table presents restricted shares compensation expense, with tax benefit information, and fair value of shares vested, for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Restricted share award expense	$	468	$	434	$	1,380	$	1,607
Restricted share award tax benefit	98		91		316		337
Fair value of shares vested	—		225		1,539		1,314

The unrecognized compensation expense related to the share awards totaled $2.6 million at September 30, 2021 and $2.0 million at December 31, 2020. The unrecognized compensation expense at September 30, 2021 is expected to be recognized over a weighted-average period of 1.8 years.

The Company maintains an employee stock purchase plan to provide its employees with an opportunity to purchase Company common stock. Eligible employees may purchase shares in an amount that does not exceed 10% of their annual salary, at the lower of 95% of the fair market value of the shares on the semi-annual offering date or related purchase date. The purchases occur in March and September of each year. The Company reserved 350,000 shares of its common stock to be issued under the employee stock purchase plan. At September 30, 2021, 151,480 shares were available to be issued under the employee stock purchase plan.

The following table presents information for the employee stock purchase plan for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Shares purchased	3,271		4,218		8,755		7,831
Weighted average price of shares purchased	$	19.16	$	13.08	$	15.58	$	14.85
Compensation expense recognized	15		3		48		6

The Company issues either new shares or treasury shares, when available, for award through its share-based compensation plans.

NOTE 7. DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used as risk management tools by the Company to manage differences in the

32

amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings and are not used for trading or speculative purposes.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. The Company, however, discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in accumulated other comprehensive income (loss) are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. During the three months ended September 30, 2021, the Company terminated its interest rate derivative of $50.0 million that was designated as a cash flow hedge of interest-rate risk associated with overnight borrowings due to the unprecedented nature and impact of the COVID-19 pandemic, and reclassified $398.0 thousand of the realized losses from AOCI to current earnings because the hedged forecasted transaction was determined to be no longer probable of occurring. At December 31, 2020, the Company had one interest rate derivative designated as a hedging instrument with an aggregate notional amount of $50.0 million. At September 30, 2021 and December 31, 2020, the Company had cash collateral of zero and $1.7 million held with the counterparty for these derivatives, respectively. The cash collateral was settled with the derivative counterparty upon termination of the cash flow hedge.

The Company enters into interest rate swaps that allow its commercial loan customers to effectively convert a variable-rate commercial loan agreement to a fixed-rate commercial loan agreement. Under these agreements, the Company enters into a variable-rate loan agreement with a customer in addition to an interest rate swap agreement, which serves to effectively swap the customer’s variable-rate loan into a fixed-rate loan. The Company then enters into a corresponding swap agreement with a third party in order to economically hedge its exposure through the customer agreement. The interest rate swaps with both the customers and third parties are not designated as hedges and are marked through earnings. At September 30, 2021, the Company had 11 customer and 11 corresponding third-party broker interest rate derivatives not designated as a hedging instrument with an aggregate notional amount of $64.9 million. The Company had $61.3 million in notional amount of such derivative instruments at December 31, 2020.

The Company entered into a risk participation agreement with a financial institution counterparty (the “Agent Bank”) for an interest rate derivative contract related to a loan in which the Company is a participant. The risk participation agreement provides credit protection to the Agent Bank should the borrower fail to perform on its interest rate derivative contracts with the Agent Bank. The Company received an upfront fee of $53 thousand upon entry into the risk participation agreement in the nine months ended September 30, 2021. The Company manages its credit risk on the risk participation agreement by monitoring the creditworthiness of the borrower, which is based on the same credit review process as though the Company had entered into the derivative instruments directly with the borrower. The notional amount of such risk participation agreement reflects the Company’s pro-rata share of the derivative instrument, consistent with its share of the related participated loan. As of September 30, 2021 and December 31, 2020, the total notional amount of the risk participation agreement was $15.9 million and zero, respectively.

As a part of its normal residential mortgage operations, the Company will enter into an interest rate lock commitment with a potential borrower. The Company will enter into a corresponding commitment with an investor to sell that loan at a specific

33

price shortly after origination. In accordance with FASB ASC 820, adjustments are recorded through earnings to account for the net change in fair value of these transactions.

The following table summarizes the fair value of the Company's derivative instruments at September 30, 2021 and December 31, 2020:

	September 30, 2021					December 31, 2020
	Notional Amount		Balance Sheet Location	Fair Value		Notional Amount		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps - balance sheet hedge	$	—		$	—	$	50,000	Other liabilities	$	(1,230)
Total derivatives designated as hedging instruments				$	—				$	(1,230)
Derivatives not designated as hedging instruments:
Interest rate swap - commercial borrower	$	32,462	Other assets	$	277	$	30,673	Other assets	$	690
Interest rate swap - counterparty	32,462		Other liabilities	(269)		30,673		Other liabilities	(726)
Risk participation	15,855		Other liabilities	(3)		—			—
Interest rate lock commitments with customers	22,025		Other assets	546		22,560		Other assets	673
Forward sale commitment	6,198		Other assets	23		10,400		Other liabilities	(61)
Total derivatives not designated as hedging instruments				$	574				$	576

The following tables summarize the effect of the Company's derivative financial instruments on OCI and net income for the three and nine months ended September 30, 2021 and 2020:

	Amount of (Loss) Gain Recognized in OCI on Derivative				Amount of Gain (Loss) Recognized in OCI on Derivative
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives in cash flow hedging relationships:
Interest rate products	$	(183)	$	208	$	473	$	(1,893)
Total	$	(183)	$	208	$	473	$	(1,893)

	Amount of Loss Reclassified from AOCI into Income				Amount of Loss Reclassified from AOCI into Income				Location of Loss Recognized from AOCI into Income
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives in cash flow hedging relationships:
Interest rate products	$	(581)	$	(114)	$	(757)	$	(239)	Interest expense / Other operating expenses(1)
Total	$	(581)	$	(114)	$	(757)	$	(239)

(1) Includes $514 thousand recorded to other operating expenses due to the loss from the termination of an interest rate swap designated as a cash flow hedge.

34

	Amount of Gain (Loss) Recognized in Income				Amount of Gain (Loss) Recognized in Income				Location of Gain (Loss) Recognized in Income
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives not designated as hedging instruments:
Interest rate products	$	8	$	(4)	$	44	$	(21)	Other operating expenses
Risk participation agreement	1		—		(3)		—		Other operating expenses
Interest rate lock commitments with customers	89		157		(128)		1,040		Mortgage banking activities
Forward sale commitment	1		71		84		(126)		Mortgage banking activities
Total	$	99	$	224	$	(3)	$	893

The following table is a summary of components for interest rate swaps designated as hedging at September 30, 2021 and December 31, 2020. During the three and nine months ended September 30, 2021, the Company terminated its interest rate derivative of $50.0 million.

	September 30, 2021		December 31, 2020
Weighted average pay rate	—	%	0.77	%
Weighted average receive rate	—	%	0.09	%
Weighted average maturity in years	0.0		4.2

NOTE 8. SHAREHOLDERS’ EQUITY AND REGULATORY CAPITAL

Banks and bank holding companies are subject to regulatory capital requirements administered by federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities and certain off-balance sheet items calculated under regulatory accounting practices. Capital amounts and classifications are also subject to qualitative judgments by regulators. Failure to meet capital requirements can initiate regulatory action. Under the Basel Committee on Banking Supervision's capital guidelines for U.S. Banks ("Basel III rules"), an entity must hold a capital conservation buffer above the adequately capitalized risk-based capital ratios. The Company and the Bank have elected not to include net unrealized gain or loss on available for sale securities in computing regulatory capital.

The consolidated asset limit on small bank holding companies is $3.0 billion and a company with assets under that limit is not subject to the FRB consolidated capital rules, but may file reports that include capital amounts and ratios. The Company has elected to file those reports.

Management believes that the Company and the Bank met all capital adequacy requirements to which they are subject at September 30, 2021 and December 31, 2020.

Prompt corrective action regulations provide five classifications: well capitalized, adequately capitalized, undercapitalized, significantly undercapitalized and critically undercapitalized, although these terms are not used to represent overall financial condition. If adequately capitalized, regulatory approval is required to accept brokered deposits. If undercapitalized, capital distributions are limited, as is asset growth and expansion, and capital restoration plans are required. At September 30, 2021, the most recent regulatory notifications categorized the Bank as well capitalized under the regulatory framework for prompt corrective action. There are no conditions or events since that notification that management believes have changed the Bank's classification.

35

The following table presents capital amounts and ratios at September 30, 2021 and December 31, 2020:

	Actual				For Capital Adequacy Purposes (includes applicable capital conservation buffer)				To Be Well Capitalized Under Prompt Corrective Action Provisions
	Amount		Ratio		Amount		Ratio		Amount		Ratio
September 30, 2021
Total risk-based capital:
Orrstown Financial Services, Inc.	$	291,785	15.6	%	$	195,965	10.5	%	n/a		n/a
Orrstown Bank	273,583		14.7	%	195,899		10.5	%	$	186,570	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	238,492		12.8	%	158,639		8.5	%	n/a		n/a
Orrstown Bank	252,238		13.5	%	158,585		8.5	%	149,256		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	238,492		12.8	%	130,644		7.0	%	n/a		n/a
Orrstown Bank	252,238		13.5	%	130,599		7.0	%	121,271		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	238,492		8.3	%	115,630		4.0	%	n/a		n/a
Orrstown Bank	252,238		8.7	%	115,706		4.0	%	144,633		5.0	%
December 31, 2020
Total risk-based capital:
Orrstown Financial Services, Inc.	$	271,184	15.6	%	$	183,099	10.5	%	n/a		n/a
Orrstown Bank	256,376		14.7	%	183,012		10.5	%	$	174,297	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	217,582		12.5	%	148,223		8.5	%	n/a		n/a
Orrstown Bank	234,677		13.5	%	148,152		8.5	%	139,437		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	217,582		12.5	%	122,066		7.0	%	n/a		n/a
Orrstown Bank	234,677		13.5	%	122,008		7.0	%	113,293		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	217,582		8.1	%	108,063		4.0	%	n/a		n/a
Orrstown Bank	234,677		8.7	%	108,148		4.0	%	135,185		5.0	%

In September 2015, the Board of Directors of the Company authorized a share repurchase program under which the Company may repurchase up to 5% of the Company's outstanding shares of common stock, or approximately 416,000 shares, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act of 1934, as amended. On April 19, 2021, the Board of Directors authorized the additional future repurchase of up to 562,000 shares of its outstanding common stock. As of September 30, 2021, 201,518 shares had been repurchased at a total cost of $3.7 million, or $18.26 per share. Common stock available for future repurchase totals approximately 776,482 shares, or 7% of the Company's outstanding common stock at September 30, 2021. When and if appropriate, repurchases may be made in the open market or privately negotiated transactions, depending on market conditions, regulatory requirements and other corporate considerations, as determined by management. Share repurchases may not occur and may be discontinued at any time.

On October 18, 2021, the Board declared a cash dividend of $0.19 per common share, which will be paid on November 8, 2021 to shareholders of record at November 1, 2021.

36

NOTE 9. EARNINGS PER SHARE

The following table presents earnings per share for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net income	$	7,192	$	4,977	$	26,175	$	16,404
Weighted average shares outstanding - basic	10,979		10,941		10,976		10,939
Dilutive effect of share-based compensation	143		84		127		88
Weighted average shares outstanding - diluted	11,122		11,025		11,103		11,027
Per share information:
Basic earnings per share	$	0.66	$	0.45	$	2.38	$	1.50
Diluted earnings per share	0.65		0.45		2.36		1.49

Average outstanding stock options totaling 0 and 6,110 for the three months ended September 30, 2021 and 2020, respectively, and 0 and 21,479 for the nine months ended September 30, 2021 and 2020, respectively, were not included in the computation of earnings per share because the effect was antidilutive. The dilutive effect of share-based compensation in each period above relates principally to restricted stock awards.

NOTE 10. FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK

The Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. Those instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the unaudited condensed consolidated balance sheets. The contract amounts of those instruments reflect the extent of involvement the Company has in particular classes of financial instruments.

The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit and financial guarantees written is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments. The following table presents these contractual, or notional, amounts:

	Contractual or Notional Amount
	September 30, 2021		December 31, 2020
Commitments to fund:
Home equity lines of credit	$	251,607	$	223,216
1-4 family residential construction loans	35,519		28,928
Commercial real estate, construction and land development loans	122,850		60,606
Commercial, industrial and other loans	339,569		268,931
Standby letters of credit	21,423		14,491

Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each customer’s credit-worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the customer. Collateral varies but may include accounts receivable, inventory, equipment, residential real estate, and income-producing commercial properties.

Standby letters of credit and financial guarantees written are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loans to customers. The Company holds collateral supporting those commitments when deemed necessary by management. The liability, at September 30, 2021 and December 31, 2020, for guarantees under standby letters of credit issued was not considered to be material.

37

The Company maintains a reserve, based on historical loss experience of the related loan class and utilization assumptions, for off-balance sheet credit exposures that currently are not funded, in other liabilities on the unaudited condensed consolidated balance sheets. A review of historical loss and line utilization experience in the nine months ended September 30, 2021 resulted in a reduction of loss and utilization assumptions from prior periods. This reserve totaled $1.4 million at September 30, 2021 and $1.5 million at December 31, 2020.

NOTE 11. FAIR VALUE

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Certain financial instruments and all non-financial instruments are excluded from disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company.

The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are:

Level 1 – quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access at the measurement date.

Level 2 – significant other observable inputs other than Level 1 prices such as prices for similar assets and liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 – at least one significant unobservable input that reflects a company's own assumptions about the assumptions that market participants would use in pricing an asset or liability.

In instances in which multiple levels of inputs are used to measure fair value, hierarchy classification is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

The Company used the following methods and significant assumptions to estimate fair value for instruments measured on a recurring basis:

Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, securities are classified within Level 2 and fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flow. Level 2 securities include U.S. agency securities, mortgage-backed securities, obligations of states and political subdivisions and certain corporate, asset backed and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy. The Company’s investment securities are classified as available for sale.

The fair values of interest rate swaps and risk participation derivatives are determined using models that incorporate readily observable market data into a market standard methodology. This methodology nets the discounted future cash receipts and the discounted expected cash payments. The discounted variable cash receipts and payments are based on expectations of future interest rates derived from observable market interest rate curves. In addition, fair value is adjusted for the effect of nonperformance risk by incorporating credit valuation adjustments for the Company and its counterparties. These assets and liabilities are classified as Level 2 fair values, based upon the lowest level of input that is significant to the fair value measurements.

38

The following table summarizes assets measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
September 30, 2021
Financial Assets
Investment securities:
U.S. Treasury securities	$	19,831	$	—	$	—	$	19,831
States and political subdivisions	—		171,304		10,217		181,521
GSE residential MBSs	—		20,518		—		20,518
GSE residential CMOs	—		70,187		—		70,187
Nonagency CMOs	—		12,400		13,257		25,657
Asset-backed	—		126,907		—		126,907
Other	397		—		—		397
Loans held for sale	—		6,412		—		6,412
Derivatives	—		277		546		823
Totals	$	20,228	$	408,005	$	24,020	$	452,253
Financial Liabilities
Derivatives	$	—	$	272	$	—	$	272
December 31, 2020
Financial Assets
Investment securities:
States and political subdivisions	$	—	$	103,591	$	9,079	$	112,670
GSE residential MBSs	—		4,293		—		4,293
GSE residential CMOs	—		58,011		—		58,011
Nonagency CMOs	—		—		16,918		16,918
Private label commercial CMOs	—		56,730		5,506		62,236
Asset-backed	—		211,966		—		211,966
Other	371		—		—		371
Loans held for sale	—		11,734		—		11,734
Derivatives	—		690		673		1,363
Totals	$	371	$	447,015	$	32,176	$	479,562
Financial Liabilities
Derivatives	$	—	$	1,956	$	—	$	1,956

The Company had one municipal bond and one CMO measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at September 30, 2021. At December 31, 2020, this municipal bond as well as three CMOs were measured on a recurring basis using Level 3 unobservable inputs. One of the CMOs held at December 31, 2020 was sold and one was called in the nine months ended September 30, 2021. The Level 3 valuation is based on a non-executable broker quote, which is considered a significant unobservable input. Such quotes are updated as available and may remain constant for a period of time for certain broker-quoted securities that do not move with the market or that are not interest rate sensitive as a result of their structure or overall attributes.

The Company’s residential mortgage loans held for sale are recorded at fair value utilizing Level 2 measurements. This fair value measurement is determined based upon third party quotes obtained on similar loans. For loans held for sale for which the fair value option has been elected, the aggregate fair value exceeded the aggregate principal balance by $151 thousand as of September 30, 2021.

The determination of the fair value of interest rate lock commitments on residential mortgages is based on agreed upon pricing with the respective investor on each loan and includes a pull through percentage. The pull through percentage represents an estimate of loans in the pipeline to be delivered to an investor versus the total loans committed for delivery. Significant changes in this input could result in a significantly higher or lower fair value measurement. As the pull through percentage is a

39

significant unobservable input, this is deemed a Level 3 valuation input. The average pull through percentage, which is based upon historical experience, was 89% as of September 30, 2021. An increase or decrease of 5% in the pull through assumption would result in a positive or negative change of $26 thousand in the fair value of interest rate lock commitments at September 30, 2021.

The following provides details of the Level 3 fair value measurement activity for the periods ended September 30, 2021 and 2020:

Investment securities:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Balance, beginning of period	$	24,925	$	23,834	$	31,503	$	24,279
Unrealized (loss) gain included in OCI	(964)		200		467		(229)
Principal payments and other	(487)		(142)		(4,951)		(158)
Sales	—		—		(3,545)		—
Balance, end of period	$	23,474	$	23,892	$	23,474	$	23,892

Interest rate lock commitments on residential mortgages:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Balance, beginning of period	$	456	$	986	$	673	$	103
Total gains (losses)
Included in earnings	90		157		(127)		1,040
Balance, end of period	$	546	$	1,143	$	546	$	1,143

Certain financial assets are measured at fair value on a nonrecurring basis. Adjustments to the fair value of these assets usually results from the application of lower of cost or market accounting or write-downs of individual assets. The Company used the following methods and significant assumptions to estimate fair value for these financial assets.

Impaired Loans

Loans are designated as impaired when, in the judgment of management and based on current information and events, it is probable that all amounts due, according to the contractual terms of the loan agreement, will not be collected. The measurement of loss associated with impaired loans for all loan classes can be based on either the observable market price of the loan, the fair value of the collateral, or discounted cash flows using the rate of return implicit in the original loan for TDRs. For collateral-dependent loans, fair value is measured based on the value of the collateral securing the loan, less estimated costs to sell. Collateral may be in the form of real estate or business assets including equipment, inventory, and accounts receivable. The value of the real estate collateral is determined utilizing an income or market valuation approach based on an appraisal conducted by an independent, licensed appraiser outside of the Company using observable market data (Level 2). However, if the collateral is a house or building in the process of construction, or if management adjusts the appraisal value, then the fair value is considered Level 3. The value of business equipment is based upon an outside appraisal, if deemed significant, or the net book value on the applicable business’ financial statements if not considered significant using observable market data. Likewise, values for inventory and accounts receivable collateral are based on financial statement balances or aging reports (Level 3). Impaired loans with an allocation to the ALL are measured at fair value on a nonrecurring basis. Any fair value adjustments are recorded in the period incurred as provision for loan losses on the unaudited condensed consolidated statements of income.

Any changes in the fair value of impaired loans still held were not material for the three and nine months ended September 30, 2021 and 2020.

Foreclosed Real Estate

OREO property acquired through foreclosure is initially recorded at the fair value of the property at the transfer date less estimated selling cost. Subsequently, OREO is carried at the lower of its carrying value or the fair value less estimated selling

40

cost. Fair value is usually determined based upon an independent third-party appraisal of the property or occasionally upon a recent sales offer. The Company had no OREO balances at September 30, 2021 and December 31, 2020.

Mortgage Servicing Rights

The MSR fair value is estimated to be equal to its carrying value, unless the quarterly valuation model calculates the present value of the estimated net servicing income is less than its carrying value, in which case an impairment charge is taken. At September 30, 2021 and December 31, 2020, an impairment reserve of $372 thousand and $1.1 million, respectively, existed on the mortgage servicing right portfolio. For the three months ended September 30, 2021 and 2020, an impairment valuation allowance reversal of $43 thousand and an impairment charge of $166 thousand were included, respectively, in mortgage banking activities on the unaudited condensed consolidated statements of income. For the nine months ended September 30, 2021 and 2020, an impairment valuation allowance reversal of $695 thousand and an impairment charge of $986 thousand, respectively, were included in mortgage banking activities on the unaudited condensed consolidated statements of income. The impairment charges in 2020 resulted from rapidly declining market rates caused by the COVID-19 pandemic. The reversals in the three and nine months ended September 30, 2021 were due to a subsequent increase in market rates.

The following table summarizes assets measured at fair value on a nonrecurring basis at September 30, 2021 and December 31, 2020:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
September 30, 2021
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	776	$	776
Non-owner occupied residential	—		—		69		69
Residential mortgage:
First lien	—		—		677		677
Home equity - lines of credit	—		—		77		77
Total impaired loans	$	—	$	—	$	1,599	$	1,599
Mortgage servicing rights	$	—	$	—	$	3,642	$	3,642
December 31, 2020
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	846	$	846
Non-owner occupied residential	—		—		36		36
Commercial and industrial	—		—		12		12
Residential mortgage:
First lien	—		—		638		638
Home equity - lines of credit	—		—		89		89
Total impaired loans	$	—	$	—	$	1,621	$	1,621
Mortgage servicing rights	$	—	$	—	$	2,745	$	2,745

41

The following table presents additional qualitative information about assets measured on a nonrecurring basis and for which the Company has utilized Level 3 inputs to determine fair value:

	Fair Value Estimate		Valuation Techniques	Unobservable Input	Range
September 30, 2021
Impaired loans	$	1,599	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	10% - 25% discount
				- Management adjustments for liquidation expenses	6% - 18% discount
Mortgage servicing rights	$	3,642	Discounted cash flows	Weighted average CPR	14.53%
				- Weighted average discount rate	9.04%
December 31, 2020
Impaired loans	$	1,621	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	5% - 25% discount
				- Management adjustments for liquidation expenses	6% - 19% discount
Mortgage servicing rights	$	2,745	Discounted cash flows	Weighted average CPR	18.02%
				- Weighted average discount rate	9.56%

42

Fair values of financial instruments

The following table presents carrying amounts and estimated fair values of the Company’s financial instruments at September 30, 2021 and December 31, 2020:

	Carrying Amount		Fair Value		Level 1		Level 2		Level 3
September 30, 2021
Financial Assets
Cash and due from banks	$	36,920	$	36,920	$	36,920	$	—	$	—
Interest-bearing deposits with banks	274,495		274,495		274,495		—		—
Restricted investments in bank stocks	7,051		n/a		n/a		n/a		n/a
Investment securities	445,018		445,018		20,228		401,316		23,474
Loans held for sale	6,412		6,412		—		6,412		—
Loans, net of allowance for loan losses	1,919,799		1,917,091		—		—		1,917,091
Derivatives	823		823		—		277		546
Accrued interest receivable	8,015		8,015		—		2,169		5,846
Financial Liabilities
Deposits	2,502,108		2,503,695		—		2,503,695		—
Securities sold under agreements to repurchase	27,595		27,595		—		27,595		—
FHLB advances and other	2,003		2,176		—		2,176		—
Subordinated notes	31,948		32,781		—		32,781		—
Derivatives	272		272		—		272		—
Accrued interest payable	631		631		—		631		—
Off-balance sheet instruments	—		—		—		—		—
December 31, 2020
Financial Assets
Cash and due from banks	$	26,203	$	26,203	$	26,203	$	—	$	—
Interest-bearing deposits with banks	99,055		99,055		99,055		—		—
Restricted investments in bank stocks	10,563		n/a		n/a		n/a		n/a
Investment securities	466,465		466,465		371		434,591		31,503
Loans held for sale	11,734		11,734		—		11,734		—
Loans, net of allowance for loan losses	1,959,539		1,953,860		—		—		1,953,860
Derivatives	1,363		1,363		—		690		673
Accrued interest receivable	8,927		8,927		—		1,529		7,398
Financial Liabilities
Deposits	2,356,880		2,359,317		—		2,359,317		—
Securities sold under agreements to repurchase	19,466		19,466		—		19,466		—
FHLB advances and other	58,045		58,298		—		58,298		—
Subordinated notes	31,903		31,712		—		31,712		—
Derivatives	1,956		1,956		—		1,956		—
Accrued interest payable	238		238		—		238		—
Off-balance sheet instruments	—		—		—		—		—

The methods used to estimate the fair value of financial instruments at September 30, 2021 and December 31, 2020 did not necessarily represent an exit price. In accordance with the Company's adoption of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, the methods utilized to measure the fair value of financial instruments at September 30, 2021 and December 31, 2020 represent an approximation of exit price; however, an actual exit price may differ.

43

NOTE 12. CONTINGENCIES

The nature of the Company’s business generates a certain amount of litigation involving matters arising out of the ordinary course of business. Except as described below, in the opinion of management, there are no legal proceedings that might have a material effect on the results of operations, liquidity, or the financial position of the Company at this time.

On March 5, 2019, Paul Parshall, a purported individual stockholder of Hamilton, filed, on behalf of himself and all of Hamilton’s stockholders other than the named defendants and their affiliates (the “Purported Class”), a derivative and putative class action complaint in the Circuit Court for Baltimore City, Maryland, captioned Paul Parshall v. Carol Coughlin et. al., naming each Hamilton director, Orrstown, and Hamilton as defendants (the “Action”). The Action alleged, among other things, that Hamilton’s directors breached their fiduciary duties to the Purported Class in connection with the merger, and that the Proxy Statement/Prospectus omitted certain material information regarding the merger. Orrstown was alleged to have aided and abetted the Hamilton directors’ alleged breaches of their fiduciary duties. The Action sought, among other remedies, to enjoin the merger or, in the event the merger was completed, rescission of the merger or rescissory damages; unspecified damages; and costs of the lawsuit, including attorneys’ and experts’ fees. A settlement was reached on the Action in March 2020 which resulted in a payment by the Company of $135 thousand in mootness fees to the defendants in April 2020.

On May 25, 2012, SEPTA filed a putative class action complaint in the U.S. District Court for the Middle District of Pennsylvania against the Company, the Bank and certain current and former directors and officers (collectively, the “Orrstown Defendants”). The complaint alleged, among other things, that (i) in connection with the Company’s Registration Statement on Form S-3 dated February 23, 2010 and its Prospectus Supplement dated March 23, 2010, and (ii) during the purported class period of March 24, 2010 through October 27, 2011, the Company issued materially false and misleading statements regarding the Company’s lending practices and financial results, including misleading statements concerning the stringent nature of the Bank’s credit practices and underwriting standards, the quality of its loan portfolio, and the intended use of the proceeds from the Company’s March 2010 public offering of common stock. The complaint asserted claims under Sections 11, 12(a) and 15 of the Securities Act of 1933, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, and sought class certification, unspecified money damages, interest, costs, fees and equitable or injunctive relief. Under the Private Securities Litigation Reform Act of 1995 (“PSLRA”), the Court appointed SEPTA Lead Plaintiff on August 20, 2012.

On March 4, 2013, SEPTA filed an amended complaint. The amended complaint expanded the list of defendants in the action to include the Company’s former independent registered public accounting firm, Smith Elliott Kearns & Company, LLC (“SEK”), and the underwriters of the Company’s March 2010 public offering of common stock. In addition, among other things, the amended complaint extended the purported 1934 Exchange Act class period from March 15, 2010 through April 5, 2012.

On June 22, 2015, in a 96-page Memorandum, the Court dismissed without prejudice SEPTA’s amended complaint against all defendants, finding that SEPTA failed to state a claim under either the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. On February 8, 2016, the Court granted SEPTA’s motion for leave to amend again and SEPTA filed its second amended complaint that same day.

On December 7, 2016, the Court issued an Order and Memorandum granting in part and denying in part defendants’ motions to dismiss SEPTA’s second amended complaint. The Court granted the motions to dismiss the Securities Act claims against all defendants, and granted the motions to dismiss the Exchange Act Section 10(b) and Rule 10b-5 claims against all defendants except Orrstown Financial Services, Inc., Orrstown Bank, Thomas R. Quinn, Jr., Bradley S. Everly, and Jeffrey W. Embly. The Court also denied the motions to dismiss the Exchange Act Section 20(a) claims against Quinn, Everly, and Embly.

On December 15, 2017, the Orrstown Defendants and SEPTA exchanged expert reports in opposition to and in support of class certification, respectively. On January 15, 2018, the parties exchanged expert rebuttal reports. SEPTA has not yet filed a motion for class certification.

On August 9, 2018, SEPTA filed a motion to compel the production of Confidential Supervisory Information (CSI) of non-parties the Board of Governors of the FRB and the Pennsylvania Department of Banking and Securities, in the possession of Orrstown and third parties. On August 30, 2018, the FRB filed an unopposed motion to intervene in the Action for the purpose of opposing SEPTA’s motion to compel. On February 12, 2019, the Court denied SEPTA’s motion to compel the production of CSI on the ground that SEPTA had failed to exhaust its administrative remedies.

On April 11, 2019, SEPTA filed a motion for leave to file a third amended complaint. The proposed third amended complaint seeks to reassert the Securities Act claims that the Court dismissed as to all defendants on December 7, 2016, when the Court granted in part and denied in part defendants’ motions to dismiss SEPTA’s second amended complaint. The proposed

44

third amended complaint also seeks to reassert the Exchange Act claims against those defendants that the Court dismissed from the case on December 7, 2016.

On June 13, 2019, Orrstown filed a motion for protective order to stay discovery pending resolution of SEPTA’s motion for leave to file a third amended complaint. On July 17, 2019, the Court entered an Order partially granting Orrstown’s motion for protective order, ruling that all deposition discovery in the case was stayed pending a decision on SEPTA’s motion for leave to file a third amended complaint. Party and non-party document discovery in the case has largely been completed.

On February 14, 2020, the Court issued an Order and Memorandum granting SEPTA’s motion for leave to file a third amended complaint. The third amended complaint is now the operative complaint. It reinstates the Orrstown Defendants, as well as SEK and the underwriter defendants, previously dismissed from the case on December 7, 2016. The third amended complaint also revives the previously dismissed Securities Act claim against the Orrstown Defendants, SEK, and the underwriter defendants. Defendants filed their motions to dismiss the third amended complaint on April 24, 2020. SEPTA’s opposition was filed on July 8, 2020, and Orrstown’s reply brief was filed on August 12, 2020.

Additionally, on February 24, 2020, the Orrstown Defendants, and the underwriter defendants and SEK, separately filed motions under 28 U.S.C. § 1292(b) asking the District Court to certify its February 14, 2020 Order granting leave to file the third amended complaint for interlocutory appeal to the Third Circuit Court of Appeals. The District Court granted those motions on July 17, 2020, and defendants filed their Petition for Permission to Appeal with the Third Circuit on July 27, 2020. The Third Circuit granted permission to appeal the Order pursuant to 28 U.S.C. § 1292(b) on August 13, 2020. Defendants filed their joint Opening Brief in the Third Circuit on November 2, 2020, asking the Court to reverse the district court’s Order. SEPTA filed its responsive brief on December 2, 2020 and defendants filed their reply brief on December 23, 2020. Oral argument was held on February 10, 2021. On September 2, 2021, the Third Circuit affirmed the District Court's February 14, 2020 Order granting SEPTA leave to file a third amended complaint. Defendants' motions to dismiss the third amended complaint are still pending in the District Court.

The Company believes that SEPTA’s allegations and claims against the defendants are without merit, and the Company and intends to defend itself vigorously against those claims. It is not possible at this time to reasonably estimate possible losses, or even a range of reasonably possible losses, in connection with the litigation.

45

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is intended to assist readers in understanding the consolidated financial condition and results of operations of Orrstown and should be read in conjunction with the preceding unaudited condensed consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q, as well as with the audited consolidated financial statements and notes thereto for the year ended December 31, 2020, included in our Annual Report on Form 10-K. Throughout this discussion, the yield on earning assets is stated on a fully taxable-equivalent basis and balances represent average daily balances unless otherwise stated. Certain prior period amounts presented in this discussion and analysis have been reclassified to conform to current period classifications.

Overview

The Company, headquartered in Shippensburg, Pennsylvania, is a one-bank holding company that has elected status as a financial holding company. The consolidated financial information presented herein reflects the Company and its wholly-owned subsidiary, the Bank. At September 30, 2021, the Company had total assets of $2.9 billion, total liabilities of $2.6 billion and total shareholders’ equity of $268.6 million.

Caution About Forward-Looking Statements

Certain statements appearing herein, which are not historical in nature, may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, we may make other written and oral communications, from time to time, that contain such statements. Such forward-looking statements refer to a future period or periods, reflecting our current beliefs as to likely future developments, and use words like “may,” “will,” “expect,” “estimate,” “anticipate” or similar terms. Forward-looking statements are statements that include projections, predictions, expectations, estimates or beliefs about events or results or otherwise are not statements of historical facts, including, but not limited to, statements related to new business development, new loan opportunities, growth in the balance sheet and fee-based revenue lines of business, merger and acquisition activity, reducing risk assets, and mitigating losses in the future. Actual results and trends could differ materially from those set forth in such statements and there can be no assurances that we will achieve the desired level of new business development and new loans, growth in the balance sheet and fee-based revenue lines of business, successful merger and acquisition activity, continue to reduce risk assets or mitigate losses in the future. In addition to risks and uncertainties related to the COVID-19 pandemic (including those related to variants, such as the delta variant) and resulting governmental and societal responses, factors that could cause actual results to differ from those expressed or implied by the forward-looking statements include, but are not limited to, the following: ineffectiveness of the Company’s strategic growth plan due to changes in current or future market conditions; the effects of competition and how it may impact our community banking model, including industry consolidation and development of competing financial products and services; the integration of the Company's strategic acquisitions; the inability to fully achieve expected savings, efficiencies or synergies from mergers and acquisitions, or taking longer than estimated for such savings, efficiencies and synergies to be realized; changes in laws and regulations; interest rate movements; changes in credit quality; inability to raise capital, if necessary, under favorable conditions; volatility in the securities markets; the demand for our products and services; deteriorating economic conditions; operational risks including, but not limited to, cybersecurity incidents, fraud, natural disasters and future pandemics; expenses associated with pending litigation and legal proceedings; the failure of the SBA to honor its guarantee of loans issued under the SBA PPP; the timing of the repayment of SBA PPP loans and the impact it has on fee recognition; our ability to convert new relationships gained through the SBA PPP efforts to full banking relationships; and other risks and uncertainties, including those detailed in our Annual Report on Form 10-K for the year ended December 31, 2020, and our Quarterly Reports on Form 10-Q under the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in other filings made with the SEC. The statements are valid only as of the date hereof and we disclaim any obligation to update this information.

Economic Climate and Market Conditions

Preliminary real GDP for the third quarter of 2021 reflected an annualized increase of 2.0%. This is a decrease from the second quarter 2021 growth rate of 6.7% and annualized growth of 4.3% for the fourth quarter of 2020. The decrease in the third quarter was driven by tapering in personal consumption expenditures of goods, notably motor vehicles and parts, and a slowdown in food services and accommodations from recent quarters. In the second quarter of 2021, the increase in the rate reflected the reopening of businesses and ongoing government efforts related to COVID-19, yet during the third quarter, new restrictions and delays have occurred in certain regions of the country resulting from an increase in COVID-19 cases. Also, during the third quarter, there was a decrease in federal government spending on unemployment insurance, payments to households established in response to the COVID-19 pandemic and the expiration of processing and administration of PPP loan

46

applications. Offsetting these decreases were increases in wholesale and retail trade and services related to transportation and health care. The national unemployment rate declined to 4.8% in September 2021 from 5.9% in June 2021 and from 6.7% in December 2020. There were notable job gains in leisure and hospitality, education, professional and business services, retail trade and transportation and warehousing.

Due to the COVID-19 pandemic, market interest rates have declined significantly, with the 10-year Treasury bond falling for the first time below 1.00% on March 3, 2020; it was at 0.93% on December 31, 2020 and has since recovered to 1.49% as of September 30, 2021. In 2020, in reaction to the increase in uncertainty, the Federal Reserve cut the Fed Funds rates by 150 basis points to 0% to 0.25%. In its most recent meeting in September 2021, the Federal Reserve Open Markets Committee left the Fed Funds rate unchanged with rates expected to remain at this level for an extended period of time. The Committee recognized the progress with vaccinations to reduce the spread of the COVID-19 virus and its effect on economic activity and employment. However, uncertainty remains with respect to the economic outlook. The Committee has indicated that they will not increase rates until the recovery achieves maximum employment and inflation has reached 2% and longer-term inflation expectations are maintained above 2%. Also, the Committee has directed the Open Markets Desk to increase its holdings of U.S. Treasury securities and agency mortgage-backed securities to sustain smooth functioning of markets for these securities. These low interest rates and other effects of the COVID-19 pandemic may adversely affect the Company's financial condition and results of operations in future periods. It is unknown how long the adverse conditions associated with the COVID-19 pandemic will last and what the complete financial effect will be to the Company. It is reasonably foreseeable that estimates made in the financial statements could be materially and adversely impacted in the near term as a result of these conditions, including expected credit losses on loans and the fair value of financial instruments that are carried at fair value.

Critical Accounting Estimates

The Company’s accounting and reporting policies are in accordance with GAAP and follow accounting and reporting guidelines prescribed by bank regulatory authorities and general practices within the financial services industry in which it operates. Our financial position and results of operations are affected by management's application of accounting policies, including estimates, and assumptions and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates, assumptions, and judgments are based on information available as of the balance sheet date and through the date the financial statements are filed with the SEC. Different assumptions in the application of these policies could result in material changes in the consolidated financial position and/or consolidated results of operations and related disclosures. The more critical accounting estimates include accounting for credit losses and valuation methodologies. Accordingly, these critical accounting estimates are discussed in detail in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2020. Significant accounting policies and any changes in accounting principles and effects of new accounting pronouncements are discussed in Note 1, Summary of Significant Accounting Policies, to the Consolidated Financial Statements under Part II, Item 8, "Financial Statements and Supplementary Data," in our Annual Report on Form 10-K for the year ended December 31, 2020. Additional disclosures regarding the effects of new accounting pronouncements are included in this report in Note 1, Summary of Significant Accounting Policies, to the unaudited condensed consolidated financial statements under Part I, Item 1, "Financial Information."

RESULTS OF OPERATIONS

Three months ended September 30, 2021 compared with three months ended September 30, 2020

Summary

Net income totaled $7.2 million for the three months ended September 30, 2021 compared with net income of $5.0 million for the same period in 2020. Diluted earnings per share for the three months ended September 30, 2021 totaled $0.65 compared with $0.45 for the three months ended September 30, 2020. Net interest income totaled $20.6 million for the three months ended September 30, 2021, a $0.2 million decrease from $20.8 million in the three months ended September 30, 2020. Noninterest income totaled $7.7 million for the three months ended September 30, 2021 compared with $6.9 million in the three months ended September 30, 2020. Noninterest expenses totaled $19.0 million and $19.3 million for the three months ended September 30, 2021 and 2020, respectively.

Net Interest Income

Net interest income decreased by $0.2 million, from $20.8 million to $20.6 million, for the three months ended September 30, 2021 compared with the three months ended September 30, 2020. Interest income on loans decreased by $1.7

47

million, from $21.6 million to $19.9 million, and investment securities interest income decreased by $0.4 million, from $2.6 million to $2.2 million. These decreases were mostly offset by the decrease of $1.8 million in total interest expense from $3.4 million to $1.6 million in comparing the three months ended September 30, 2021 with the three months ended September 30, 2020.

The following table presents net interest income, net interest spread and net interest margin for the three months ended September 30, 2021 and 2020 on a taxable-equivalent basis:

	Three Months Ended September 30, 2021						Three Months Ended September 30, 2020
	Average Balance		Taxable- Equivalent Interest		Taxable- Equivalent Rate		Average Balance		Taxable- Equivalent Interest		Taxable- Equivalent Rate
Assets
Federal funds sold & interest-bearing bank balances	$	347,242	$	135	0.15	%	$	31,087	$	9	0.12	%
Investment securities (1)	464,417		2,339		2.00		496,107		2,673		2.14
Loans (1)(2)(3)	1,919,926		19,945		4.12		2,054,193		21,741		4.21
Total interest-earning assets	2,731,585		22,419		3.26		2,581,387		24,423		3.76
Other assets	195,089						190,119
Total	$	2,926,674					$	2,771,506
Liabilities and Shareholders’ Equity
Interest-bearing demand deposits	$	1,411,243	286		0.08		$	1,213,208	939		0.31
Savings deposits	209,112		53		0.10		168,377		67		0.16
Time deposits	349,215		598		0.68		432,438		1,477		1.36
Total interest-bearing deposits	1,969,570		937		0.19		1,814,023		2,483		0.54
Securities sold under agreements to repurchase	23,578		8		0.13		21,145		20		0.38
FHLB Advances and other	45,071		123		1.09		219,567		394		0.71
Subordinated notes	31,938		503		6.29		31,881		501		6.29
Total interest-bearing liabilities	2,070,157		1,571		0.30		2,086,616		3,398		0.65
Noninterest-bearing demand deposits	548,923						417,939
Other	38,409						37,330
Total liabilities	2,657,489						2,541,885
Shareholders’ equity	269,185						229,621
Total	$	2,926,674					$	2,771,506
Taxable-equivalent net interest income /net interest spread			20,848		2.96	%			21,025		3.12	%
Taxable-equivalent net interest margin					3.03	%					3.24	%
Taxable-equivalent adjustment			(228)						(207)
Net interest income			$	20,620					$	20,818

NOTES TO ANALYSIS OF NET INTEREST INCOME:
(1)	Yields and interest income on tax-exempt assets have been computed on a taxable-equivalent basis assuming a 21% tax rate.
(2)	Average balances include nonaccrual loans.
(3)	Interest income on loans includes prepayment and late fees.

48

For the three months ended September 30, 2021, taxable-equivalent basis net interest income decreased by $177 thousand compared with the three months ended September 30, 2020. The decrease in net interest income reflected a decline in taxable-equivalent interest income of $1.8 million, offset by a decrease of $1.8 million in interest expense on interest-bearing liabilities from the three months ended September 30, 2020 to the three months ended September 30, 2021. Average interest-earning assets increased by $150.2 million due to an increase in average cash and average interest-bearing liabilities decreased by $16.5 million from the three months ended September 30, 2020 to the three months ended September 30, 2021.

For the three months ended September 30, 2021, taxable-equivalent net interest margin was 3.03%, which was 21 basis points lower than 3.24% for the three months ended September 30, 2020. This reduction was driven by an increase in average cash of $316.2 million, lower purchase accounting accretion of $835 thousand and reduced yield on investment securities. The increase in liquidity has resulted from SBA PPP forgiveness, child tax credits and a seasonal inflow of municipal deposit funds, which continue to negatively impact net interest margin.

The yield on loans was 4.12% for the three months ended September 30, 2021 compared to 4.21% for the three months ended September 30, 2020. Taxable-equivalent interest income earned on loans decreased by $1.8 million year-over-year due primarily to consumer loan runoff and lower purchase accounting accretion partially offset by the impact of SBA PPP forgiveness. There was a $134.3 million decrease in average loan balance year-over-year. Average residential mortgages decreased by $81.0 million from $284.0 million for the three months ended September 30, 2020 to $203.0 million for the three months ended September 30, 2021 due to the competitive and low interest rate environment since September 30, 2020. Average other consumer loans was $191.6 million for the three months ended September 30, 2021 compared to $217.3 million for the three months ended September 30, 2020, which was a decrease of $25.7 million. Accretion of purchase accounting adjustments was $296 thousand for the three months ended September 30, 2021 as compared to $861 thousand for the three months ended September 30, 2020. The three months ended September 30, 2021 and 2020 included $154 thousand and $650 thousand, respectively, of accelerated accretion related to the payoff of acquired loans. Average commercial loans, excluding average SBA PPP loans, increased by $125.3 million from $1.1 billion for the three months ended September 30, 2020 to $1.2 billion for the three months ended September 30, 2021. New commercial loan originations in 2021 had a lower yield than those in the existing portfolio.

SBA PPP loans, net of deferred fees and costs, averaged $303.2 million during the three months ended September 30, 2021 as compared to $456.1 million in the three months ended September 30, 2020. For both the three months ended September 30, 2021 and September 30, 2020, interest income on loans included $3.4 million of interest and net deferred fee income associated with the SBA PPP loans. While the average balance of SBA PPP loans declined over the period, the acceleration of net deferred fees in 2021 resulted in an increased yield on those loans. Net deferred SBA PPP fees of $8.6 million remain at September 30, 2021. These net deferred fees are being recognized over the life of the loans, which was originally between two and five years, but can be accelerated upon satisfactorily completing forgiveness steps with the SBA.

Taxable-equivalent investment securities interest income decreased by $334 thousand year-over-year, with the taxable equivalent yield decreasing from 2.14% for the three months ended September 30, 2020 to 2.00% for the three months ended September 30, 2021. The 14 basis point decrease reflected the decreased interest rate environment between years and certain repositioning within the portfolio under the Company's asset/liability management strategies. Interest income on securities was also impacted by a decrease of $31.7 million in the average balance of securities from the three months ended September 30, 2020 to the three months ended September 30, 2021 due primarily to the sale of asset-backed securities during the three months ended September 30, 2021.

The cost of interest-bearing liabilities decreased by 35 basis points from 0.65% for the three months ended September 30, 2020 to 0.30% for the three months ended September 30, 2021. The average balance of interest-bearing deposits increased by $155.5 million and the average balance of total borrowings decreased by $172.0 million. The increase in average interest-bearing deposits was due primarily to SBA PPP forgiveness since the prior year and an influx of municipal deposits during the third quarter of 2021, which offset a decline in certificates of deposits, due to maturities, and SBA PPP deposit usage. The cost of total deposits was 0.15% for the three months ended September 30, 2021 compared to 0.44% for the three months ended September 30, 2020. Rate reductions in 2021 combined with the maturity of higher yielding certificates of deposits caused this decrease. Average borrowings declined due to repayments and maturities of overnight borrowings.

Provision for Loan Losses

The Company continues to experience a low level of charge-offs and nonperforming loans. A provision for loan losses of $365 thousand was recorded for the three months ended September 30, 2021 due to commercial loan growth compared with $2.2 million for the same period in 2020. The provision recorded in the three months ended September 30, 2020 was driven by an increase in qualitative factor assumptions as a result of the COVID-19 pandemic. Due to continuing uncertainty in the external environment, management increased the qualitative factors for certain commercial loan segments in the Bank’s

49

allowance for loan loss analysis in the three months ended September 30, 2020. During the three months ended September 30, 2021, the Company's COVID-19 related reserve was reversed by $991 thousand as a result of the relative strength of the economy and performance of the Bank's borrowers. As a result, the Company's COVID-19 related reserve was reduced to zero at September 30, 2021. Net recoveries in the three months ended September 30, 2021 totaled $219 thousand, compared to net recoveries of $8 thousand in the comparable prior year period.

Additional information is included in the "Credit Risk Management" section herein.

Noninterest Income

The following table compares noninterest income for the three months ended September 30, 2021 and 2020:

	Three Months Ended September 30,				$ Change		% Change
	2021		2020		2021-2020		2021-2020
Service charges on deposit accounts	$	796	$	684	$	112	16	%
Interchange income	1,030		900		130		14	%
Other service charges and fees	197		168		29		17	%
Swap fees	67		95		(28)		(29)	%
Trust and investment management income	1,930		1,713		217		13	%
Brokerage income	987		751		236		31	%
Mortgage banking activities	1,333		1,985		(652)		(33)	%
Income from life insurance	569		543		26		5	%
Other income	263		35		228		651	%
Investment securities gains (losses)	479		(13)		492		3,785	%
Total noninterest income	$	7,651	$	6,861	$	790	12	%

The following factors contributed to the more significant changes in noninterest income between the three months ended September 30, 2021 and 2020:

•Service charges on deposit accounts increased in 2021 following the implementation of fee waivers in 2020 due to the COVID-19 pandemic and increased deposit account activity associated with the re-opening of the economy in the second quarter of 2021. In addition, cash management fees have increased between periods due to an increase in client activity.

•Interchange income grew from 2020 to 2021 due to increased spending upon the reopening of the economy and expanded usage of debit cards by consumers.

•Strong market conditions and the addition of new clients continue to drive trust and investment management income and brokerage income. Assets under management increased by $239 million from $1.6 billion at September 30, 2020 to $1.8 billion at September 30, 2021.

•Mortgage banking income declined $652 thousand driven by reduced residential mortgage production as refinancing activity slowed during the three months ended September 30, 2021 as compared to the three months ended September 30, 2020. Mortgage loans sold totaled $48.0 million in the third quarter of 2021 compared with $72.8 million in the third quarter of 2020 resulting in a decrease in the gain on sale of residential mortgages of $415 thousand, a decrease in the fair value of residential mortgages held for sale and valuation of interest rate lock commitments of $138 thousand and a decrease of $298 thousand in residential mortgage servicing income, offset partially by the MSR valuation reserve reversal of $43 thousand in the three months ended September 30, 2021 compared to the impairment charge of $166 thousand in the three months ended September 30, 2020.

•Other income increased due primarily to the recognition of tax credits of $230 thousand from the Bank's investment in solar renewable energy partnerships.

•Investment securities gains increased during the third quarter of 2021 from $482 thousand in gains recorded from the sales of $72.8 million of asset-backed securities.

•Other line items within noninterest income showed fluctuations between 2021 and 2020 attributable to normal business operations.

50

Noninterest Expenses

The following table compares noninterest expenses for the three months ended September 30, 2021 and 2020:

	Three Months Ended September 30,				$ Change		% Change
	2021		2020		2021-2020		2021-2020
Salaries and employee benefits	$	11,498	$	10,695	$	803	7.5	%
Occupancy	1,154		1,231		(77)		(6.3)	%
Furniture and equipment	1,220		1,203		17		1.4	%
Data processing	990		958		32		3.3	%
Automated teller machine and interchange fees	294		278		16		5.8	%
Advertising and bank promotions	735		197		538		273.1	%
FDIC insurance	218		230		(12)		(5.2)	%
Professional services	562		603		(41)		(6.8)	%
Directors' compensation	155		214		(59)		(27.6)	%
Taxes other than income	16		453		(437)		(96.5)	%
Intangible asset amortization	314		357		(43)		(12.0)	%
Branch consolidation expenses	—		1,310		(1,310)		—	%
Other operating expenses	1,879		1,536		343		22.3	%
Total noninterest expenses	$	19,035	$	19,265	$	(230)	(1.2)	%

The following factors contributed to the more significant changes in noninterest expenses between the three months ended September 30, 2021 and 2020:

•Salaries and employee benefits increased for the three months ended September 30, 2021 compared to the three months ended September 30, 2020 due primarily to increases in performance-based incentives, additions to personnel and higher benefit costs.

•Advertising and bank promotions increased by $538 thousand due to reduced marketing efforts in 2020 due to the COVID-19 pandemic and the recognition of Pennsylvania Educational Improvement Tax Credit ("EITC") contributions in the three months ended September 30, 2021.

•Taxes other than income decreased by $437 thousand due to tax credits recorded from the EITC contributions in the three months ended September 30, 2021.

•Intangible asset amortization decreased principally due to the elimination of a customer intangible associated with the discontinuance of Wheatland Advisors, Inc. on July 31, 2020 and full amortization of a covenant not to compete in 2020.

•Branch consolidation expenses were $1.3 million for the three months September 30, 2020 related to the consolidation of six branches and three loan production offices. There were no similar charges for the three months ended September 30, 2021.

•Other operating expenses increased by $343 thousand due to a loss of $514 thousand from the termination of an interest rate derivative designated as a cash flow hedge recorded in the three months ended September 30, 2021, partially offset by a decrease of $172 thousand in the reserve for unfunded commitments from the three months ended September 30, 2020. A review of historical loss and line utilization experience resulted in no provision expense in the three months ended September 30, 2021.

•Other line items within noninterest expenses showed fluctuations between 2021 and 2020 attributable to normal business operations.

51

Income Tax Expense

Income tax expense totaled $1.7 million, an effective tax rate of 18.9%, for the three months ended September 30, 2021, compared with $1.2 million, an effective tax rate of 19.9%, for the three months ended September 30, 2020. The Company’s effective tax rate is less than the 21% federal statutory rate, principally due to tax-free income, which includes interest income on tax-free loans and securities and income from life insurance policies, federal income tax credits, and the impact of non-tax deductible expenses. The difference in the effective tax rate from the three months ended September 30, 2020 to the three months ended September 30, 2021 was due primarily to an increase in estimated earnings before income taxes for which the impact was reflected in the three months ended September 30, 2020.

Nine months ended September 30, 2021 compared with nine months ended September 30, 2020

Summary

Net income totaled $26.2 million for the nine months ended September 30, 2021 compared with net income of $16.4 million for the same period in 2020. Diluted earnings per share for the nine months ended September 30, 2021 totaled $2.36, compared with $1.49 for the nine months ended September 30, 2020. Net interest income positively influenced results of operations, and totaled $64.4 million for the nine months ended September 30, 2021, as compared to $59.9 million in the nine months ended September 30, 2020. Noninterest income totaled $21.9 million for the nine months ended September 30, 2021 compared with $21.1 million in the nine months ended September 30, 2020. Noninterest expenses totaled $53.9 million and $56.0 million for the nine months ended September 30, 2021 and 2020, respectively.

The comparability of operating results for 2021 with 2020 have generally been impacted by the SBA PPP loans and related deposits.

Net Interest Income

Net interest income increased by $4.5 million, from $59.9 million to $64.4 million, for the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020. Total interest expense decreased from $13.3 million to $5.4 million, in comparing the nine months ended September 30, 2021 with the nine months ended September 30, 2020. Interest income on loans decreased by $881 thousand, from $63.6 million to $62.7 million, and investment securities interest income decreased by $2.7 million, from $9.5 million to $6.8 million for the same period.

52

The following table presents net interest income, net interest spread and net interest margin for the nine months ended September 30, 2021 and 2020 on a taxable-equivalent basis:

	Nine Months Ended September 30, 2021						Nine Months Ended September 30, 2020
	Average Balance		Taxable- Equivalent Interest		Taxable- Equivalent Rate		Average Balance		Taxable- Equivalent Interest		Taxable- Equivalent Rate
Assets
Federal funds sold & interest-bearing bank balances	$	261,697	$	255	0.13	%	$	27,315	$	101	0.49	%
Investment securities (1)	456,919		7,272		2.13		496,977		9,797		2.63
Loans (1)(2)(3)	1,988,834		62,895		4.23		1,899,186		63,940		4.50
Total interest-earning assets	2,707,450		70,422		3.48		2,423,478		73,838		4.07
Other assets	188,924						193,057
Total	$	2,896,374					$	2,616,535
Liabilities and Shareholders’ Equity
Interest-bearing demand deposits	$	1,380,241	1,014		0.10		$	1,113,740	4,100		0.49
Savings deposits	197,792		149		0.10		160,133		194		0.16
Time deposits	376,142		2,247		0.80		466,032		5,853		1.68
Total interest-bearing deposits	1,954,175		3,410		0.23		1,739,905		10,147		0.78
Securities sold under agreements to repurchase	22,490		25		0.15		17,395		72		0.55
FHLB Advances and other	53,608		458		1.14		194,197		1,604		1.10
Subordinated notes	31,924		1,507		6.29		31,867		1,504		6.29
Total interest-bearing liabilities	2,062,197		5,400		0.35		1,983,364		13,327		0.90
Noninterest-bearing demand deposits	537,247						373,614
Other	37,413						35,874
Total liabilities	2,636,857						2,392,852
Shareholders’ equity	259,517						223,683
Total	$	2,896,374					$	2,616,535
Taxable-equivalent net interest income /net interest spread			65,022		3.13	%			60,511		3.17	%
Taxable-equivalent net interest margin					3.21	%					3.34	%
Taxable-equivalent adjustment			(646)						(633)
Net interest income			$	64,376					$	59,878

NOTES TO ANALYSIS OF NET INTEREST INCOME:
(1)	Yields and interest income on tax-exempt assets have been computed on a taxable-equivalent basis assuming a 21% tax rate.
(2)	Average balances include nonaccrual loans.
(3)	Interest income on loans includes prepayment and late fees.

For the nine months ended September 30, 2021, taxable-equivalent basis net interest income increased by $4.5 million compared with the nine months ended September 30, 2020. This increase reflected an increase of $284.0 million in average interest-earning assets due to an increase in average cash, partially offset by an increase of $78.8 million in average interest-bearing liabilities from the nine months ended September 30, 2020 to the nine months ended September 30, 2021. These balances increased primarily due to the SBA PPP loans originated from April 2020 to May 2021.

Taxable-equivalent net interest margin was 3.21% for the nine months ended September 30, 2021, which was 13 basis points lower than 3.34% for the nine months ended September 30, 2020. This reduction was driven by an increase in average cash of $234.4 million, lower purchase accounting accretion of $1.9 million and reduced yields on investment securities.

53

The yield on loans was 4.23% for the nine months ended September 30, 2021 compared to 4.50% for the nine months ended September 30, 2020. Taxable-equivalent interest income earned on loans decreased by $1.0 million year-over-year despite an increase in the average balance of commercial loans of $210.2 million. The decline in the yield on total loans reflects the impact from an increase in average SBA PPP loans, which have a 1% note rate, and the payoff of higher yielding loans with new loan originations at lower interest rates.

SBA PPP loans, net of deferred fees and costs, averaged $412.2 million during the nine months ended September 30, 2021 as compared to $269.8 million in the nine months ended September 30, 2020. Partially offsetting the increase in loans from SBA PPP were decreases in average consumer loans due to runoff and average residential mortgage loans during the period due to the competitive and low interest rate environment. Average consumer loans decreased by $22.0 million from $63.4 million for the nine months ended September 30, 2020 to $41.4 million for the nine months ended September 30, 2021. Average residential mortgages were $216.9 million for the nine months ended September 30, 2021, a decrease of $89.2 million from $306.1 million for the nine months ended September 30, 2020.

For the nine months ended September 30, 2021, interest income on loans includes $13.0 million of interest and net deferred fee income recognized associated with the SBA PPP loans compared to $6.1 million for the nine months ended September 30, 2020. Net deferred fees of $8.6 million remain at September 30, 2021, which will be recognized over the life of the loans that was originally between two and five years, but can be accelerated upon satisfactorily completing forgiveness steps with the SBA. Accretion of purchase accounting adjustments was $1.4 million for the nine months ended September 30, 2021 as compared to $2.5 million for the nine months ended September 30, 2020. The nine months ended September 30, 2021 and 2020 included $919 thousand and $1.4 million, respectively, of accelerated accretion related to the payoff of acquired loans.

Taxable-equivalent securities interest income decreased by $2.5 million year-over-year, with the taxable equivalent yield decreasing from 2.63% for the nine months ended September 30, 2020 to 2.13% for the nine months ended September 30, 2021. The 50 basis point decrease reflected the decreased interest rate environment between years and certain repositioning within the portfolio under the Company's asset/liability management strategies. Interest income on securities was also impacted by the decrease of $40.1 million in the average balance of securities from the nine months ended September 30, 2020 to the nine months ended September 30, 2021 due primarily to the sale of the non-agency CMBS portfolio during the nine months ended September 30, 2021.

Interest expense on deposits and borrowings decreased by $7.9 million year-over-year, with the average balance of interest-bearing deposits increasing by $214.3 million and the average balance of total borrowings decreasing by $135.4 million. The increase in average interest-bearing deposits was due primarily to the SBA PPP forgiveness since the prior year, which was partially offset by maturities of certificates of deposits. The decrease in average borrowings was due to maturities and repayments of overnight borrowings. There was a decrease of 55 basis points in the cost of interest-bearing liabilities, which was driven by rate reductions in 2021 as well as maturities of higher yielding certificates of deposits. The balance of deposits associated with the SBA PPP loans are expected to decline into the second half of 2021 as the funds are drawn by the borrowers.

Provision for Loan Losses

The Company continues to experience a low level of charge-offs and nonperforming loans. The provision for loan losses was negative $10 thousand for the nine months ended September 30, 2021 compared with expense of $5.0 million for the same period in 2020. The provision recorded in the nine months ended September 30, 2020 was driven by an increase in qualitative factor assumptions as a result of the COVID-19 pandemic. The negative provision recorded in the nine months ended September 30, 2021 was due to the release of $2.7 million of the Company's COVID-19 related reserves, as the credit performance was strong in the past year following the re-opening of the economy. As a result, the Company's COVID-19 reserve was reduced to zero at September 30, 2021. Offsetting the impact to the provision for loan losses from the decrease in the COVID-19 qualitative factors was an increase in the provision expense from commercial loan production. Net charge-offs in the nine months ended September 30, 2021 totaled $176 thousand, as compared to net recoveries of $45 thousand in the comparable prior year period. Nonaccrual loans were 0.47% of gross loans at September 30, 2021, compared with 0.39% of gross loans at September 30, 2020. Nonaccrual loans increased by $1.2 million from September 30, 2020 to September 30, 2021; however, classified loans decreased by $9.5 million to $26.9 million from September 30, 2020 to September 30, 2021.

Additional information is included in the "Credit Risk Management" section herein.

54

Noninterest Income

The following table compares noninterest income for the nine months ended September 30, 2021 and 2020:

	Nine Months Ended September 30,				$ Change		% Change
	2021		2020		2021-2020		2021-2020
Service charges on deposit accounts	$	2,231	$	2,085	$	146	7	%
Interchange income	3,049		2,507		542		22	%
Other service charges and fees	527		473		54		11	%
Swap fees	135		527		(392)		(74)	%
Trust and investment management income	5,862		5,049		813		16	%
Brokerage income	2,708		2,069		639		31	%
Mortgage banking activities	4,684		3,926		758		19	%
Gain on sale of portfolio loans	—		2,803		(2,803)		(100)	%
Income from life insurance	1,690		1,615		75		5	%
Other income	338		118		220		186	%
Investment securities gains (losses)	635		(44)		679		1,543	%
Total noninterest income	$	21,859	$	21,128	$	731	3	%

The following factors contributed to the more significant changes in noninterest income between the nine months ended September 30, 2021 and 2020:

•Service charges on deposit accounts increased in 2021 following the implementation of fee waivers in 2020 due to the COVID-19 pandemic and increased deposit account activity associated with the re-opening of the economy in the second quarter of 2021.

•Interchange income grew from 2020 to 2021 due to increased spending upon the reopening of the economy and expanded usage of debit cards by consumers.

•Swap fees declined due to less interest from potential clients in a low interest rate environment. Swap fee income fluctuates based on the number of transactions entered into in a period.

•Strong market conditions and the addition of new clients continue to drive trust and investment management income and brokerage income. Assets under management increased by $239 million from $1.6 billion at September 30, 2020 to $1.8 billion at September 30, 2021.

•Mortgage banking income increased by $758 thousand due to an MSR valuation reserve reversal of $695 thousand in the nine months ended September 30, 2021 compared to an MSR impairment charge of $986 thousand in the nine months ended September 30, 2020, which was driven by significant market interest rate reductions caused by the COVID-19 pandemic. This was partially offset by a decrease of $1.1 million in the fair value of the residential mortgages held for sale and valuation of interest rate lock commitments attributed to reduced production due to less refinancing activity and the impact of higher rates on the valuations during the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020. Refinance activity was strong in the second and third quarters of 2020 due to the decrease in interest rates, and the gain on sale margin increased.

•During the nine months ended September 30, 2020, the Bank recorded $2.8 million in gains due to the sale of $10.9 million of classified loans for net gains of $2.5 million, and the sale of an $11.0 million portfolio of recreational vehicle loans for a gain of $314 thousand.

•Other income increased due primarily to the recognition of tax credits of $230 thousand from the Bank's investment in solar renewable energy partnerships in the nine months ended September 30, 2021.

•During the nine months ended September 30, 2021, the Company recorded net investment securities gains of $635 thousand from the sales of $148.4 million of commercial mortgage-backed securities and asset-backed securities. There were no sales of debt securities during the nine months ended September 30, 2020.

•Other line items within noninterest income showed fluctuations between 2021 and 2020 attributable to normal business operations.

55

Noninterest Expenses

The following table compares noninterest expenses for the nine months ended September 30, 2021 and 2020:

	Nine Months Ended September 30,				$ Change		% Change
	2021		2020		2021-2020		2021-2020
Salaries and employee benefits	$	31,907	$	32,352	$	(445)	(1.4)	%
Occupancy	3,492		3,480		12		0.3	%
Furniture and equipment	3,800		3,569		231		6.5	%
Data processing	3,041		2,620		421		16.1	%
Automated teller machine and interchange fees	862		778		84		10.8	%
Advertising and bank promotions	1,434		1,153		281		24.4	%
FDIC insurance	570		491		79		16.1	%
Professional services	1,862		2,340		(478)		(20.4)	%
Directors' compensation	624		679		(55)		(8.1)	%
Taxes other than income	929		904		25		2.8	%
Intangible asset amortization	972		1,224		(252)		(20.6)	%
Branch consolidation expenses	—		1,310		(1,310)		—	%
Insurance claim receivable recovery	—		(486)		486		(100.0)	%
Other operating expenses	4,358		5,586		(1,228)		(22.0)	%
Total noninterest expenses	$	53,851	$	56,000	$	(2,149)	(3.8)	%

The following factors contributed to the more significant changes in noninterest expenses between the nine months ended September 30, 2021 and 2020:

•The decrease in salaries and employee benefits from 2020 to 2021 was driven by reduced staffing as a result of the prior year's restructurings.

•Data processing expenses increased by $421 thousand due primarily to increased core system costs and trust data processing activity.

•Advertising and bank promotions increased by $281 thousand due to increased marketing efforts from the post-pandemic environment.

•The increase in FDIC insurance expense reflects the increase in FDIC assessments during 2021 compared to 2020, which is impacted by credits in the nine months ended September 30, 2020 that did not recur in 2021.

•Professional services decreased by $478 thousand due to legal costs incurred in the nine months ended September 30, 2020 in connection with the SEPTA litigation.

•Intangible asset amortization decreased principally due to the elimination of a customer intangible associated with the discontinuance of Wheatland Advisors, Inc. on July 31, 2020 and full amortization of a covenant not to compete in 2020.

•Branch consolidation expenses were $1.3 million for the nine months September 30, 2020 related to the consolidation of six branches and three loan production offices. There were no similar charges for the nine months September 30, 2021.

•During the nine months ended September 30, 2020, $486 thousand of refunds were received from an insurance company related to a 2018 cyber security incident.

•Other operating expenses declined by $1.2 million primarily due to a reduction in the reserve for unfunded commitments of $340 thousand and a reduction of $724 thousand in expenses associated with the sale of a property recorded in the nine months ended September 30, 2020. For the nine months ended September 30, 2020, the reserve for unfunded commitments was higher due to increased qualitative factors from the COVID-19 pandemic, which were reversed in 2021 following a review of historical loss and line utilization experience. This was partially offset by the loss of $514 thousand from the termination of the interest rate derivative designated as a cash flow hedge during the nine months September 30, 2021.

•Other line items within noninterest expenses showed fluctuations between 2021 and 2020 attributable to normal business operations.

56

Income Tax Expense

Income tax expense totaled $6.2 million, an effective tax rate of 19.2%, for the nine months ended September 30, 2021 compared with $3.6 million, an effective tax rate of 17.9%, for the nine months ended September 30, 2020. The Company’s effective tax rate is less than the 21% federal statutory rate, principally due to tax-free income, which includes interest income on tax-free loans and securities and income from life insurance policies, federal income tax credits, and the impact of non-tax deductible expenses. The difference in the effective tax rate from the nine months ended September 30, 2020 to the nine months ended September 30, 2021 was due primarily to higher estimated earnings before income taxes for the 2021 fiscal year.

FINANCIAL CONDITION

Management devotes substantial time to overseeing the investment of funds in loans and investment securities and the formulation of policies directed toward the profitability and management of the risks associated with these investments.

Investment Securities

The Company utilizes investment securities to manage interest rate risk, to enhance income through interest and dividend income, to provide liquidity and to provide collateral for certain deposits and borrowings. At September 30, 2021, securities available for sale totaled $445.0 million, a decrease of $21.4 million, from $466.5 million at December 31, 2020. During the nine months ended September 30, 2021, the Company sold $148.4 million of commercial mortgage-backed securities and asset-backed securities for a net gain of $609 thousand, and purchased $156.9 million of mortgage-backed securities, municipal securities and United States Treasury notes.

During the nine months ended September 30, 2021 and 2020, the Company recorded a gain of $26 thousand and a loss of $44 thousand, respectively, due to market value adjustments on an equity security. The balance of investment securities included net unrealized gains of $7.2 million at September 30, 2021 as compared to net unrealized gains of $5.5 million at December 31, 2020. This increase reflects the impact of improved market rates on the Company's investment security portfolio.

57

The following table summarizes the credit ratings and collateral associated with the Company's investment portfolio, excluding equity securities, at September 30, 2021:

Sector	Portfolio Mix		Amortized Book		Fair Value		Credit Enhancement		AAA		AA		A		BBB		NR		Collateral Type
Unsecured ABS	1	%	$	3,103	$	3,159	31	%	—	%	—	%	—	%	—	%	100	%	Unsecured Consumer Debt
Student Loan ABS	2		9,385		9,367		18		—		—		—		—		100		Seasoned Student Loans
Federal Family Education Loan ABS	23		101,309		101,383		5		67		27		5		—		—		Federal Family Education Loan (1)
PACE Loan ABS	1		3,880		3,969		5		100		—		—		—		—		PACE Loans
Non-Agency RMBS	6		25,929		25,657		49		100		—		—		—		—		Reverse Mortgages (2)
Municipal - General Obligation	21		93,094		97,365				7		86		7		—		—
Municipal - Revenue	18		81,145		84,156				—		76		12		—		13
SBA ReRemic	2		9,049		9,029				—		100		—		—		—		SBA Guarantee (3)
Agency MBS	21		90,474		90,705				—		100		—		—		—		Residential Mortgages (3)
U.S. Treasury securities	5		20,087		19,831				—		100		—		—		—
Bank CDs	—		249		249				—		—		—		—		100		FDIC Insured CD
	100	%	$	437,704	$	444,870			24	%	66	%	5	%	—	%	5	%
(1) Minimum of 97% guaranteed by U.S. government
(2) Reverse mortgages fund over time, credit enhancement is estimated based on prior experience
(3) 100% guaranteed by U.S. government agencies
Note : Ratings in table are the lowest of the six rating agencies (Standard & Poor's, Moody's, Morningstar, DBRS, KBRA and Fitch). Standard & Poor's rates U.S. government obligations at AA+

Loan Portfolio

The Company offers a variety of products to meet the credit needs of its borrowers, principally commercial real estate loans, commercial and industrial loans, and retail loans consisting of loans secured by residential properties, and to a lesser extent, installment loans. No loans are extended to non-domestic borrowers or governments.

The risks associated with lending activities differ among loan classes and are subject to the impact of changes in interest rates, market conditions of collateral securing the loans and general economic conditions. Any of these factors may adversely impact a borrower’s ability to repay loans, and also impact the associated collateral. See Note 3, Loans and Allowance for Loan Losses, to the unaudited condensed consolidated financial statements under Part I, Item 1, "Financial Information," for a description of the Company’s loan classes and differing levels of associated credit risk.

58

The following table presents the loan portfolio, excluding residential LHFS, by segment and class at September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
Commercial real estate:
Owner occupied	$	196,585	$	174,908
Non-owner occupied	509,703		409,567
Multi-family	112,002		113,635
Non-owner occupied residential	100,088		114,505
Acquisition and development:
1-4 family residential construction	12,246		9,486
Commercial and land development	71,784		51,826
Commercial and industrial (1)	540,205		647,368
Municipal	13,631		20,523
Residential mortgage:
First lien	203,360		244,321
Home equity - term	7,079		10,169
Home equity - lines of credit	154,004		157,021
Installment and other loans	19,077		26,361
	$	1,939,764	$	1,979,690

(1) This balance includes $259.9 million and $403.3 million of SBA PPP loans at September 30, 2021 and December 31, 2020, respectively.

Total loans declined by $39.9 million from December 31, 2020 to September 30, 2021. This decrease is due primarily to SBA PPP loan forgiveness of $376.0 million in the nine months ended September 30, 2021 and payoffs in the residential mortgage loan and installment and other loan portfolios, offset by commercial loan production, excluding SBA PPP loans, of $157.9 million during the nine months ended September 30, 2021. Overall loan growth, excluding SBA PPP loans, was 7% for the nine months ended September 30, 2021.

Asset Quality

Risk Elements

The Company’s loan portfolio is subject to varying degrees of credit risk. Credit risk is managed through our underwriting standards, on-going credit reviews, and monitoring of asset quality measures. Additionally, loan portfolio diversification, which limits exposure to a single industry or borrower, and collateral requirements also mitigate our risk of credit loss.

The loan portfolio consists principally of loans to borrowers in south central Pennsylvania and the greater Baltimore, Maryland region. As the majority of loans are concentrated in these geographic regions, a substantial portion of the borrowers' ability to honor their obligations may be affected by the level of economic activity in the market areas.

Nonperforming assets include nonaccrual loans and foreclosed real estate. In addition, restructured loans still accruing and loans past due 90 days or more and still accruing are also deemed to be risk assets. For all loan classes, the accrual of interest income generally ceases when principal or interest is past due 90 days or more and collateral is inadequate to cover principal and interest or immediately if, in the opinion of management, full collection is unlikely. Interest will continue to accrue on loans past due 90 days or more if the collateral is adequate to cover principal and interest, and the loan is in the process of collection. Interest accrued, but not collected, as of the date of placement on nonaccrual status, is generally reversed and charged against interest income, unless fully collateralized. Subsequent payments received are either applied to the outstanding principal balance or recorded as interest income, depending on management’s assessment of the ultimate collectability of principal. Loans are returned to accrual status, for all loan classes, when all the principal and interest amounts contractually due are brought current, the loans have performed in accordance with the contractual terms of the note for a reasonable period of time, generally six months, and the ultimate collectability of the total contractual principal and interest is reasonably assured. Past due status is based on contract terms of the loan.

Loans, the terms of which are modified, are classified as TDRs if a concession was granted for legal or economic reasons related to a borrower’s financial difficulties. Concessions granted under a TDR typically involve a temporary deferral of scheduled loan payments, an extension of a loan’s stated maturity date, temporary reduction in interest rates, or below market rates. If a modification occurs while the loan is on accruing status, it will continue to accrue interest under the modified terms.

59

Nonaccrual TDRs are restored to accrual status if scheduled principal and interest payments, under the modified terms, are current for six months after modification, and the borrower continues to demonstrate its ability to meet the modified terms. TDRs are evaluated individually for impairment if they have been restructured during the most recent calendar year, or if they are not performing according to their modified terms.

The following table presents the Company’s risk elements, including the aggregate balances of nonaccrual loans, restructured loans still accruing, loans past due 90 days or more, and OREO as of September 30, 2021 and December 31, 2020. Relevant asset quality ratios are also presented.

	September 30, 2021			December 31, 2020
Nonaccrual loans	$	9,116		$	10,310
OREO	—			—
Total nonperforming assets	9,116			10,310
Restructured loans still accruing	839			934
Loans past due 90 days or more and still accruing	362			554
Total nonperforming and other risk assets (total risk assets)	$	10,317		$	11,798
Loans 30-89 days past due	$	1,534		$	10,291
Asset quality ratios:
Total nonaccrual loans to total loans	0.47		%	0.52		%
Total nonperforming assets to total assets	0.32		%	0.37		%
Total nonperforming assets to total loans and OREO	0.47		%	0.52		%
Total risk assets to total loans and OREO	0.53		%	0.60		%
Total risk assets to total assets	0.36		%	0.43		%
ALL to total loans	1.03		%	1.02		%
ALL to nonperforming loans	219.01		%	195.45		%
ALL to nonperforming loans and restructured loans still accruing	200.55		%	179.22		%

Total nonperforming and other risk assets decreased by $1.5 million, or 12.6%, from December 31, 2020 to September 30, 2021. There was a reduction of $1.2 million in non-accrual loans due to payment activity and a decrease of $192 thousand in loans past 90 days and still accruing from December 31, 2020 to September 30, 2021.

The following table presents detail of impaired loans at September 30, 2021 and December 31, 2020:

	September 30, 2021						December 31, 2020
	Nonaccrual Loans		Restructured Loans Still Accruing		Total		Nonaccrual Loans		Restructured Loans Still Accruing		Total
Commercial real estate:
Owner occupied	$	3,806	$	26	$	3,832	$	3,232	$	28	$	3,260
Non-owner occupied residential	171		—		171		268		—		268
Acquisition and development:
Commercial and land development	—		—		—		814		—		814
Commercial and industrial	2,941		—		2,941		3,639		—		3,639
Residential mortgage:
First lien	1,659		813		2,472		1,730		898		2,628
Home equity - term	7		—		7		10		—		10
Home equity - lines of credit	495		—		495		600		8		608
Installment and other loans	37		—		37		17		—		17
	$	9,116	$	839	$	9,955	$	10,310	$	934	$	11,244

60

The following table presents our exposure to borrowers with impaired loans, partial charge-offs taken to date and specific reserves established on the borrowing relationships at September 30, 2021 and December 31, 2020. Of the relationships deemed to be impaired at September 30, 2021, two had a recorded balance in excess of $1.0 million, and 62, which represents 35.1% of total impaired loans, had recorded balances of less than $250 thousand.

	# of Relationships	Recorded Investment		Partial Charge-offs to Date		Specific Reserves
September 30, 2021
Relationships greater than $1,000,000	2	$	5,225	$	—	$	—
Relationships greater than $500,000 but less than $1,000,000	1	619		17		—
Relationships greater than $250,000 but less than $500,000	2	612		—		—
Relationships less than $250,000	62	3,499		623		29
	67	$	9,955	$	640	$	29
December 31, 2020
Relationships greater than $1,000,000	2	$	5,639	$	—	$	—
Relationships greater than $500,000 but less than $1,000,000	2	1,211		17		—
Relationships greater than $250,000 but less than $500,000	2	637		—		—
Relationships less than $250,000	65	3,757		545		33
	71	$	11,244	$	562	$	33

The Company takes partial charge-offs on collateral-dependent loans when carrying value exceeds estimated fair value, as determined by the most recent appraisal adjusted for current (within the quarter) conditions, less costs to dispose. Impairment reserves remain in place if updated appraisals are pending, and represent management’s estimate of potential loss.

Internal loan reviews are completed annually on all commercial relationships with a committed loan balance in excess of $1.0 million, which includes confirmation of risk rating by an independent credit officer. In addition, all relationships greater than $500 thousand rated Substandard, Doubtful or Loss are reviewed and corresponding risk ratings are reaffirmed by the Bank's Problem Loan Committee, with subsequent reporting to the Management ERM Committee.

In its individual loan impairment analysis, the Company determines the extent of any full or partial charge-offs that may be required, or any reserves that may be needed. The determination of the Company’s charge-offs or impairment reserve include an evaluation of the outstanding loan balance and the related collateral securing the credit. Through a combination of collateral securing the loans and partial charge-offs taken to date, the Company believes that it has adequately provided for the potential losses that it may incur on these relationships at September 30, 2021. However, over time, additional information may result in increased reserve allocations or, alternatively, it may be deemed that the reserve allocations exceed those that are needed.

In an effort to assist clients that were negatively impacted by the COVID-19 pandemic, the Bank offered various mitigation options, including a loan payment deferral program. Under this program, most commercial deferrals were for a 90-day period, while most consumer deferrals were for a 180-day period. As of September 30, 2021, the Company had loan deferrals under this program for consumer clients with a total loan balance of $317 thousand. In accordance with the revised Interagency Statement on Loan Modifications by Financial Institutions Working with Customers Affected by the Coronavirus issued on April 7, 2020, these deferrals are exempt from TDR status as they meet the specified requirements.

The following table summarizes outstanding COVID-19 related modifications, including deferrals and forbearances at September 30, 2021 and December 31, 2020:

Loan Type	Amount of Loans				Percent of Non-PPP Loans
	September 30, 2021		December 31, 2020		September 30, 2021		December 31, 2020
Commercial	$	—	$	15,702	—	%	1.4	%
Consumer	317		2,504		0.1		0.6
Total Loans	$	317	$	18,206	—	%	1.2	%

61

Credit Risk Management

Allowance for Loan Losses

The Company maintains the ALL at a level deemed adequate by management for probable incurred credit losses. The ALL is established and maintained through a provision for loan losses charged to earnings. Quarterly, management assesses the adequacy of the ALL using a defined methodology which considers specific credit evaluation of impaired loans, past loan loss historical experience and qualitative factors. Management addresses the requirements for loans individually identified as impaired, loans collectively evaluated for impairment, and other bank regulatory guidance in its assessment.

The ALL is evaluated based on review of the collectability of loans in light of historical experience; the nature and volume of the loan portfolio; adverse situations that may affect a borrower’s ability to repay; estimated value of any underlying collateral; and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available. A description of the methodology for establishing the allowance and provision for loan losses and related procedures in establishing the appropriate level of reserve is included in Note 3, Loans and Allowance for Loan Losses, to the unaudited condensed consolidated financial statements under Part I, Item 1, "Financial Information."

62

The following table summarizes the Company’s internal risk ratings at September 30, 2021 and December 31, 2020:

	Pass		Special Mention		Non-Impaired Substandard		Impaired - Substandard		Doubtful		PCI Loans		Total
September 30, 2021
Commercial real estate:
Owner occupied	$	176,029	$	8,219	$	6,147	$	3,832	$	—	$	2,358	$	196,585
Non-owner occupied	476,947		32,272		168		—		—		316		509,703
Multi-family	91,726		19,662		614		—		—		—		112,002
Non-owner occupied residential	95,338		2,028		1,344		171		—		1,207		100,088
Acquisition and development:
1-4 family residential construction	12,246		—		—		—		—		—		12,246
Commercial and land development	70,648		636		500		—		—		—		71,784
Commercial and industrial	521,530		7,939		5,505		2,941		—		2,290		540,205
Municipal	13,631		—		—		—		—		—		13,631
Residential mortgage:
First lien	195,717		—		240		2,472		—		4,931		203,360
Home equity - term	7,056		—		—		7		—		16		7,079
Home equity - lines of credit	153,436		21		52		495		—		—		154,004
Installment and other loans	19,002		—		—		37		—		38		19,077
	$	1,833,306	$	70,777	$	14,570	$	9,955	$	—	$	11,156	$	1,939,764
December 31, 2020
Commercial real estate:
Owner occupied	$	148,846	$	12,491	$	7,855	$	3,260	$	—	$	2,456	$	174,908
Non-owner occupied	351,860		57,378		—		—		—		329		409,567
Multi-family	92,769		20,224		642		—		—		—		113,635
Non-owner occupied residential	107,557		3,948		1,422		268		—		1,310		114,505
Acquisition and development:
1-4 family residential construction	9,101		385		—		—		—		—		9,486
Commercial and land development	49,832		655		525		814		—		—		51,826
Commercial and industrial	617,213		17,561		6,118		3,639		—		2,837		647,368
Municipal	20,523		—		—		—		—		—		20,523
Residential mortgage:
First lien	236,381		—		—		2,628		—		5,312		244,321
Home equity - term	10,076		—		64		10		—		19		10,169
Home equity - lines of credit	156,264		95		54		608		—		—		157,021
Installment and other loans	26,283		—		—		17		—		61		26,361
	$	1,826,705	$	112,737	$	16,680	$	11,244	$	—	$	12,324	$	1,979,690

Potential problem loans are defined as performing loans which have characteristics that cause management concern over the ability of the borrower to perform under present loan repayment terms and which may result in the reporting of these loans as nonperforming loans in the future. Generally, management feels that Substandard loans that are currently performing and not considered impaired result in some doubt as to the borrower’s ability to continue to perform under the terms of the loan, and

63

represent potential problem loans. Additionally, the Special Mention classification is intended to be a temporary classification reflective of loans that have potential weaknesses that may, if not monitored or corrected, weaken the asset or inadequately protect the Company’s position at some future date. Special Mention loans represent an elevated risk, but their weakness does not yet justify a more severe, or classified, rating. These loans require inquiry by lenders on the cause of the potential weakness and, once analyzed, the loan classification may be downgraded to Substandard or, alternatively, could be upgraded to Pass. Special Mention loans decreased by $42.0 million from December 31, 2020 to September 30, 2021 due to continued improvements in economic conditions as COVID-19 restrictions are eased and government stimulus drives increases in spending.

The following table summarizes activity in the ALL for the three and nine months ended September 30, 2021 and 2020:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
Three Months Ended
September 30, 2021
Balance, beginning of period	$	11,315	$	1,243	$	3,495	$	29	$	16,082	$	2,863	$	227	$	3,090	$	209	$	19,381
Provision for loan losses	(179)		290		386		(2)		495		(147)		18		(129)		(1)		365
Charge-offs	(89)		—		(55)		—		(144)		—		(20)		(20)		—		(164)
Recoveries	305		8		60		—		373		5		5		10		—		383
Balance, end of period	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
September 30, 2020
Balance, beginning of period	$	9,347	$	1,069	$	2,916	$	75	$	13,407	$	3,552	$	386	$	3,938	$	172	$	17,517
Provision for loan losses	1,520		(219)		963		(19)		2,245		(71)		18		(53)		8		2,200
Charge-offs	(3)		—		(193)		—		(196)		—		(31)		(31)		—		(227)
Recoveries	171		—		45		—		216		6		13		19		—		235
Balance, end of period	$	11,035	$	850	$	3,731	$	56	$	15,672	$	3,487	$	386	$	3,873	$	180	$	19,725
Nine Months Ended
September 30, 2021
Balance, beginning of period	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151
Provision for loan losses	133		418		109		(13)		647		(578)		(69)		(647)		(10)		(10)
Charge-offs	(270)		—		(621)		—		(891)		(92)		(49)		(141)		—		(1,032)
Recoveries	338		9		456		—		803		29		24		53		—		856
Balance, end of period	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
September 30, 2020
Balance, beginning of period	$	7,634	$	959	$	2,356	$	100	$	11,049	$	3,147	$	319	$	3,466	$	140	$	14,655
Provision for loan losses	2,780		(117)		1,875		(44)		4,494		329		162		491		40		5,025
Charge-offs	(3)		—		(689)		—		(692)		(109)		(117)		(226)		—		(918)
Recoveries	624		8		189		—		821		120		22		142		—		963
Balance, end of period	$	11,035	$	850	$	3,731	$	56	$	15,672	$	3,487	$	386	$	3,873	$	180	$	19,725

The ALL at September 30, 2021, decreased by $186 thousand from December 31, 2020, reflecting a negative provision for loan losses of $10 thousand during the nine months ended September 30, 2021. The allowance for loan losses decreased in the nine months ended September 30, 2021 as a result of the reduction of qualitative factor adjustments for the impact of the COVID-19 pandemic on the Bank’s loan portfolio as the COVID-19 related deferrals returned to normal paying status and the loans performed for an extended period of time, partially offset by the impact of increased commercial loan production.

The increase of $240 thousand in the ALL from September 30, 2020 to September 30, 2021 reflects the COVID-19 related exposure in the loan portfolio and non-SBA PPP commercial loan production. Net recoveries totaled $219 thousand and net charge-offs totaled $176 thousand for the three and nine months ended September 30, 2021, respectively, compared with net recoveries of $8 thousand and $45 thousand for the three and nine months ended September 30, 2020.

Classified loans totaled $26.9 million at September 30, 2021, or 1.4% of total loans outstanding, reflecting a decrease from $33.1 million, or 1.7% of loans outstanding, at December 31, 2020. The asset quality ratios previously noted are indicative of the continued benefit the Company has received from favorable historical charge-off statistics and generally stable economic and market conditions for the last few years, even while the loan portfolio has been growing. Recent loan growth trends

64

contributed to management's determination that an increased provision for loan losses was required to maintain an adequate ALL, with an ALL to total loans ratio of 1.03% at September 30, 2021 as compared to 1.02% at December 31, 2020. Excluding SBA loans, which are 100% guaranteed, the ALL to total loans was 1.2% at September 30, 2021 and 1.3% at December 31, 2020. Despite generally favorable historical charge-off data, the impact of the COVID-19 pandemic on economic conditions may result in the need for additional provisions for loan losses in future quarters.

The following table summarizes the ending loan balances individually or collectively evaluated for impairment based on loan type, as well as the ALL allocation for each, at September 30, 2021 and December 31, 2020, including PCI loans:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
September 30, 2021
Loans allocated by:
Individually evaluated for impairment	$	4,003	$	—	$	2,941	$	—	$	6,944	$	2,974	$	37	$	3,011	$	—	$	9,955
Collectively evaluated for impairment	914,375		84,030		537,264		13,631		1,549,300		361,469		19,040		380,509		—		1,929,809
	$	918,378	$	84,030	$	540,205	$	13,631	$	1,556,244	$	364,443	$	19,077	$	383,520	$	—	$	1,939,764
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	29	$	—	$	29	$	—	$	29
Collectively evaluated for impairment	11,352		1,541		3,886		27		16,806		2,692		230		2,922		208		19,936
	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
December 31, 2020
Loans allocated by:
Individually evaluated for impairment	$	3,528	$	814	$	3,639	$	—	$	7,981	$	3,246	$	17	$	3,263	$	—	$	11,244
Collectively evaluated for impairment	809,087		60,498		643,729		20,523		1,533,837		408,265		26,344		434,609		—		1,968,446
	$	812,615	$	61,312	$	647,368	$	20,523	$	1,541,818	$	411,511	$	26,361	$	437,872	$	—	$	1,979,690
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	33	$	—	$	33	$	—	$	33
Collectively evaluated for impairment	11,151		1,114		3,942		40		16,247		3,329		324		3,653		218		20,118
	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151

In addition to the specific reserve allocations on impaired loans noted previously, 12 loans, with aggregate outstanding principal balances of $1.2 million, have had cumulative partial charge-offs to the ALL totaling $640 thousand at September 30, 2021. As updated appraisals are received on collateral-dependent loans, partial charge-offs are taken to the extent the loans’ principal balance exceeds their fair value.

Management believes the allocation of the ALL between the various loan classes adequately reflects the probable incurred credit losses in each portfolio and is based on the methodology outlined in Note 3, Loans and Allowance for Loan Losses, to the Consolidated Financial Statements under Part I, Item 1, "Financial Information." Management re-evaluates and makes enhancements to its reserve methodology to better reflect the risks inherent in the different segments of the portfolio, particularly in light of increased charge-offs, with noticeable differences between the different loan classes. Management believes these enhancements to the ALL methodology improve the accuracy of quantifying probable incurred credit losses inherent in the portfolio. Management charges actual loan losses to the reserve and bases the provision for loan losses on its overall analysis.

The unallocated portion of the ALL reflects estimated inherent losses within the portfolio that have not been detected, as well as the risk of error in the specific and general reserve allocation, other potential exposure in the loan portfolio, variances in

65

management’s assessment of national and local economic conditions and other factors management believes appropriate at the time. The unallocated portion of the ALL totaled $208 thousand, or 1.0% of the ALL balance, at September 30, 2021 compared with $218 thousand, or 1.1% of the ALL balance at December 31, 2020. The Company monitors the unallocated portion of the ALL and, by policy, has determined it should not exceed 3% of the total reserve. Future negative provisions for loan losses may result if the unallocated portion was to increase, and management determined the reserves were not required for the anticipated risk in the portfolio.

Management believes the Company’s ALL is adequate based on currently available information. Future adjustments to the ALL and enhancements to the methodology may be necessary due to changes in economic conditions, regulatory guidance, or management’s assumptions as to future delinquencies or loss rates.

Deposits

Deposits totaled $2.5 billion at September 30, 2021, an increase of $145.2 million, or 6.2%, from $2.4 billion at December 31, 2020.

Noninterest-bearing deposits increased by $88.5 million, or 19.4%, to $545.3 million, from December 31, 2020 to September 30, 2021. Interest-bearing deposits totaled $2.0 billion at September 30, 2021, an increase of $56.7 million, or 3.0%, from the $1.9 billion balance at December 31, 2020.

Deposit growth in the first nine months of 2021 was principally due to the high usage of checking accounts for SBA PPP loan funds and an influx of municipal deposits. As the SBA PPP clients continue to utilize their borrowings to fund operations, the associated deposits are expected to decline, in addition to a decrease from the runoff of certificates of deposit.

Shareholders' Equity, Capital Adequacy and Regulatory Matters

Capital management in a regulated financial services industry must properly balance return on equity to its shareholders while maintaining sufficient levels of capital and related risk-based regulatory capital ratios to satisfy statutory regulatory requirements. The Company’s capital management strategies have been developed to provide attractive rates of returns to its shareholders, while maintaining a “well capitalized” position of regulatory strength.

Shareholders’ equity totaled $268.6 million at September 30, 2021, an increase of $22.4 million, or 9.1%, from $246.2 million at December 31, 2020. The increase was primarily attributable to net income totaling $26.2 million and other comprehensive income of $2.3 million for the nine months ended September 30, 2021. This is offset by dividends paid on common stock totaling $6.2 million during the nine months ended September 30, 2021.

The Company routinely evaluates its capital levels in light of its risk profile to assess its capital needs. The Company and the Bank are subject to various regulatory capital requirements administered by federal and state banking agencies. The consolidated asset limit on small bank holding companies is $3.0 billion and a company with assets under that limit is not subject to the FRB consolidated capital rules, but may file reports that include capital amounts and ratios. The Company has elected to file those reports.

At September 30, 2021 and December 31, 2020, the Bank was considered well capitalized under applicable banking regulations. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Bank must meet specific guidelines that involve quantitative measures of assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. Prompt corrective action provisions are not applicable to bank holding companies, including financial holding companies.

Note 8, Shareholders' Equity and Regulatory Capital, to the Notes to Unaudited Condensed Consolidated Financial Statements under Part I, Item 1, "Financial Information," includes a table presenting capital amounts and ratios for the Company and the Bank at September 30, 2021 and December 31, 2020.

In addition to the minimum capital ratio requirement and minimum capital ratio to be well capitalized presented in the referenced table in Note 8, the Bank must maintain a capital conservation buffer as more fully described in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, Item 1 - Business, under the topic Basel III Capital Rules. At September 30, 2021, the Bank's capital conservation buffer, based on the most restrictive Total Capital to risk weighted assets capital ratio, was 6.7%, which is greater than the 2.5% requirement.

66

Liquidity

The primary function of asset/liability management is to ensure adequate liquidity and manage the Company’s sensitivity to changing interest rates. Liquidity management involves the ability to meet the cash flow requirements of customers who may be either depositors wanting to withdraw funds or borrowers needing assurance that sufficient funds will be available to meet their credit needs. Our primary sources of funds consist of deposit inflows, loan repayments, maturities and sales of investment securities, the sale of mortgage loans and borrowings from the FHLB of Pittsburgh. While maturities and scheduled amortization of loans and securities are predictable sources of funds, deposit flows and mortgage prepayments are greatly influenced by general interest rates, economic conditions and competition. The maximum borrowing capacity from the FHLB is $841.6 million at September 30, 2021.

We regularly adjust our investments in liquid assets based upon our assessment of expected loan demand, expected deposit flows, yields available on interest-earning deposits and securities and the objectives of our asset/liability management policy. Unencumbered investment securities totaled $128.9 million at September 30, 2021. At September 30, 2021, the Company had $34.2 million of investment securities pledged at the FRB Discount Window, with no associated borrowings outstanding.

The Company had applied for and received access to the Paycheck Protection Program Liquidity Facility ("PPPLF"), created by the FRB for the pledging of PPP loans, to further expand its already robust access to off balance sheet liquidity. Effective July 30, 2021, PPPLF was terminated and no new extensions of credit under the PPPLF were made.

Supplemental Reporting of Non-GAAP Measures

As a result of acquisitions, the Company had intangible assets consisting of goodwill and core deposit and other intangible assets totaling $23.2 million and $24.2 million at September 30, 2021 and December 31, 2020, respectively.

Management believes providing certain “non-GAAP” financial information will assist investors in their understanding of the effect of acquisition activity on reported results, particularly to overcome comparability issues related to the influence of intangibles (principally goodwill) created in acquisitions.

Tangible book value per share and the allowance to non-SBA guarantee loans, as used by the Company in this supplemental reporting presentation, are determined by methods other than in accordance with GAAP. While we believe this information is a useful supplement to GAAP based measures presented in this Form 10-Q, readers are cautioned that this non-GAAP disclosure has limitations as an analytical tool, should not be viewed as a substitute for financial measures determined in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of our results and financial condition as reported under GAAP, nor are such measures necessarily comparable to non-GAAP performance measures that may be presented by other companies. This supplemental presentation should not be construed as an inference that our future results will be unaffected by similar adjustments to be determined in accordance with GAAP.

The following table presents the computation of each non-GAAP based measure shown together with its most directly comparable GAAP based measure.

	September 30, 2021		December 31, 2020
Tangible Book Value per Common Share
Shareholders' equity	$	268,569	$	246,249
Less: Goodwill	18,724		18,724
Other intangible assets	4,486		5,458
Related tax effect	(942)		(1,146)
Tangible common equity (non-GAAP)	$	246,301	$	223,213
Common shares outstanding	11,205		11,201
Book value per share (most directly comparable GAAP based measure)	$	23.97	$	21.98
Intangible assets per share	1.99		2.05
Tangible book value per share (non-GAAP)	$	21.98	$	19.93

67

	September 30, 2021			December 31, 2020
Allowance to Non-SBA Guaranteed Loans:
Allowance for loan losses	$	19,965		$	20,151
Gross loans	$	1,939,764		$	1,979,690
less: SBA guaranteed loans	(261,138)			(404,205)
Non-SBA guaranteed loans	$	1,678,626		$	1,575,485
Allowance to non-SBA guaranteed loans	1.2		%	1.3		%

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market risk comprises exposure to interest rate risk, foreign currency exchange rate risk, commodity price risk, and other relevant market rate or price risks. In the banking industry, a major risk exposure is changing interest rates. The primary objective of monitoring our interest rate sensitivity, or risk, is to provide management the tools necessary to manage the balance sheet to minimize adverse changes in net interest income as a result of changes in the direction and level of interest rates. Federal Reserve Board monetary control efforts, the effects of deregulation, economic uncertainty and legislative changes have been significant factors affecting the task of managing interest rate sensitivity positions in recent years.

Interest Rate Risk

Interest rate risk is the exposure to fluctuations in the Company’s future earnings (earnings at risk) and value (value at risk) resulting from changes in interest rates. This exposure results from differences between the amounts of interest-earning assets and interest-bearing liabilities that reprice within a specified time period as a result of scheduled maturities, scheduled and unscheduled repayments, the propensity of borrowers and depositors to react to changes in their economic interests, and loan contractual interest rate changes.

We attempt to manage the level of repricing and maturity mismatch through our asset/liability management process so that fluctuations in net interest income are maintained within policy limits across a range of market conditions, while satisfying liquidity and capital requirements. Management recognizes that a certain amount of interest rate risk is inherent, appropriate and necessary to ensure the Company’s profitability. Thus, the goal of interest rate risk management is to evaluate the amount of reward for taking risk and adjusting both the size and composition of the balance sheet relative to the level of reward available for taking risk.

Management endeavors to control the exposure to changes in interest rates by understanding, reviewing and making decisions based on its risk position. The Company primarily uses its securities portfolio, FHLB advances, interest rate swaps and brokered deposits to manage its interest rate risk position. Additionally, pricing, promotion and product development activities are directed in an effort to emphasize the loan and deposit term or repricing characteristics that best meet current interest rate risk objectives.

We use simulation analysis to assess earnings at risk and net present value analysis to assess value at risk. These methods allow management to regularly monitor both the direction and magnitude of our interest rate risk exposure. These analyses require numerous assumptions including, but not limited to, changes in balance sheet mix, prepayment rates on loans and securities, cash flows and repricing of all financial instruments, changes in volumes and pricing, future shapes of the yield curve, relationship of market interest rates to each other (basis risk), credit spread and deposit sensitivity. Assumptions are based on management’s best estimates but may not accurately reflect actual results under certain changes in interest rate due to the timing, magnitude and frequency of rate changes and changes in market conditions and management strategies, among other factors. However, the analyses are useful in quantifying risk and providing a relative gauge of our interest rate risk position over time.

Our asset/liability committee operates under management policies, approved by the Board of Directors, which define guidelines and limits on the level of risk. The committee meets regularly and reviews our interest rate risk position and monitors various liquidity ratios to ensure a satisfactory liquidity position. By utilizing our analyses, we can determine changes that may need to be made to the asset and liability mixes to mitigate the change in net interest income under various interest rate scenarios. Management continually evaluates the condition of the economy, the pattern of market interest rates and other economic data to inform the committee on the selection of investment securities. Regulatory authorities also monitor our interest rate risk position along with other liquidity ratios.

68

Net Interest Income Sensitivity

Simulation analysis evaluates the effect of upward and downward changes in market interest rates on future net interest income. The analysis involves changing the interest rates used in determining net interest income over the next twelve months. The resulting percentage change in net interest income in various rate scenarios is an indication of our short-term interest rate risk. The analysis assumes recent pricing trends in new loan and deposit volumes will continue while balances remain constant. Additional assumptions are applied to modify pricing under the various rate scenarios.

The simulation analysis results are presented in the Net Interest Income table below. At September 30, 2021 and December 31, 2020, results indicated the Company would be better positioned over the subsequent 12 months in an increasing rate environment than it would be if interest rates decreased. This is due to the composition of the balance sheet between fixed- and floating-rate assets, and liabilities that will reprice more rapidly as deposits migrate from certificates of deposit to non-maturity deposits, coupled with the steep decline in rates during 2020. The Company has become more asset sensitive since December 31, 2020 due to the increase in liquidity and overall size of the balance sheet size and mix, specifically through non-maturity deposits. As such, an increase in interest rates would benefit the Company more than in prior periods.

Economic Value

Net present value analysis provides information on the risk inherent in the balance sheet that might not be considered in the simulation analysis due to the short time horizon used in that analysis. The net present value of the balance sheet incorporates the discounted present value of expected asset cash flows minus the discounted present value of expected liability cash flows. The analysis involves changing the interest rates used in determining the expected cash flows and in discounting the cash flows. The resulting percentage change in net present value in various rate scenarios is an indication of the longer term repricing risk and options embedded in the balance sheet.

At September 30, 2021, similar to December 31, 2020, these results indicate the Company would be better positioned in a rising interest rate environment than it would be if interest rates decreased. The results at September 30, 2021 are driven by the impact of the low interest rate environment and the composition of the balance sheet. To improve the comparability across periods, the Company follows best practices and maintains the size and mix of the period end balance sheet; thus, the results do not reflect actions management may take to improve results.

Net Interest Income					Economic Value
	% Change in Net Interest Income					% Change in Market Value
Change in Market Interest Rates (basis points)	September 30, 2021		December 31, 2020		Change in Market Interest Rates (basis points)	September 30, 2021		December 31, 2020
(100)	(0.9)	%	(0.8)	%	(100)	(48.0)	%	(99.6)	%
100	3.1	%	1.7	%	100	29.0	%	70.7	%
200	5.4	%	2.4	%	200	46.0	%	116.4	%
300	4.7	%	0.7	%	300	56.0	%	144.9	%

Item 4. Controls and Procedures

Based on the evaluation required by Securities Exchange Act Rules 13a-15(b) and 15d-15(b), the Company's management, including the Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of its disclosure controls and procedures, as defined in Securities Exchange Act Rules 13a-15(e) and 15d-15(e), at September 30, 2021.  Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective at September 30, 2021.  There have been no changes in internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting during the nine months ended September 30, 2021.

69

PART II – OTHER INFORMATION

Item 1 – Legal Proceedings

Information regarding legal proceedings is included in Note 12, Contingencies, to the Consolidated Financial Statements under Part I, Item 1, "Financial Statements" and incorporated herein by reference.

Item 1A – Risk Factors

There have been no material changes from the risk factors as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020 and our Quarterly Report on Form 10-Q for the quarterly periods ended March 31, 2021 and June 30, 2021.

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

	(a)	(b)		(c)	(d)
Period	Total number of shares (or units) purchased	Average price paid per share (or unit)		Total number of shares (or units) purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs
July 1, 2021 to July 31, 2021	—	$	—	—	823,320
August 1, 2021 to August 29, 2021	1,973	22.86		1,973	821,347
September 1, 2021 to September 30, 2021	44,865	22.82		44,865	776,482
Total	46,838	$	22.82	46,838

In September 2015, the Board of Directors of the Company authorized a share repurchase program under which the Company may repurchase up to 5% of the Company's outstanding shares of common stock, or approximately 416,000 shares, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act. On April 19, 2021, the Board of Directors authorized the additional future repurchase of up to 562,000 shares of its outstanding common stock. At September 30, 2021, 201,518 shares had been repurchased under the program at a total cost of $3.7 million, or $18.26 per share. Common stock available for future repurchase totals approximately 776,482 shares, or 7% of the Company's outstanding common stock at September 30, 2021. When and if appropriate, repurchases may be made in open market or privately negotiated transactions, depending on market conditions, regulatory requirements and other corporate considerations, as determined by management. Share repurchases may not occur and may be discontinued at any time. For the three months ended September 30, 2021, the Company repurchased 46,838 shares of its common stock at an average price of $22.82 per share.

Item 3 – Defaults Upon Senior Securities

Not applicable.

Item 4 – Mine Safety Disclosures

Not applicable.

Item 5 – Other Information

None.

70

Item 6 – Exhibits

3.1	Articles of Incorporation as amended, incorporated by reference to Exhibit 3.1 of the Registrant’s Report on Form 8-K filed on January 29, 2010.
3.2	By-laws as amended, incorporated by reference to Exhibit 3.2 to the Registrant’s Report on Form 8-K filed June 2, 2021.
4.1	Specimen Common Stock Certificate, incorporated by reference to the Registrant’s Registration Statement on Form S-3 filed February 8, 2010 (File No. 333-164780).
31.1	Rule 13a – 14(a)/15d-14(a) Certification (Principal Executive Officer)
31.2	Rule 13a – 14(a)/15d-14(a) Certifications (Principal Financial Officer)
32.1	Section 1350 Certifications (Principal Executive Officer)
32.2	Section 1350 Certifications (Principal Financial Officer)
101.LAB	XBRL Taxonomy Extension Label Linkbase
101.PRE	XBRL Taxonomy Extension Presentation Linkbase
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation Linkbase
101.DEF	XBRL Taxonomy Extension Definition Linkbase
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

All other exhibits for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are not required under the related instructions or are inapplicable and therefore have been omitted.

71

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

/s/ Thomas R. Quinn, Jr.

Thomas R. Quinn, Jr.

President and Chief Executive Officer

(Principal Executive Officer)

/s/ Neelesh Kalani

Neelesh Kalani

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

Date: November 5, 2021

72

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Thomas R. Quinn, Jr., certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Orrstown Financial Services, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 5, 2021	By:	/s/ Thomas R. Quinn, Jr.
		Thomas R. Quinn, Jr.
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Neelesh Kalani, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Orrstown Financial Services, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2021	By:	/s/ Neelesh Kalani
		Neelesh Kalani
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Orrstown Financial Services, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date therein specified (the “Report”), I, Thomas R. Quinn, Jr., President and Chief Executive Officer (Principal Executive Officer) of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: November 5, 2021	By:	/s/ Thomas R. Quinn, Jr.
		Thomas R. Quinn, Jr.
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Orrstown Financial Services, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date therein specified (the “Report”), I, Neelesh Kalani, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: November 5, 2021	By:	/s/ Neelesh Kalani
		Neelesh Kalani
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

XML

Cover - shares	9 Months Ended
	Sep. 30, 2021	Nov. 01, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-34292
Entity Registrant Name	ORRSTOWN FINANCIAL SERVICES, INC.
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	23-2530374
Entity Address, Address Line One	77 East King Street
Entity Address, Address Line Two	P. O. Box 250
Entity Address, City or Town	Shippensburg
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	17257
City Area Code	(717)
Local Phone Number	532-6114
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	ORRF
Securities Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		11,206,452
Entity Central Index Key	0000826154
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Assets
Cash and due from banks	$ 36,920	$ 26,203
Interest-bearing deposits with banks	274,495	99,055
Cash and cash equivalents	311,415	125,258
Restricted investments in bank stocks	7,051	10,563
Securities available for sale (amortized cost of $437,852 and $460,999 at September 30, 2021 and December 31, 2020, respectively)	445,018	466,465
Loans held for sale, at fair value	6,412	11,734
Loans	1,939,764	1,979,690
Less: Allowance for loan losses	(19,965)	(20,151)
Net loans	1,919,799	1,959,539
Premises and equipment, net	34,279	35,149
Cash surrender value of life insurance	69,792	68,554
Goodwill	18,724	18,724
Other intangible assets, net	4,486	5,458
Accrued interest receivable	8,015	8,927
Other assets	45,191	40,201
Total assets	2,870,182	2,750,572
Deposits:
Noninterest-bearing	545,323	456,778
Interest-bearing	1,956,785	1,900,102
Total deposits	2,502,108	2,356,880
Securities sold under agreements to repurchase	27,595	19,466
FHLB advances and other borrowings	2,003	58,045
Subordinated notes	31,948	31,903
Other liabilities	37,959	38,029
Total liabilities	2,601,613	2,504,323
Shareholders’ Equity
Preferred stock, value	0	0
Common stock, value	586	586
Additional paid - in capital	189,168	189,066
Retained earnings	74,122	54,099
Accumulated other comprehensive income	5,661	3,346
Treasury stock— 43,865 and 55,729 shares, at cost at September 30, 2021 and December 31, 2020, respectively	(968)	(848)
Total shareholders’ equity	268,569	246,249
Total liabilities and shareholders’ equity	$ 2,870,182	$ 2,750,572

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Securities available for sale amortized cost	$ 437,852	$ 460,999
Preferred stock, par value (usd per share)	$ 1.25	$ 1.25
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, stated value (usd per share)	$ 0.05205	$ 0.05205
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	11,248,917	11,257,046
Common stock, shares outstanding (in shares)	11,205,052	11,201,317
Treasury stock - common - shares (in shares)	43,865	55,729

XML

Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Interest income
Loans	$ 19,890	$ 21,645	$ 62,724	$ 63,605
Investment securities - taxable	1,514	2,145	5,007	8,378
Investment securities - tax-exempt	652	417	1,790	1,121
Short-term investments	135	9	255	101
Total interest income	22,191	24,216	69,776	73,205
Interest expense
Deposits	937	2,483	3,410	10,147
Securities sold under agreements to repurchase	8	20	25	72
FHLB advances and other borrowings	123	394	458	1,604
Subordinated notes	503	501	1,507	1,504
Total interest expense	1,571	3,398	5,400	13,327
Net interest income	20,620	20,818	64,376	59,878
Provision for loan losses	365	2,200	(10)	5,025
Net interest income after provision for loan losses	20,255	18,618	64,386	54,853
Noninterest income
Service charges on deposit accounts	796	684	2,231	2,085
Interchange income	1,030	900	3,049	2,507
Other service charges and fees	197	168	527	473
Swap fee income	67	95	135	527
Trust and investment management income	1,930	1,713	5,862	5,049
Brokerage income	987	751	2,708	2,069
Mortgage banking activities	1,333	1,985	4,684	3,926
Gains on sale of portfolio loans	0	0	0	2,803
Income from life insurance	569	543	1,690	1,615
Investment securities gains (losses)	479	(13)	635	(44)
Other income	263	35	338	118
Total noninterest income	7,651	6,861	21,859	21,128
Noninterest expenses
Salaries and employee benefits	11,498	10,695	31,907	32,352
Occupancy	1,154	1,231	3,492	3,480
Furniture and equipment	1,220	1,203	3,800	3,569
Data processing	990	958	3,041	2,620
Automated teller and interchange fees	294	278	862	778
Advertising and bank promotions	735	197	1,434	1,153
FDIC insurance	218	230	570	491
Professional services	562	603	1,862	2,340
Directors' compensation	155	214	624	679
Taxes other than income	16	453	929	904
Intangible asset amortization	314	357	972	1,224
Branch consolidation expenses	0	1,310	0	1,310
Insurance claim receivable recovery	0	0	0	(486)
Other operating expenses	1,879	1,536	4,358	5,586
Total noninterest expenses	19,035	19,265	53,851	56,000
Income before income tax expense	8,871	6,214	32,394	19,981
Income tax expense	1,679	1,237	6,219	3,577
Net income	$ 7,192	$ 4,977	$ 26,175	$ 16,404
Per share information:
Basic earnings per share (in usd per share)	$ 0.66	$ 0.45	$ 2.38	$ 1.50
Diluted earnings per share (in usd per share)	0.65	0.45	2.36	1.49
Dividends paid per share (in usd per share)	$ 0.19	$ 0.17	$ 0.55	$ 0.51

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 7,192	$ 4,977	$ 26,175	$ 16,404
Other comprehensive income (loss), net of tax:
Unrealized (losses) gains on securities available for sale arising during the period	(2,346)	4,296	2,335	375
Reclassification adjustment for (gains) losses realized in net income	(479)	13	(635)	44
Net unrealized (losses) gains on securities available for sale	(2,825)	4,309	1,700	419
Tax effect	593	(904)	(357)	(87)
Total other comprehensive (loss) income, net of tax and reclassification adjustments on securities available for sale	(2,232)	3,405	1,343	332
Unrealized (losses) gains on interest rate swaps used in cash flow hedges	(183)	208	473	(1,893)
Reclassification adjustment for losses realized in net income	581	114	757	239
Net unrealized gains (losses) on interest rate swaps used in cash flow hedges	398	322	1,230	(1,654)
Tax effect	(83)	(68)	(258)	347
Total other comprehensive gains (losses), net of tax and reclassification adjustments on interest rate swaps used in cash flow hedges	315	254	972	(1,307)
Total other comprehensive (loss) income, net of tax and reclassification adjustments	(1,917)	3,659	2,315	(975)
Total comprehensive income	$ 5,275	$ 8,636	$ 28,490	$ 15,429

XML

Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance at Dec. 31, 2019	$ 223,249	$ 584	$ 188,365	$ 35,246	$ (480)	$ (466)
Increase (Decrease) in Shareholders' Equity
Net income	16,404			16,404
Total other comprehensive income (loss) net of taxes	(975)				(975)
Cash dividends	(5,712)			(5,712)
Shares-based compensation plans:
Shares issued, shares acquired including compensation expense	(119)	2	223			(344)
Ending balance at Sep. 30, 2020	232,847	586	188,588	45,938	(1,455)	(810)
Beginning balance at Jun. 30, 2020	225,638	586	188,226	42,862	(5,114)	(922)
Increase (Decrease) in Shareholders' Equity
Net income	4,977			4,977
Total other comprehensive income (loss) net of taxes	3,659				3,659
Cash dividends	(1,901)			(1,901)
Shares-based compensation plans:
Shares issued, shares acquired including compensation expense	474	0	362			112
Ending balance at Sep. 30, 2020	232,847	586	188,588	45,938	(1,455)	(810)
Beginning balance at Dec. 31, 2020	246,249	586	189,066	54,099	3,346	(848)
Increase (Decrease) in Shareholders' Equity
Net income	26,175			26,175
Total other comprehensive income (loss) net of taxes	2,315				2,315
Cash dividends	(6,152)			(6,152)
Shares-based compensation plans:
Shares issued, shares acquired including compensation expense	(18)	0	102			(120)
Ending balance at Sep. 30, 2021	268,569	586	189,168	74,122	5,661	(968)
Beginning balance at Jun. 30, 2021	265,938	586	188,772	69,052	7,578	(50)
Increase (Decrease) in Shareholders' Equity
Net income	7,192			7,192
Total other comprehensive income (loss) net of taxes	(1,917)				(1,917)
Cash dividends	(2,122)			(2,122)
Shares-based compensation plans:
Shares issued, shares acquired including compensation expense	(522)	0	396			(918)
Ending balance at Sep. 30, 2021	$ 268,569	$ 586	$ 189,168	$ 74,122	$ 5,661	$ (968)

XML

Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Stockholders' Equity [Abstract]
Dividends per share (in usd per share)	$ 0.19	$ 0.17	$ 0.55	$ 0.51
Common shares issued during the period (in shares)	16,593		8,129	36,442
Common shares forfeited (in shares)		11,383
Treasury stock, shares issued/acquired (in shares)	41,106	5,634	11,864	32,804
Compensation expense, issuance of stock	$ 483	$ 437	$ 1,428	$ 1,613

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities
Net income	$ 26,175	$ 16,404
Adjustments to reconcile net income to net cash provided by operating activities:
Net discount accretion	(690)	(2,898)
Depreciation and amortization expense	4,014	4,980
Impairment of intangibles	0	153
Provision for loan losses	(10)	5,025
Share-based compensation	1,428	1,613
Gains on sales of loans originated for sale	(3,980)	(4,028)
Mortgage loans originated for sale	(150,652)	(147,647)
Proceeds from sales of loans originated for sale	159,425	146,890
Gains on sale of portfolio loans	0	(2,803)
Net gain on disposal of OREO	0	164
Writedown of OREO	0	544
Deferred income taxes	(267)	(672)
Investment securities (gains) losses	(635)	44
Loss on derivative terminations	514	0
Income from life insurance	(1,690)	(1,615)
Decrease (increase) in accrued interest receivable	912	(2,772)
Increase in accrued interest payable and other liabilities	(221)	(504)
Other, net	(4,108)	3,460
Net cash provided by operating activities	30,215	16,338
Cash flows from investing activities
Proceeds from sales of AFS securities	149,038	0
Maturities, repayments and calls of AFS securities	30,525	38,970
Purchases of AFS securities	(156,912)	(26,691)
Net redemptions of restricted investments in bank stocks	3,512	3,538
Net decrease in loans	41,504	65,605
Proceeds from sales of portfolio loans	0	22,665
Purchases of bank premises and equipment	(891)	(914)
Proceeds from disposal of OREO	0	3,734
Proceeds from disposal of bank premises and equipment	0	59
Purchases of bank owned life insurance	0	(3,636)
Net cash provided by investing activities	66,776	103,330
Cash flows from financing activities
Net increase (decrease) in deposits	145,203	(63,761)
Net increase (decrease) in borrowings with original maturities less than 90 days	8,129	(137,424)
Proceeds from FHLB advances and other borrowings	0	180,955
Payments on FHLB advances and other borrowings	(56,042)	(60,649)
Settlement of terminated derivatives	(525)	0
Dividends paid	(6,152)	(5,712)
Acquisition of treasury stock	(1,069)	(1,170)
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting	(514)	(679)
Proceeds from issuance of employee stock purchase plan shares	136	116
Net cash provided by (used in) financing activities	89,166	(88,324)
Net increase in cash and cash equivalents	186,157	31,344
Cash and cash equivalents at beginning of period	125,258	55,963
Cash and cash equivalents at end of period	311,415	87,307
Cash paid during the period for:
Interest	5,007	13,387
Income taxes	$ 4,100	$ 0

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

See the Glossary of Defined Terms at the beginning of this Report for terms used throughout the unaudited condensed consolidated financial statements and related notes of this Form 10-Q.

Nature of Operations – Orrstown Financial Services, Inc. is a financial holding company that operates Orrstown Bank, a commercial bank providing banking and financial advisory services in Berks, Cumberland, Dauphin, Franklin, Lancaster, Perry and York Counties, Pennsylvania, and in Anne Arundel, Baltimore, Howard and Washington Counties, Maryland, as well as Baltimore City, Maryland. The Company operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services, including checking, savings, time, and money market deposits. The Company also provides fiduciary services, investment advisory, insurance and brokerage services. The Company and the Bank are subject to regulation by certain federal and state agencies and undergo periodic examinations by such regulatory authorities.

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements include the accounts of Orrstown Financial Services, Inc. and its wholly owned subsidiary, the Bank. The Company has prepared these unaudited condensed consolidated financial statements in accordance with GAAP for interim financial information, SEC rules that permit reduced disclosure for interim periods, and Article 10 of Regulation S-X. In the opinion of management, all adjustments (all of which are of a normal recurring nature) that are necessary for a fair statement are reflected in the unaudited condensed consolidated financial statements. The December 31, 2020 consolidated balance sheet information contained in this Quarterly Report on Form 10-Q was derived from the Company's 2020 audited consolidated financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. All significant intercompany transactions and accounts have been eliminated.

The Company's management has evaluated all activity of the Company and concluded that subsequent events are properly reflected in the Company's unaudited condensed consolidated financial statements and notes as required by GAAP.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. The effects of the COVID-19 pandemic may impact material estimates. Material estimates that are particularly susceptible to significant change include the determination of the ALL and those used in valuation methodologies in areas with no observable market, such as loans, deposits, borrowings, goodwill, core deposit and other intangible assets, mortgage servicing rights, other assets and liabilities obtained or assumed in business combinations. Certain prior-year amounts have been reclassified to conform to the current year presentation. These reclassifications did not have a material impact on the Company's consolidated financial condition or results of operations.

Derivatives - FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge.

The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company's objectives in using interest rate derivatives are to add stability to interest income and to manage its exposure to interest rate movements. To accomplish this objective, the Company uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of fixed amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount.

Changes to the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income and are subsequently reclassified into earnings in the period that the hedged transaction affects earnings. The Company discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in accumulated other comprehensive income (loss) are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. Such derivatives were used to hedge the variable cash flows associated with overnight borrowings. During the three and nine months ended September 30, 2021, the Company terminated its interest rate derivative designated as a cash flow hedge.

Derivatives not designated as hedges are not speculative and result from a service the Company provides to certain customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting derivatives that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate derivatives associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer derivatives and the offsetting derivatives are recognized directly in earnings.

Leases - The Company evaluates its contracts at inception to determine if an arrangement either is a lease or contains one. Operating lease ROU assets are included in other assets and operating lease liabilities in accrued interest payable and other liabilities in the unaudited condensed consolidated balance sheets. The Company had no finance leases at September 30, 2021.

ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company's leases do not provide an implicit rate, so the Company's incremental borrowing rate is used, which approximates its fully collateralized borrowing rate, based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is reevaluated upon lease modification. The operating lease ROU asset also includes any initial direct costs and prepaid lease payments made less any lease incentives. In calculating the present value of lease payments, the Company may include options to extend the lease when it is reasonably certain that it will exercise that option.

In accordance with ASU 2016-02, “Leases (Topic 842)” (“ASU 2016-02”), the Company keeps leases with an initial term of 12 months or less off of the balance sheet. The Company recognizes these lease payments in the unaudited condensed consolidated statements of income on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components and has elected the practical expedient to account for them as a single lease component.

Recent Accounting Pronouncements - ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The amendments in this update require an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Organizations will continue to use judgment to determine which loss estimation method is appropriate for their circumstances. Additionally, the amendments in this update amend the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For certain public companies, this update was effective for interim and annual periods beginning after December 15, 2019. The Company delayed the adoption of ASU 2016-13 as noted below.

ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates ("ASU 2019-10"), extended the implementation deadline of ASU 2016-13 for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company meets the requirements to be considered a smaller reporting company under SEC Regulation S-K and SEC Rule 405, and did not adopt ASU 2016-13 on January 1, 2020. The Company is evaluating the impact of the delay for adoption of ASU 2016-13, and is working with a third-party vendor solution to assist with the application of ASU 2016-13 and finalizing the loss estimation models to be used. Once management determines which methods will be utilized, a third party will be contracted to perform a model validation prior to adoption. While the Company anticipates the allowance for loan losses will increase under its current

assumptions, it expects the impact of adopting ASU 2016-13 will be influenced by the composition, characteristics and quality of its loan and securities portfolios, as well as general economic conditions and forecasts at the adoption date. The other provisions of ASU 2019-10 were not applicable to the Company.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). ASU 2020-04 contains optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The optional expedients apply consistently to all contracts or transactions within the scope of this topic, while the optional expedients for hedging relationships can be elected on an individual basis. The Company has formed a cross-functional working group to lead the transition from LIBOR to a planned adoption of an alternate index. The Company currently plans to replace LIBOR with the 30-Day Average SOFR in its loan agreements. The Company is in the process of implementing fallback language for loans that will mature after 2021. The Company expects to adopt the LIBOR transition relief allowed under this standard, and is currently evaluating the potential impact of this guidance on its financial statements.

XML

INVESTMENT SECURITIES

9 Months Ended

Sep. 30, 2021

Investments, Debt and Equity Securities [Abstract]

INVESTMENT SECURITIES

INVESTMENT SECURITIESAt September 30, 2021 and December 31, 2020, all investment securities were classified as AFS. The following table summarizes amortized cost and fair value of investment securities, and the corresponding amounts of gross unrealized gains and losses recognized in AOCI, at September 30, 2021 and December 31, 2020:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
September 30, 2021
U.S. Treasury securities	$	20,087	$	—	$	256	$	19,831
States and political subdivisions	174,239		8,072		790		181,521
GSE residential MBSs	20,552		80		114		20,518
GSE residential CMOs	69,922		921		656		70,187
Non-agency CMOs	25,929		1		273		25,657
Asset-backed	126,726		457		276		126,907
Other	397		—		—		397
Totals	$	437,852	$	9,531	$	2,365	$	445,018
December 31, 2020
States and political subdivisions	$	104,704	$	9,091	$	1,125	$	112,670
GSE residential MBSs	4,197		96		—		4,293
GSE residential CMOs	56,856		2,226		1,071		58,011
Non-agency CMOs	16,505		413		—		16,918
Private label commercial CMOs	63,941		57		1,762		62,236
Asset-backed	214,425		171		2,630		211,966
Other	371		—		—		371
Totals	$	460,999	$	12,054	$	6,588	$	466,465

The following table summarizes investment securities with unrealized losses at September 30, 2021 and December 31, 2020, aggregated by major investment security type and the length of time in a continuous unrealized loss position.

	Less Than 12 Months					12 Months or More					Total
	# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses
September 30, 2021
U.S. Treasury securities	3	$	19,831	$	256	—	$	—	$	—	3	$	19,831	$	256
States and political subdivisions	11	40,666		790		—	—		—		11	40,666		790
GSE residential MBSs	5	17,354		114		—	—		—		5	17,354		114
GSE residential CMOs	7	43,267		656		—	—		—		7	43,267		656
Non-agency CMOs	1	13,257		273		—	—		—		1	13,257		273
Asset-backed	2	19,084		14		3	36,067		262		5	55,151		276
Totals	29	$	153,459	$	2,103	3	$	36,067	$	262	32	$	189,526	$	2,365
December 31, 2020
States and political subdivisions	1	$	9,079	$	1,125	—	$	—	$	—	1	$	9,079	$	1,125
GSE residential CMOs	3	23,954		1,071		—	—		—		3	23,954		1,071
Private label commercial CMOs	1	4,314		685		10	42,403		1,077		11	46,717		1,762
Asset-backed	2	16,921		12		15	183,161		2,618		17	200,082		2,630
Totals	7	$	54,268	$	2,893	25	$	225,564	$	3,695	32	$	279,832	$	6,588

The Company determines whether unrealized losses are temporary in nature in accordance with FASB ASC 320-10, Investments - Overall, (“FASB ASC 320-10”) and FASB ASC 325-40, Investments – Beneficial Interests in Securitized Financial Assets, when applicable. The evaluation is based upon factors such as the creditworthiness of the underlying borrowers, performance of the underlying collateral, if applicable, and the level of credit support in the security structure. Management also evaluates other factors and circumstances that may be indicative of an OTTI condition. This includes, but is not limited to, an evaluation of the type of security, length of time and extent to which the fair value has been less than cost and near-term prospects of the issuer.

FASB ASC 320-10 requires the Company to assess if an OTTI exists by considering whether the Company has the intent to sell the security or it is more likely than not that it will be required to sell the security before recovery. If either of these situations applies, the guidance requires the Company to record an OTTI charge to earnings on debt securities for the difference between the amortized cost basis of the security and the fair value of the security. If neither of these situations applies, the Company is required to assess whether it is expected to recover the entire amortized cost basis of the security. If the Company is not expected to recover the entire amortized cost basis of the security, the guidance requires the Company to bifurcate the identified OTTI into a credit loss component and a component representing loss related to other factors. A discount rate is applied which equals the effective yield of the security. The difference between the present value of the expected flows and the amortized book value is considered a credit loss, which would be recorded through earnings as an OTTI charge. When a market price is not readily available, the market value of the security is determined using the same expected cash flows; the discount rate is a rate the Company determines from the open market and other sources as appropriate for the security. The difference between the market value and the present value of cash flows expected to be collected is recognized in accumulated other comprehensive loss on the unaudited condensed consolidated statements of financial condition.

As of September 30, 2021, the Company had no cumulative OTTI. There were no OTTI charges recognized in earnings as a result of credit losses on investments in the three and nine months ended September 30, 2021 and 2020. During 2020, unrealized losses were substantially higher due to market uncertainty brought about by the COVID-19 pandemic. The sudden and desperate need for liquidity from many institutional pools of capital, combined with the global economic implications of the COVID-19 pandemic, caused significant widening of spreads. Market conditions improved in the second half of 2020 and into 2021 as the uncertainty dissipated with economies re-opening and the distribution of vaccines.

U.S. Treasury Securities. The unrealized losses presented in the table above have been caused by an increase in rates from the time these securities were purchased. Management considers the full faith and credit of the U.S. government in determining whether a security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021.

States and Political Subdivisions. The unrealized losses presented in the table above have been caused by a widening of spreads from the time these securities were purchased. Management considers the investment rating, the state of the issuer of

the security and other credit support in determining whether the security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021 or December 31, 2020.

GSE Residential CMOs and GSE Residential MBS. The unrealized losses presented in the table above have been caused by a widening of spreads from the time these securities were purchased. The contractual terms of these securities do not permit the issuer to settle the securities at a price less than its par value basis. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021 or December 31, 2020.

Non-Agency CMOs. The unrealized losses presented in the table above were caused by a widening of spreads and/or a rise in interest rates from the time the securities were purchased. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021.

Asset-backed. The unrealized losses presented in the table above were caused by a widening of spreads from the time the securities were purchased. Management considers the investment rating and other credit support in determining whether a security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at September 30, 2021 or December 31, 2020.

The following table summarizes amortized cost and fair value of investment securities by contractual maturity at September 30, 2021. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date are shown separately.

	Amortized Cost		Fair Value
Due in one year or less	$	—	$	—
Due after one year through five years	249		249
Due after five years through ten years	69,999		71,976
Due after ten years	124,475		129,524
CMOs and MBSs	116,403		116,362
Asset-backed	126,726		126,907
Totals	$	437,852	$	445,018

The following table summarizes proceeds from sales of investment securities and gross gains and gross losses for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Proceeds from sale of investment securities	$	73,319	$	—	$	149,038	$	—
Gross gains	482		—		1,844		—
Gross losses	3		13		1,209		44

During the three and nine months ended September 30, 2021, net investment security gains of $479 thousand and $635 thousand were recorded, respectively, compared to a net loss of $13 thousand and $44 thousand recorded to adjust an equity security to market value for the three and nine months ended September 30, 2020, respectively. During the nine months ended September 30, 2021, 18 securities with a principal balance of $148.4 million were sold for proceeds of $149.0 million compared to none during the nine months ended September 30, 2020. There were four investment securities with a principal balance of $72.8 million sold for proceeds of $73.3 million during the three months ended September 30, 2021, compared to none during the three months ended September 30, 2020. Investment securities with a fair value of $316.0 million and $398.7 million at September 30, 2021 and December 31, 2020, respectively, were pledged to secure public funds and for other purposes as required or permitted by law.

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES

9 Months Ended

Sep. 30, 2021

Receivables [Abstract]

LOANS AND ALLOWANCE FOR LOAN LOSSES

LOANS AND ALLOWANCE FOR LOAN LOSSES

Consistent with ASU 2010-20, Disclosures about the Credit Quality of Financing Receivables and the Allowance for Loan Losses, the Company’s loan portfolio is grouped into segments which are further broken down into classes to allow management to monitor the performance by the borrower and to monitor the yield on the portfolio.

The risks associated with lending activities differ among the various loan classes and are subject to the impact of changes in interest rates, market conditions of collateral securing the loans, and general economic conditions. All of these factors may adversely impact both the borrower’s ability to repay its loans and associated collateral.

The Company has various types of commercial real estate loans, which have differing levels of credit risk. Owner occupied commercial real estate loans are generally dependent upon the successful operation of the borrower’s business, with the cash flows generated from the business being the primary source of repayment of the loan. If the business suffers a downturn in sales or profitability, the borrower’s ability to repay the loan could be in jeopardy.

Non-owner occupied and multi-family commercial real estate loans and non-owner occupied residential loans present a different credit risk to the Company than owner occupied commercial real estate loans, as the repayment of the loan is dependent upon the borrower’s ability to generate a sufficient level of occupancy to produce rental income that exceeds debt service requirements and operating expenses. Lower occupancy or lease rates may result in a reduction in cash flows, which hinders the ability of the borrower to meet debt service requirements, and may result in lower collateral values. The Company generally recognizes that greater risk is inherent in these credit relationships compared to owner occupied loans mentioned above.

Acquisition and development loans consist of 1-4 family residential construction and commercial and land development loans. The risk of loss on these loans is largely dependent on the Company’s ability to assess the property’s value at the completion of the project, which should exceed the property’s construction costs. During the construction phase, a number of factors could potentially negatively impact the collateral value, including cost overruns, delays in completing the project, competition, and real estate market conditions, which may change based on the supply of similar properties in the area. In the event the collateral value at the completion of the project is not sufficient to cover the outstanding loan balance, the Company must rely upon other repayment sources, if any, including the guarantors of the project or other collateral securing the loan.

Commercial and industrial loans include advances to local and regional businesses for general commercial purposes and include permanent and short-term working capital, machinery and equipment financing, and may be either in the form of lines of credit or term loans. Although commercial and industrial loans may be unsecured to our highest-rated borrowers, the majority of these loans are secured by the borrower’s accounts receivable, inventory and machinery and equipment. In a significant number of these loans, the collateral also includes the business real estate or the business owner’s personal real estate or assets. Commercial and industrial loans present credit exposure to the Company, as they are more susceptible to risk of loss during a downturn in the economy as borrowers may have greater difficulty in meeting their debt service requirements and the value of the collateral may decline. The Company attempts to mitigate this risk through its underwriting standards, including evaluating the creditworthiness of the borrower and, to the extent available, credit ratings on the business. Additionally, monitoring of the loans through annual renewals and meetings with the borrowers are typical. However, these procedures cannot eliminate the risk of loss associated with commercial and industrial lending. At September 30, 2021 and December 31, 2020, commercial and industrial loans include $259.9 million and $403.3 million, respectively, of loans, net of deferred fees and costs, originated through the SBA PPP.

Municipal loans consist of extensions of credit to municipalities and school districts within the Company’s market area. These loans generally present a lower risk than commercial and industrial loans, as they are generally secured by the municipality’s full taxing authority, by revenue obligations, or by its ability to raise assessments on its customers for a specific utility.

The Company originates loans to its retail customers, including fixed-rate and adjustable first lien mortgage loans, with the underlying 1-4 family owner occupied residential property securing the loan. The Company’s risk exposure is minimized in these types of loans through the evaluation of the creditworthiness of the borrower, including credit scores and debt-to-income ratios, and underwriting standards, which limit the loan-to-value ratio to generally no more than 80% upon loan origination, unless the borrower obtains private mortgage insurance.

Home equity loans, including term loans and lines of credit, present a slightly higher risk to the Company than 1-4 family first liens, as these loans can be first or second liens on 1-4 family owner occupied residential property, but can have loan-to-value ratios of no greater than 90% of the value of the real estate taken as collateral. The creditworthiness of the borrower is also considered, including credit scores and debt-to-income ratios.

Installment and other loans’ credit risk is mitigated through prudent underwriting standards, including evaluation of the creditworthiness of the borrower through credit scores and debt-to-income ratios and, if secured, the collateral value of the assets. These loans can be unsecured or secured by assets the value of which may depreciate quickly or may fluctuate, and may present a greater risk to the Company than 1-4 family residential loans.

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was enacted. The CARES Act established the SBA PPP. The SBA PPP is intended to provide economic relief to small businesses nationwide adversely impacted under the COVID-19 Emergency Declaration issued on March 13, 2020. The SBA PPP, which began on April 3, 2020, provided small businesses with funds to cover up to 24 weeks of payroll costs and other expenses, including benefits. It also provides for forgiveness of up to the full principal amount of qualifying loans. Through December 31, 2020, the Bank closed and funded almost 3,200 loans for a total gross loan amount of $467.7 million. These loans resulted in net processing fees of $13.5 million to be recognized through net interest income over the life of the loans, which is between two and five years. For the nine months ended September 30, 2021, the Bank closed and funded almost 3,300 PPP loans for a total loan amount of $231.7 million. In total, the Bank closed and funded almost 6,500 PPP loans for a total gross loan amount of $699.4 million. The loans originated in 2021 resulted in net processing fees of $12.3 million. At September 30, 2021, the Bank has $8.6 million of net deferred SBA PPP fees remaining to be recognized through net interest income over the life of the loans. The timing of the recognition of these fees is dependent upon the loan forgiveness process established by the SBA. As these loans are 100% guaranteed by the SBA, there is no associated allowance for loan losses at September 30, 2021.

In an effort to assist clients that were negatively impacted by the COVID-19 pandemic, the Bank offered various mitigation options, including a loan payment deferral program. Under this program, most commercial deferrals were for a 90-day period, while most consumer deferrals were for a 180-day period. Commercial and consumer deferrals totaled zero and $317 thousand, respectively, at September 30, 2021 and $15.7 million and $2.5 million, respectively, at December 31, 2020. In accordance with the revised Interagency Statement on Loan Modifications by Financial Institutions Working with Customers Affected by the Coronavirus issued by the federal bank regulatory agencies on April 7, 2020, these deferrals are exempt from TDR status as they meet the specified requirements.

The following table presents the loan portfolio by segment and class, excluding residential mortgage LHFS, at September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
Commercial real estate:
Owner occupied	$	196,585	$	174,908
Non-owner occupied	509,703		409,567
Multi-family	112,002		113,635
Non-owner occupied residential	100,088		114,505
Acquisition and development:
1-4 family residential construction	12,246		9,486
Commercial and land development	71,784		51,826
Commercial and industrial (1)	540,205		647,368
Municipal	13,631		20,523
Residential mortgage:
First lien	203,360		244,321
Home equity - term	7,079		10,169
Home equity - lines of credit	154,004		157,021
Installment and other loans	19,077		26,361
Total loans	$	1,939,764	$	1,979,690

(1) This balance includes $259.9 million and $403.3 million of SBA PPP loans, net of deferred fees and costs, at September 30, 2021 and December 31, 2020, respectively.

In order to monitor ongoing risk associated with its loan portfolio and specific loans within the segments, management uses an internal grading system. The first several rating categories, representing the lowest risk to the Bank, are combined and given a “Pass” rating. Management generally follows regulatory definitions in assigning criticized ratings to loans, including "Special Mention," "Substandard," "Doubtful" or "Loss." The Special Mention category includes loans that have potential

weaknesses that may, if not monitored or corrected, weaken the asset or inadequately protect the Bank's position at some future date. These assets pose elevated risk, but their weakness does not yet justify a more severe, or classified rating. Substandard loans are classified as they have a well-defined weakness, or weaknesses that jeopardize liquidation of the debt. These loans are characterized by the distinct possibility that the Bank will sustain some loss if the deficiencies are not corrected. Substandard loans include loans that management has determined not to be impaired, as well as loans considered to be impaired. A Doubtful loan has a high probability of total or substantial loss, but because of specific pending events that may strengthen the asset, its classification as Loss is deferred. Loss loans are considered uncollectible, as the borrowers are often in bankruptcy, have suspended debt repayments, or have ceased business operations. Once a loan is classified as Loss, there is little prospect of collecting the loan’s principal or interest and it is charged-off.

The Company has a loan review policy and program which is designed to identify and monitor risk in the lending function. The Management ERM Committee, comprised of executive officers and loan department personnel, is charged with the oversight of overall credit quality and risk exposure of the Company's loan portfolio. This includes the monitoring of the lending activities of all Company personnel with respect to underwriting and processing new loans and the timely follow-up and corrective action for loans showing signs of deterioration in quality. A loan review program provides the Company with an independent review of the commercial loan portfolio on an ongoing basis. Generally, consumer and residential mortgage loans are included in the Pass categories unless a specific action, such as extended delinquencies, bankruptcy, repossession or death of the borrower occurs, which heightens awareness as to a possible credit event.

Internal loan reviews are completed annually on all commercial relationships with a committed loan balance in excess of $1.0 million, which includes confirmation of risk rating by an independent credit officer. In addition, all commercial relationships greater than $500 thousand rated Substandard, Doubtful or Loss are reviewed quarterly and corresponding risk ratings are reaffirmed by the Company's Problem Loan Committee, with subsequent reporting to the Management ERM Committee and the Board of Directors.

The following table summarizes the Company’s loan portfolio ratings based on its internal risk rating system at September 30, 2021 and December 31, 2020:

	Pass		Special Mention		Non-Impaired Substandard		Impaired - Substandard		Doubtful		PCI Loans		Total
September 30, 2021
Commercial real estate:
Owner occupied	$	176,029	$	8,219	$	6,147	$	3,832	$	—	$	2,358	$	196,585
Non-owner occupied	476,947		32,272		168		—		—		316		509,703
Multi-family	91,726		19,662		614		—		—		—		112,002
Non-owner occupied residential	95,338		2,028		1,344		171		—		1,207		100,088
Acquisition and development:
1-4 family residential construction	12,246		—		—		—		—		—		12,246
Commercial and land development	70,648		636		500		—		—		—		71,784
Commercial and industrial	521,530		7,939		5,505		2,941		—		2,290		540,205
Municipal	13,631		—		—		—		—		—		13,631
Residential mortgage:
First lien	195,717		—		240		2,472		—		4,931		203,360
Home equity - term	7,056		—		—		7		—		16		7,079
Home equity - lines of credit	153,436		21		52		495		—		—		154,004
Installment and other loans	19,002		—		—		37		—		38		19,077
	$	1,833,306	$	70,777	$	14,570	$	9,955	$	—	$	11,156	$	1,939,764
December 31, 2020
Commercial real estate:
Owner occupied	$	148,846	$	12,491	$	7,855	$	3,260	$	—	$	2,456	$	174,908
Non-owner occupied	351,860		57,378		—		—		—		329		409,567
Multi-family	92,769		20,224		642		—		—		—		113,635
Non-owner occupied residential	107,557		3,948		1,422		268		—		1,310		114,505
Acquisition and development:
1-4 family residential construction	9,101		385		—		—		—		—		9,486
Commercial and land development	49,832		655		525		814		—		—		51,826
Commercial and industrial	617,213		17,561		6,118		3,639		—		2,837		647,368
Municipal	20,523		—		—		—		—		—		20,523
Residential mortgage:
First lien	236,381		—		—		2,628		—		5,312		244,321
Home equity - term	10,076		—		64		10		—		19		10,169
Home equity - lines of credit	156,264		95		54		608		—		—		157,021
Installment and other loans	26,283		—		—		17		—		61		26,361
	$	1,826,705	$	112,737	$	16,680	$	11,244	$	—	$	12,324	$	1,979,690

For commercial real estate, acquisition and development and commercial and industrial loans, a loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by

management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays and payment shortfalls generally are not classified as impaired. Generally, loans that are more than 90 days past due are deemed impaired. Management determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed to determine if the loan should be placed on nonaccrual status. Nonaccrual loans in the commercial and commercial real estate portfolios and any TDRs are, by definition, deemed to be impaired. Impairment is measured on a loan-by-loan basis for commercial, construction and restructured loans by either the present value of the expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price, or the fair value of the collateral if the loan is collateral dependent. A loan is collateral dependent if the repayment of the loan is expected to be provided solely by the underlying collateral. For loans that are deemed to be impaired for extended periods of time, periodic updates on fair values are obtained, which may include updated appraisals. Updated fair values are incorporated into the impairment analysis in the next reporting period.

Loan charge-offs, which may include partial charge-offs, are taken on an impaired loan that is collateral dependent if the loan’s carrying balance exceeds its collateral’s appraised value, the loan has been identified as uncollectible, and it is deemed to be a confirmed loss. Typically, impaired loans with a charge-off or partial charge-off will continue to be considered impaired, unless the note is split into two, and management expects the performing note to continue to perform and is adequately secured. The second, or non-performing note, would be charged-off. Generally, an impaired loan with a partial charge-off may continue to have an impairment reserve on it after the partial charge-off, if factors warrant.

At September 30, 2021 and December 31, 2020, nearly all of the Company’s loan impairments were measured based on the estimated fair value of the collateral securing the loan, except for TDRs. By definition, TDRs are considered impaired. All TDR impairment analyses are initially based on discounted cash flows for those loans. For real estate loans, collateral generally consists of commercial real estate, but in the case of commercial and industrial loans, it could also consist of accounts receivable, inventory, equipment or other business assets. Commercial and industrial loans may also have real estate collateral.

Updated appraisals are generally required every 18 months for classified commercial loans in excess of $250 thousand. The “as is" value provided in the appraisal is often used as the fair value of the collateral in determining impairment, unless circumstances, such as subsequent improvements, approvals, or other circumstances, dictate that another value than that provided by the appraiser is more appropriate.

Generally, impaired commercial loans secured by real estate, other than performing TDRs, are measured at fair value using certified real estate appraisals that had been completed within the last 18 months. Appraised values are discounted for estimated costs to sell the property and other selling considerations to arrive at the property’s fair value. In those situations in which it is determined an updated appraisal is not required for loans individually evaluated for impairment, fair values are based on either an existing appraisal or a discounted cash flow analysis as determined by management. The approaches are discussed below:

•Existing appraisal – if the existing appraisal provides a strong loan-to-value ratio (generally 70% or lower) and, after consideration of market conditions and knowledge of the property and area, it is determined by the Credit Administration staff that there has not been a significant deterioration in the collateral value, the existing certified appraised value may be used. Discounts to the appraised value, as deemed appropriate for selling costs, are factored into the fair value.

•Discounted cash flows – in limited cases, discounted cash flows may be used on projects in which the collateral is liquidated to reduce the borrowings outstanding, and is used to validate collateral values derived from other approaches.

Collateral on certain impaired loans is not limited to real estate, and may consist of accounts receivable, inventory, equipment or other business assets. Estimated fair values are determined based on borrowers’ financial statements, inventory ledgers, accounts receivable aging or appraisals from individuals with knowledge in the business. Stated balances are generally discounted for the age of the financial information or the quality of the assets. In determining fair value, liquidation discounts are applied to this collateral based on existing loan evaluation policies.

The Company distinguishes substandard loans on both an impaired and non-impaired basis, as it places less emphasis on a loan’s classification, and increased reliance on whether the loan was performing in accordance with the contractual terms. A substandard classification does not automatically meet the definition of impaired. Loss potential, while existing in the aggregate amount of substandard loans, does not have to exist in individual extensions of credit classified as substandard. As a result, the Company’s methodology includes an evaluation of certain accruing commercial real estate, acquisition and development, and commercial and industrial loans rated substandard to be collectively evaluated for impairment. Although the Company believes

these loans meet the definition of substandard, they are generally performing and management has concluded that it is likely the Company will be able to collect the scheduled payments of principal and interest when due according to the contractual terms of the loan agreement.

Larger groups of smaller balance homogeneous loans are collectively evaluated for impairment. Generally, the Company does not separately identify individual consumer and residential loans for impairment disclosures, unless such loans are the subject of a restructuring agreement due to financial difficulties of the borrower.

The following table, which excludes accruing PCI loans, summarizes impaired loans by segment and class, segregated by those for which a specific allowance was required and those for which a specific allowance was not required at September 30, 2021 and December 31, 2020. The recorded investment in loans excludes accrued interest receivable due to insignificance. Related allowances established generally pertain to those loans in which loan forbearance agreements were in the process of being negotiated or updated appraisals were pending, and any partial charge-off will be recorded when final information is received.

	Impaired Loans with a Specific Allowance						Impaired Loans with No Specific Allowance
	Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)		Related Allowance		Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)
September 30, 2021
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,832	$	4,923
Non-owner occupied residential	—		—		—		171		383
Commercial and industrial	—		—		—		2,941		3,592
Residential mortgage:
First lien	469		469		29		2,003		3,161
Home equity—term	—		—		—		7		10
Home equity—lines of credit	—		—		—		495		733
Installment and other loans	—		—		—		37		37
	$	469	$	469	$	29	$	9,486	$	12,839
December 31, 2020
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,260	$	4,091
Non-owner occupied residential	—		—		—		268		393
Acquisition and development:
Commercial and land development	—		—		—		814		875
Commercial and industrial	—		—		—		3,639		4,269
Residential mortgage:
First lien	424		508		33		2,204		3,264
Home equity—term	—		—		—		10		13
Home equity—lines of credit	—		—		—		608		832
Installment and other loans	—		—		—		17		18
	$	424	$	508	$	33	$	10,820	$	13,755

The following table, which excludes accruing PCI loans, summarizes the average recorded investment in impaired loans and related recognized interest income for the three and nine months ended September 30, 2021 and 2020:

	2021				2020
	Average Impaired Balance		Interest Income Recognized		Average Impaired Balance		Interest Income Recognized
Three Months Ended September 30,
Commercial real estate:
Owner-occupied	$	4,179	$	—	$	4,424	$	—
Non-owner occupied	—		—		102		—
Multi-family	—		—		141		—
Non-owner occupied residential	232		—		433		—
Acquisition and development:
Commercial and land development	—		—		837		—
Commercial and industrial	3,073		—		1,044		—
Residential mortgage:
First lien	2,541		11		3,209		12
Home equity – term	10		—		12		—
Home equity - lines of credit	463		—		645		—
Installment and other loans	24		—		17		—
	$	10,522	$	11	$	10,864	$	12
Nine Months Ended September 30,
Commercial real estate:
Owner occupied	$	3,848	$	1	$	5,033	$	1
Non-owner occupied	—		—		108		—
Multi-family	7		—		259		—
Non-owner occupied residential	252		—		422		—
Acquisition and development:
Commercial and land development	246		—		586		—
Commercial and industrial	3,046		—		1,316		—
Residential mortgage:
First lien	2,575		32		3,050		36
Home equity - term	12		—		12		—
Home equity - lines of credit	547		—		699		1
Installment and other loans	17		—		29		—
	$	10,550	$	33	$	11,514	$	38

The following table presents impaired loans that are TDRs, with the recorded investment at September 30, 2021 and December 31, 2020:

	September 30, 2021			December 31, 2020
	Number of Contracts	Recorded Investment		Number of Contracts	Recorded Investment
Accruing:
Commercial real estate:
Owner occupied	1	$	26	1	$	28
Residential mortgage:
First lien	8	813		9	898
Home equity - lines of credit	—	—		1	8
	9	839		11	934
Nonaccruing:
Residential mortgage:
First lien	5	291		5	320
	5	291		5	320
	14	$	1,130	16	$	1,254

There were no new TDR's for the three and nine months ended September 30, 2021 or 2020.

Management further monitors the performance and credit quality of the loan portfolio by analyzing the length of time a portfolio is past due, by aggregating loans based on its delinquencies. The following table presents the classes of loan portfolio summarized by aging categories of performing loans and nonaccrual loans at September 30, 2021 and December 31, 2020:

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
September 30, 2021
Commercial real estate:
Owner occupied	$	190,183	$	238	$	—	$	—	$	238	$	3,806	$	194,227
Non-owner occupied	509,387		—		—		—		—		—		509,387
Multi-family	112,002		—		—		—		—		—		112,002
Non-owner occupied residential	98,459		—		251		—		251		171		98,881
Acquisition and development:
1-4 family residential construction	12,246		—		—		—		—		—		12,246
Commercial and land development	71,774		10		—		—		10		—		71,784
Commercial and industrial	534,967		7		—		—		7		2,941		537,915
Municipal	13,631		—		—		—		—		—		13,631
Residential mortgage:
First lien	196,076		341		318		35		694		1,659		198,429
Home equity - term	7,041		15		—		—		15		7		7,063
Home equity - lines of credit	153,266		208		35		—		243		495		154,004
Installment and other loans	18,891		70		41		—		111		37		19,039
Subtotal	1,917,923		889		645		35		1,569		9,116		1,928,608
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,358		—		—		—		—		—		2,358
Non-owner occupied	316		—		—		—		—		—		316
Non-owner occupied residential	1,081		—		—		126		126		—		1,207
Commercial and industrial	2,290		—		—		—		—		—		2,290
Residential mortgage:
First lien	4,730		—		—		201		201		—		4,931
Home equity - term	16		—		—		—		—		—		16
Installment and other loans	38		—		—		—		—		—		38
Subtotal	10,829		—		—		327		327		—		11,156
	$	1,928,752	$	889	$	645	$	362	$	1,896	$	9,116	$	1,939,764

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
December 31, 2020
Commercial real estate:
Owner occupied	$	168,262	$	958	$	—	$	—	$	958	$	3,232	$	172,452
Non-owner occupied	409,130		108		—		—		108		—		409,238
Multi-family	113,635		—		—		—		—		—		113,635
Non-owner occupied residential	112,443		484		—		—		484		268		113,195
Acquisition and development:
1-4 family residential construction	9,486		—		—		—		—		—		9,486
Commercial and land development	50,922		32		58		—		90		814		51,826
Commercial and industrial	640,573		9		310		—		319		3,639		644,531
Municipal	19,677		846		—		—		846		—		20,523
Residential mortgage:
First lien	230,903		5,758		535		83		6,376		1,730		239,009
Home equity - term	10,099		40		—		1		41		10		10,150
Home equity - lines of credit	156,153		268		—		—		268		600		157,021
Installment and other loans	26,052		168		49		14		231		17		26,300
Subtotal	1,947,335		8,671		952		98		9,721		10,310		1,967,366
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,456		—		—		—		—		—		2,456
Non-owner occupied	329		—		—		—		—		—		329
Non-owner occupied residential	1,161		—		—		149		149		—		1,310
Commercial and industrial	2,837		—		—		—		—		—		2,837
Residential mortgage:
First lien	4,341		655		9		307		971		—		5,312
Home equity - term	19		—		—		—		—		—		19
Installment and other loans	57		4		—		—		4		—		61
Subtotal	11,200		659		9		456		1,124		—		12,324
	$	1,958,535	$	9,330	$	961	$	554	$	10,845	$	10,310	$	1,979,690

The Company maintains its ALL at a level management believes adequate for probable incurred credit losses. The ALL is established and maintained through a provision for loan losses charged to earnings. On a quarterly basis, management assesses the adequacy of the ALL utilizing a defined methodology, which considers specific credit evaluation of impaired loans as discussed above, historical loan loss experience, and qualitative factors. Management believes its approach properly addresses relevant accounting guidance for loans individually identified as impaired and for loans collectively evaluated for impairment, and other bank regulatory guidance.

In connection with its quarterly evaluation of the adequacy of the ALL, management reviews its methodology to determine if it properly addresses the current risk in the loan portfolio. For each loan class, general allowances based on quantitative factors, principally historical loss trends, are provided for loans that are collectively evaluated for impairment. An

adjustment to historical loss factors may be incorporated for delinquency and other potential risk not elsewhere defined within the ALL methodology.

In addition to this quantitative analysis, adjustments to the ALL requirements are allocated on loans collectively evaluated for impairment based on additional qualitative factors, including:

Nature and Volume of Loans – including loan growth in the current and subsequent quarters based on the Company’s targeted growth and strategic plan, coupled with the types of loans booked based on risk management and credit culture; the number of exceptions to loan policy; and supervisory loan to value exceptions.

Concentrations of Credit and Changes within Credit Concentrations – including the composition of the Company’s overall portfolio makeup and management's evaluation related to concentration risk management and the inherent risk associated with the concentrations identified.

Underwriting Standards and Recovery Practices – including changes to underwriting standards and perceived impact on anticipated losses; trends in the number of exceptions to loan policy; supervisory loan to value exceptions; and administration of loan recovery practices.

Delinquency Trends – including delinquency percentages noted in the portfolio relative to economic conditions; severity of the delinquencies; and whether the ratios are trending upwards or downwards.

Classified Loans Trends – including internal loan ratings of the portfolio; severity of the ratings; whether the loan segment’s ratings show a more favorable or less favorable trend; and underlying market conditions and impact on the collateral values securing the loans.

Experience, Ability and Depth of Management/Lending staff – including the years’ experience of senior and middle management and the lending staff; turnover of the staff; and instances of repeat criticisms of ratings.

Quality of Loan Review – including the years of experience of the loan review staff; in-house versus outsourced provider of review; turnover of staff and the perceived quality of their work in relation to other external information.

National and Local Economic Conditions – including trends in the consumer price index, unemployment rates, the housing price index, housing statistics compared to the prior year, bankruptcy rates, regulatory and legal environment risks and competition.

All factors noted above were evaluated and remained unchanged for the nine months ended September 30, 2021, except for a reduction in the National and Local Economic Conditions qualitative factor during the three months ended March 31, 2021.

COVID-19 – during the nine months ended September 30, 2020, a qualitative allocation was implemented associated with the potential impact of the COVID-19 pandemic on the Company's commercial loan portfolio. The factor assumes downgrades of loans which were granted deferrals or forbearances based upon identified hardships resulting from the economic shutdown driven by the pandemic. The qualitative reserve on these loans was reduced over time as sustained performance was demonstrated after the loans were removed from deferral status or the forbearance period ended. During the three and nine months ended September 30, 2021, this qualitative reserve was reduced by $1.0 million and $2.7 million, respectively. This reserve is zero at September 30, 2021.

The following table presents the activity in the ALL for the three and nine months ended September 30, 2021 and 2020:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
Three Months Ended
September 30, 2021
Balance, beginning of period	$	11,315	$	1,243	$	3,495	$	29	$	16,082	$	2,863	$	227	$	3,090	$	209	$	19,381
Provision for loan losses	(179)		290		386		(2)		495		(147)		18		(129)		(1)		365
Charge-offs	(89)		—		(55)		—		(144)		—		(20)		(20)		—		(164)
Recoveries	305		8		60		—		373		5		5		10		—		383
Balance, end of period	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
September 30, 2020
Balance, beginning of period	$	9,347	$	1,069	$	2,916	$	75	$	13,407	$	3,552	$	386	$	3,938	$	172	$	17,517
Provision for loan losses	1,520		(219)		963		(19)		2,245		(71)		18		(53)		8		2,200
Charge-offs	(3)		—		(193)		—		(196)		—		(31)		(31)		—		(227)
Recoveries	171		—		45		—		216		6		13		19		—		235
Balance, end of period	$	11,035	$	850	$	3,731	$	56	$	15,672	$	3,487	$	386	$	3,873	$	180	$	19,725
Nine Months Ended
September 30, 2021
Balance, beginning of period	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151
Provision for loan losses	133		418		109		(13)		647		(578)		(69)		(647)		(10)		(10)
Charge-offs	(270)		—		(621)		—		(891)		(92)		(49)		(141)		—		(1,032)
Recoveries	338		9		456		—		803		29		24		53		—		856
Balance, end of period	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
September 30, 2020
Balance, beginning of period	$	7,634	$	959	$	2,356	$	100	$	11,049	$	3,147	$	319	$	3,466	$	140	$	14,655
Provision for loan losses	2,780		(117)		1,875		(44)		4,494		329		162		491		40		5,025
Charge-offs	(3)		—		(689)		—		(692)		(109)		(117)		(226)		—		(918)
Recoveries	624		8		189		—		821		120		22		142		—		963
Balance, end of period	$	11,035	$	850	$	3,731	$	56	$	15,672	$	3,487	$	386	$	3,873	$	180	$	19,725

The following table summarizes the ending loan balance individually evaluated for impairment based upon loan segment, as well as the related ALL loss allocation for each at September 30, 2021 and December 31, 2020. Accruing PCI loans are excluded from loans individually evaluated for impairment.

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
September 30, 2021
Loans allocated by:
Individually evaluated for impairment	$	4,003	$	—	$	2,941	$	—	$	6,944	$	2,974	$	37	$	3,011	$	—	$	9,955
Collectively evaluated for impairment	914,375		84,030		537,264		13,631		1,549,300		361,469		19,040		380,509		—		1,929,809
	$	918,378	$	84,030	$	540,205	$	13,631	$	1,556,244	$	364,443	$	19,077	$	383,520	$	—	$	1,939,764
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	29	$	—	$	29	$	—	$	29
Collectively evaluated for impairment	11,352		1,541		3,886		27		16,806		2,692		230		2,922		208		19,936
	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
December 31, 2020
Loans allocated by:
Individually evaluated for impairment	$	3,528	$	814	$	3,639	$	—	$	7,981	$	3,246	$	17	$	3,263	$	—	$	11,244
Collectively evaluated for impairment	809,087		60,498		643,729		20,523		1,533,837		408,265		26,344		434,609		—		1,968,446
	$	812,615	$	61,312	$	647,368	$	20,523	$	1,541,818	$	411,511	$	26,361	$	437,872	$	—	$	1,979,690
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	33	$	—	$	33	$	—	$	33
Collectively evaluated for impairment	11,151		1,114		3,942		40		16,247		3,329		324		3,653		218		20,118
	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151

The following table provides activity for the accretable yield of PCI loans for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Accretable yield, beginning of period	$	3,016	$	4,182	$	3,438	$	6,950
Additions (1)	—		—		—		570
Accretion of income	(203)		(546)		(878)		(2,459)
Reclassifications from nonaccretable difference due to improvement in expected cash flows	11		139		128		1,260
Other changes, net (2)	(12)		(231)		124		(2,777)
Accretable yield, end of period	$	2,812	$	3,544	$	2,812	$	3,544

(1) The amount for the nine months ended September 30, 2020 reflects a measurement period adjustment for Hamilton loans that should have been in the PCI pool at the acquisition date.

(2) The amount for the nine months ended September 30, 2020 represents the impact of PCI loans sold during that period

XML

LEASES

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

LEASES

LEASESA lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. The Company has primarily entered into operating leases for branches and office space. Most of the Company's

leases contain renewal options, which the Company is reasonably certain to exercise. Including renewal options, the Company's leases range from seven to 32 years. Operating lease right-of-use assets and lease liabilities are included in other assets and accrued interest and other liabilities on the Company's unaudited condensed consolidated balance sheets.

The Company uses its incremental borrowing rate to determine the present value of the lease payments, as the rate implicit in the Company's leases is not readily determinable. Lease agreements that contain non-lease components are generally accounted for as a single lease component, while variable costs, such as common area maintenance expenses and property taxes, are expensed as incurred.

The following table summarizes the Company's operating leases at September 30, 2021 and December 31, 2020:

	September 30, 2021			December 31, 2020
Operating lease ROU assets	$	9,301		$	8,686
Operating lease ROU liabilities	9,832			9,143
Weighted-average remaining lease term (in years)	16.0			16.8
Weighted-average discount rate	4.2		%	4.3		%

The following table presents information related to the Company's operating leases for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Cash paid for operating lease liabilities	$	331	$	210	$	947	$	847
Operating lease expense	388		421		1,179		1,171

The following table presents expected future maturities of the Company's lease liabilities as of September 30, 2021:

Remainder of 2021	$	296
2022	926
2023	951
2024	974
2025	991
Thereafter	10,387
	14,525
Less: imputed interest	4,693
Total lease liabilities	$	9,832

XML

GOODWILL AND OTHER INTANGIBLE ASSETS

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

GOODWILL AND OTHER INTANGIBLE ASSETS

The following table presents changes in goodwill for the nine months ended September 30, 2021 and 2020:

	September 30, 2021		September 30, 2020
Balance, beginning of year	$	18,724	$	19,925
Adjustments to acquired goodwill (1)	—		(1,201)
Balance, end of period	$	18,724	$	18,724

(1) The Company finalized its purchase accounting adjustments associated with Hamilton as of May 1, 2020.

Goodwill is not amortized but is reviewed for potential impairment on at least an annual basis, with testing between annual tests if an event occurs or circumstances change that could potentially reduce the fair value of a reporting unit.

The Company typically completes its annual goodwill impairment assessment as of November 30. Due to the severe economic impact of COVID-19 and a resulting sustained decline in the Company's market value below book value, management performed a quantitative Step 1 impairment analysis of its goodwill to determine whether the Company's goodwill was impaired as of August 31, 2020. This analysis, which was performed in accordance with ASU 2017-04, Intangibles-Goodwill and Other, considered several factors, such as future cash flow projections and estimated market acquisition

premiums in its analysis. In performing the analysis, management made several assumptions with respect to future operating performance, economic and market conditions and various others, many of which required significant judgment. The analysis performed and the related assumptions reflected the best currently available estimates and judgements regarding future performance of the Company. It was concluded that no impairment existed at August 31, 2020 as the calculated fair value of the reporting unit exceeded its book value. No changes have occurred that would impact the results of that analysis through September 30, 2021.

The following table presents changes in other intangible assets for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Beginning of period	$	4,800	$	6,160	$	5,458	$	7,180
Amortization expense	(314)		(357)		(972)		(1,224)
Impairment	—		—		—		(153)
Balance, end of period	$	4,486	$	5,803	$	4,486	$	5,803

No impairment charges were recorded in the three and nine months ended September 30, 2021. During the nine months ended September 30, 2020, the Company recorded an impairment charge of $153 thousand for the full remaining balance attributable to a customer list intangible asset due to the dissolution of Wheatland Advisors, Inc.

The following table presents the components of other identifiable intangible assets at September 30, 2021 and December 31, 2020:

	September 30, 2021				December 31, 2020
	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
Amortized intangible assets:
Core deposit intangibles	$	8,390	$	3,906	$	8,390	$	2,935
Other customer relationship intangibles	25		23		25		22
Total	$	8,415	$	3,929	$	8,415	$	2,957

The following table presents future estimated aggregate amortization expense for intangible assets remaining at September 30, 2021:

Remainder of 2021	$	303
2022	1,105
2023	935
2024	766
2025	596
Thereafter	781
	$	4,486

XML

SHARE-BASED COMPENSATION PLANS

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

SHARE-BASED COMPENSATION PLANS

SHARE-BASED COMPENSATION PLANS

The Company maintains share-based compensation plans under the shareholder-approved 2011 Plan. The purpose of the share-based compensation plans is to provide officers, employees, and non-employee members of the Board of Directors of the Company with additional incentive to further the success of the Company. 881,920 shares of the common stock of the Company were originally reserved, of which 258,020 shares are available to be issued as of September 30, 2021.

The 2011 Plan incentive awards may consist of grants of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units and performance shares. All employees and members of the Board of Directors of the Company are eligible to participate in the 2011 Plan. The 2011 Plan allows for the Compensation Committee of

the Board of Directors to determine the type of incentive to be awarded, its term, manner of exercise, vesting and restrictions on shares. Generally, awards are nonqualified under the IRC, unless the awards are deemed to be incentive awards to employees at the Compensation Committee’s discretion.

The table below presents a summary of nonvested restricted shares activity for the nine months ended September 30, 2021:

	Shares	Weighted Average Grant Date Fair Value
Nonvested shares, beginning of year	245,576	$	21.45
Granted	127,847	19.21
Forfeited	(29,388)	19.69
Vested	(78,588)	23.52
Nonvested shares, at period end	265,447	$	19.92

The following table presents restricted shares compensation expense, with tax benefit information, and fair value of shares vested, for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Restricted share award expense	$	468	$	434	$	1,380	$	1,607
Restricted share award tax benefit	98		91		316		337
Fair value of shares vested	—		225		1,539		1,314

The unrecognized compensation expense related to the share awards totaled $2.6 million at September 30, 2021 and $2.0 million at December 31, 2020. The unrecognized compensation expense at September 30, 2021 is expected to be recognized over a weighted-average period of 1.8 years.

The Company maintains an employee stock purchase plan to provide its employees with an opportunity to purchase Company common stock. Eligible employees may purchase shares in an amount that does not exceed 10% of their annual salary, at the lower of 95% of the fair market value of the shares on the semi-annual offering date or related purchase date. The purchases occur in March and September of each year. The Company reserved 350,000 shares of its common stock to be issued under the employee stock purchase plan. At September 30, 2021, 151,480 shares were available to be issued under the employee stock purchase plan.

The following table presents information for the employee stock purchase plan for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Shares purchased	3,271		4,218		8,755		7,831
Weighted average price of shares purchased	$	19.16	$	13.08	$	15.58	$	14.85
Compensation expense recognized	15		3		48		6

The Company issues either new shares or treasury shares, when available, for award through its share-based compensation plans.

XML

DERIVATIVE FINANCIAL INSTRUMENTS

9 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE FINANCIAL INSTRUMENTS

DERIVATIVE FINANCIAL INSTRUMENTS The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used as risk management tools by the Company to manage differences in the

amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings and are not used for trading or speculative purposes.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. The Company, however, discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in accumulated other comprehensive income (loss) are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. During the three months ended September 30, 2021, the Company terminated its interest rate derivative of $50.0 million that was designated as a cash flow hedge of interest-rate risk associated with overnight borrowings due to the unprecedented nature and impact of the COVID-19 pandemic, and reclassified $398.0 thousand of the realized losses from AOCI to current earnings because the hedged forecasted transaction was determined to be no longer probable of occurring. At December 31, 2020, the Company had one interest rate derivative designated as a hedging instrument with an aggregate notional amount of $50.0 million. At September 30, 2021 and December 31, 2020, the Company had cash collateral of zero and $1.7 million held with the counterparty for these derivatives, respectively. The cash collateral was settled with the derivative counterparty upon termination of the cash flow hedge.

The Company enters into interest rate swaps that allow its commercial loan customers to effectively convert a variable-rate commercial loan agreement to a fixed-rate commercial loan agreement. Under these agreements, the Company enters into a variable-rate loan agreement with a customer in addition to an interest rate swap agreement, which serves to effectively swap the customer’s variable-rate loan into a fixed-rate loan. The Company then enters into a corresponding swap agreement with a third party in order to economically hedge its exposure through the customer agreement. The interest rate swaps with both the customers and third parties are not designated as hedges and are marked through earnings. At September 30, 2021, the Company had 11 customer and 11 corresponding third-party broker interest rate derivatives not designated as a hedging instrument with an aggregate notional amount of $64.9 million. The Company had $61.3 million in notional amount of such derivative instruments at December 31, 2020.

The Company entered into a risk participation agreement with a financial institution counterparty (the “Agent Bank”) for an interest rate derivative contract related to a loan in which the Company is a participant. The risk participation agreement provides credit protection to the Agent Bank should the borrower fail to perform on its interest rate derivative contracts with the Agent Bank. The Company received an upfront fee of $53 thousand upon entry into the risk participation agreement in the nine months ended September 30, 2021. The Company manages its credit risk on the risk participation agreement by monitoring the creditworthiness of the borrower, which is based on the same credit review process as though the Company had entered into the derivative instruments directly with the borrower. The notional amount of such risk participation agreement reflects the Company’s pro-rata share of the derivative instrument, consistent with its share of the related participated loan. As of September 30, 2021 and December 31, 2020, the total notional amount of the risk participation agreement was $15.9 million and zero, respectively.

As a part of its normal residential mortgage operations, the Company will enter into an interest rate lock commitment with a potential borrower. The Company will enter into a corresponding commitment with an investor to sell that loan at a specific

price shortly after origination. In accordance with FASB ASC 820, adjustments are recorded through earnings to account for the net change in fair value of these transactions.

The following table summarizes the fair value of the Company's derivative instruments at September 30, 2021 and December 31, 2020:

	September 30, 2021					December 31, 2020
	Notional Amount		Balance Sheet Location	Fair Value		Notional Amount		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps - balance sheet hedge	$	—		$	—	$	50,000	Other liabilities	$	(1,230)
Total derivatives designated as hedging instruments				$	—				$	(1,230)
Derivatives not designated as hedging instruments:
Interest rate swap - commercial borrower	$	32,462	Other assets	$	277	$	30,673	Other assets	$	690
Interest rate swap - counterparty	32,462		Other liabilities	(269)		30,673		Other liabilities	(726)
Risk participation	15,855		Other liabilities	(3)		—			—
Interest rate lock commitments with customers	22,025		Other assets	546		22,560		Other assets	673
Forward sale commitment	6,198		Other assets	23		10,400		Other liabilities	(61)
Total derivatives not designated as hedging instruments				$	574				$	576

The following tables summarize the effect of the Company's derivative financial instruments on OCI and net income for the three and nine months ended September 30, 2021 and 2020:

	Amount of (Loss) Gain Recognized in OCI on Derivative				Amount of Gain (Loss) Recognized in OCI on Derivative
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives in cash flow hedging relationships:
Interest rate products	$	(183)	$	208	$	473	$	(1,893)
Total	$	(183)	$	208	$	473	$	(1,893)

	Amount of Loss Reclassified from AOCI into Income				Amount of Loss Reclassified from AOCI into Income				Location of Loss Recognized from AOCI into Income
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives in cash flow hedging relationships:
Interest rate products	$	(581)	$	(114)	$	(757)	$	(239)	Interest expense / Other operating expenses(1)
Total	$	(581)	$	(114)	$	(757)	$	(239)

(1) Includes $514 thousand recorded to other operating expenses due to the loss from the termination of an interest rate swap designated as a cash flow hedge.

	Amount of Gain (Loss) Recognized in Income				Amount of Gain (Loss) Recognized in Income				Location of Gain (Loss) Recognized in Income
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives not designated as hedging instruments:
Interest rate products	$	8	$	(4)	$	44	$	(21)	Other operating expenses
Risk participation agreement	1		—		(3)		—		Other operating expenses
Interest rate lock commitments with customers	89		157		(128)		1,040		Mortgage banking activities
Forward sale commitment	1		71		84		(126)		Mortgage banking activities
Total	$	99	$	224	$	(3)	$	893

The following table is a summary of components for interest rate swaps designated as hedging at September 30, 2021 and December 31, 2020. During the three and nine months ended September 30, 2021, the Company terminated its interest rate derivative of $50.0 million.

	September 30, 2021		December 31, 2020
Weighted average pay rate	—	%	0.77	%
Weighted average receive rate	—	%	0.09	%
Weighted average maturity in years	0.0		4.2

XML

SHAREHOLDERS' EQUITY AND REGULATORY CAPITAL

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

SHAREHOLDERS’ EQUITY AND REGULATORY CAPITAL

SHAREHOLDERS’ EQUITY AND REGULATORY CAPITAL

Banks and bank holding companies are subject to regulatory capital requirements administered by federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities and certain off-balance sheet items calculated under regulatory accounting practices. Capital amounts and classifications are also subject to qualitative judgments by regulators. Failure to meet capital requirements can initiate regulatory action. Under the Basel Committee on Banking Supervision's capital guidelines for U.S. Banks ("Basel III rules"), an entity must hold a capital conservation buffer above the adequately capitalized risk-based capital ratios. The Company and the Bank have elected not to include net unrealized gain or loss on available for sale securities in computing regulatory capital.

The consolidated asset limit on small bank holding companies is $3.0 billion and a company with assets under that limit is not subject to the FRB consolidated capital rules, but may file reports that include capital amounts and ratios. The Company has elected to file those reports.

Management believes that the Company and the Bank met all capital adequacy requirements to which they are subject at September 30, 2021 and December 31, 2020.

Prompt corrective action regulations provide five classifications: well capitalized, adequately capitalized, undercapitalized, significantly undercapitalized and critically undercapitalized, although these terms are not used to represent overall financial condition. If adequately capitalized, regulatory approval is required to accept brokered deposits. If undercapitalized, capital distributions are limited, as is asset growth and expansion, and capital restoration plans are required. At September 30, 2021, the most recent regulatory notifications categorized the Bank as well capitalized under the regulatory framework for prompt corrective action. There are no conditions or events since that notification that management believes have changed the Bank's classification.

The following table presents capital amounts and ratios at September 30, 2021 and December 31, 2020:

	Actual				For Capital Adequacy Purposes (includes applicable capital conservation buffer)				To Be Well Capitalized Under Prompt Corrective Action Provisions
	Amount		Ratio		Amount		Ratio		Amount		Ratio
September 30, 2021
Total risk-based capital:
Orrstown Financial Services, Inc.	$	291,785	15.6	%	$	195,965	10.5	%	n/a		n/a
Orrstown Bank	273,583		14.7	%	195,899		10.5	%	$	186,570	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	238,492		12.8	%	158,639		8.5	%	n/a		n/a
Orrstown Bank	252,238		13.5	%	158,585		8.5	%	149,256		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	238,492		12.8	%	130,644		7.0	%	n/a		n/a
Orrstown Bank	252,238		13.5	%	130,599		7.0	%	121,271		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	238,492		8.3	%	115,630		4.0	%	n/a		n/a
Orrstown Bank	252,238		8.7	%	115,706		4.0	%	144,633		5.0	%
December 31, 2020
Total risk-based capital:
Orrstown Financial Services, Inc.	$	271,184	15.6	%	$	183,099	10.5	%	n/a		n/a
Orrstown Bank	256,376		14.7	%	183,012		10.5	%	$	174,297	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	217,582		12.5	%	148,223		8.5	%	n/a		n/a
Orrstown Bank	234,677		13.5	%	148,152		8.5	%	139,437		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	217,582		12.5	%	122,066		7.0	%	n/a		n/a
Orrstown Bank	234,677		13.5	%	122,008		7.0	%	113,293		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	217,582		8.1	%	108,063		4.0	%	n/a		n/a
Orrstown Bank	234,677		8.7	%	108,148		4.0	%	135,185		5.0	%

In September 2015, the Board of Directors of the Company authorized a share repurchase program under which the Company may repurchase up to 5% of the Company's outstanding shares of common stock, or approximately 416,000 shares, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act of 1934, as amended. On April 19, 2021, the Board of Directors authorized the additional future repurchase of up to 562,000 shares of its outstanding common stock. As of September 30, 2021, 201,518 shares had been repurchased at a total cost of $3.7 million, or $18.26 per share. Common stock available for future repurchase totals approximately 776,482 shares, or 7% of the Company's outstanding common stock at September 30, 2021. When and if appropriate, repurchases may be made in the open market or privately negotiated transactions, depending on market conditions, regulatory requirements and other corporate considerations, as determined by management. Share repurchases may not occur and may be discontinued at any time.

On October 18, 2021, the Board declared a cash dividend of $0.19 per common share, which will be paid on November 8, 2021 to shareholders of record at November 1, 2021.

XML

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

EARNINGS PER SHARE

EARNINGS PER SHARE

The following table presents earnings per share for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net income	$	7,192	$	4,977	$	26,175	$	16,404
Weighted average shares outstanding - basic	10,979		10,941		10,976		10,939
Dilutive effect of share-based compensation	143		84		127		88
Weighted average shares outstanding - diluted	11,122		11,025		11,103		11,027
Per share information:
Basic earnings per share	$	0.66	$	0.45	$	2.38	$	1.50
Diluted earnings per share	0.65		0.45		2.36		1.49

Average outstanding stock options totaling 0 and 6,110 for the three months ended September 30, 2021 and 2020, respectively, and 0 and 21,479 for the nine months ended September 30, 2021 and 2020, respectively, were not included in the computation of earnings per share because the effect was antidilutive. The dilutive effect of share-based compensation in each period above relates principally to restricted stock awards.

XML

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK

The Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. Those instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the unaudited condensed consolidated balance sheets. The contract amounts of those instruments reflect the extent of involvement the Company has in particular classes of financial instruments.

The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit and financial guarantees written is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments. The following table presents these contractual, or notional, amounts:

	Contractual or Notional Amount
	September 30, 2021		December 31, 2020
Commitments to fund:
Home equity lines of credit	$	251,607	$	223,216
1-4 family residential construction loans	35,519		28,928
Commercial real estate, construction and land development loans	122,850		60,606
Commercial, industrial and other loans	339,569		268,931
Standby letters of credit	21,423		14,491

Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each customer’s credit-worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the customer. Collateral varies but may include accounts receivable, inventory, equipment, residential real estate, and income-producing commercial properties.

Standby letters of credit and financial guarantees written are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loans to customers. The Company holds collateral supporting those commitments when deemed necessary by management. The liability, at September 30, 2021 and December 31, 2020, for guarantees under standby letters of credit issued was not considered to be material.

The Company maintains a reserve, based on historical loss experience of the related loan class and utilization assumptions, for off-balance sheet credit exposures that currently are not funded, in other liabilities on the unaudited condensed consolidated balance sheets. A review of historical loss and line utilization experience in the nine months ended September 30, 2021 resulted in a reduction of loss and utilization assumptions from prior periods. This reserve totaled $1.4 million at September 30, 2021 and $1.5 million at December 31, 2020.

XML

FAIR VALUE

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

FAIR VALUE

FAIR VALUE

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Certain financial instruments and all non-financial instruments are excluded from disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company.

The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are:

Level 1 – quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access at the measurement date.

Level 2 – significant other observable inputs other than Level 1 prices such as prices for similar assets and liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 – at least one significant unobservable input that reflects a company's own assumptions about the assumptions that market participants would use in pricing an asset or liability.

In instances in which multiple levels of inputs are used to measure fair value, hierarchy classification is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

The Company used the following methods and significant assumptions to estimate fair value for instruments measured on a recurring basis:

Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, securities are classified within Level 2 and fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flow. Level 2 securities include U.S. agency securities, mortgage-backed securities, obligations of states and political subdivisions and certain corporate, asset backed and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy. The Company’s investment securities are classified as available for sale.

The fair values of interest rate swaps and risk participation derivatives are determined using models that incorporate readily observable market data into a market standard methodology. This methodology nets the discounted future cash receipts and the discounted expected cash payments. The discounted variable cash receipts and payments are based on expectations of future interest rates derived from observable market interest rate curves. In addition, fair value is adjusted for the effect of nonperformance risk by incorporating credit valuation adjustments for the Company and its counterparties. These assets and liabilities are classified as Level 2 fair values, based upon the lowest level of input that is significant to the fair value measurements.

The following table summarizes assets measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
September 30, 2021
Financial Assets
Investment securities:
U.S. Treasury securities	$	19,831	$	—	$	—	$	19,831
States and political subdivisions	—		171,304		10,217		181,521
GSE residential MBSs	—		20,518		—		20,518
GSE residential CMOs	—		70,187		—		70,187
Nonagency CMOs	—		12,400		13,257		25,657
Asset-backed	—		126,907		—		126,907
Other	397		—		—		397
Loans held for sale	—		6,412		—		6,412
Derivatives	—		277		546		823
Totals	$	20,228	$	408,005	$	24,020	$	452,253
Financial Liabilities
Derivatives	$	—	$	272	$	—	$	272
December 31, 2020
Financial Assets
Investment securities:
States and political subdivisions	$	—	$	103,591	$	9,079	$	112,670
GSE residential MBSs	—		4,293		—		4,293
GSE residential CMOs	—		58,011		—		58,011
Nonagency CMOs	—		—		16,918		16,918
Private label commercial CMOs	—		56,730		5,506		62,236
Asset-backed	—		211,966		—		211,966
Other	371		—		—		371
Loans held for sale	—		11,734		—		11,734
Derivatives	—		690		673		1,363
Totals	$	371	$	447,015	$	32,176	$	479,562
Financial Liabilities
Derivatives	$	—	$	1,956	$	—	$	1,956

The Company had one municipal bond and one CMO measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at September 30, 2021. At December 31, 2020, this municipal bond as well as three CMOs were measured on a recurring basis using Level 3 unobservable inputs. One of the CMOs held at December 31, 2020 was sold and one was called in the nine months ended September 30, 2021. The Level 3 valuation is based on a non-executable broker quote, which is considered a significant unobservable input. Such quotes are updated as available and may remain constant for a period of time for certain broker-quoted securities that do not move with the market or that are not interest rate sensitive as a result of their structure or overall attributes.

The Company’s residential mortgage loans held for sale are recorded at fair value utilizing Level 2 measurements. This fair value measurement is determined based upon third party quotes obtained on similar loans. For loans held for sale for which the fair value option has been elected, the aggregate fair value exceeded the aggregate principal balance by $151 thousand as of September 30, 2021.

The determination of the fair value of interest rate lock commitments on residential mortgages is based on agreed upon pricing with the respective investor on each loan and includes a pull through percentage. The pull through percentage represents an estimate of loans in the pipeline to be delivered to an investor versus the total loans committed for delivery. Significant changes in this input could result in a significantly higher or lower fair value measurement. As the pull through percentage is a

significant unobservable input, this is deemed a Level 3 valuation input. The average pull through percentage, which is based upon historical experience, was 89% as of September 30, 2021. An increase or decrease of 5% in the pull through assumption would result in a positive or negative change of $26 thousand in the fair value of interest rate lock commitments at September 30, 2021.

The following provides details of the Level 3 fair value measurement activity for the periods ended September 30, 2021 and 2020:

Investment securities:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Balance, beginning of period	$	24,925	$	23,834	$	31,503	$	24,279
Unrealized (loss) gain included in OCI	(964)		200		467		(229)
Principal payments and other	(487)		(142)		(4,951)		(158)
Sales	—		—		(3,545)		—
Balance, end of period	$	23,474	$	23,892	$	23,474	$	23,892

Interest rate lock commitments on residential mortgages:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Balance, beginning of period	$	456	$	986	$	673	$	103
Total gains (losses)
Included in earnings	90		157		(127)		1,040
Balance, end of period	$	546	$	1,143	$	546	$	1,143

Certain financial assets are measured at fair value on a nonrecurring basis. Adjustments to the fair value of these assets usually results from the application of lower of cost or market accounting or write-downs of individual assets. The Company used the following methods and significant assumptions to estimate fair value for these financial assets.

Impaired Loans

Loans are designated as impaired when, in the judgment of management and based on current information and events, it is probable that all amounts due, according to the contractual terms of the loan agreement, will not be collected. The measurement of loss associated with impaired loans for all loan classes can be based on either the observable market price of the loan, the fair value of the collateral, or discounted cash flows using the rate of return implicit in the original loan for TDRs. For collateral-dependent loans, fair value is measured based on the value of the collateral securing the loan, less estimated costs to sell. Collateral may be in the form of real estate or business assets including equipment, inventory, and accounts receivable. The value of the real estate collateral is determined utilizing an income or market valuation approach based on an appraisal conducted by an independent, licensed appraiser outside of the Company using observable market data (Level 2). However, if the collateral is a house or building in the process of construction, or if management adjusts the appraisal value, then the fair value is considered Level 3. The value of business equipment is based upon an outside appraisal, if deemed significant, or the net book value on the applicable business’ financial statements if not considered significant using observable market data. Likewise, values for inventory and accounts receivable collateral are based on financial statement balances or aging reports (Level 3). Impaired loans with an allocation to the ALL are measured at fair value on a nonrecurring basis. Any fair value adjustments are recorded in the period incurred as provision for loan losses on the unaudited condensed consolidated statements of income.

Any changes in the fair value of impaired loans still held were not material for the three and nine months ended September 30, 2021 and 2020.

Foreclosed Real Estate

OREO property acquired through foreclosure is initially recorded at the fair value of the property at the transfer date less estimated selling cost. Subsequently, OREO is carried at the lower of its carrying value or the fair value less estimated selling

cost. Fair value is usually determined based upon an independent third-party appraisal of the property or occasionally upon a recent sales offer. The Company had no OREO balances at September 30, 2021 and December 31, 2020.

Mortgage Servicing Rights

The MSR fair value is estimated to be equal to its carrying value, unless the quarterly valuation model calculates the present value of the estimated net servicing income is less than its carrying value, in which case an impairment charge is taken. At September 30, 2021 and December 31, 2020, an impairment reserve of $372 thousand and $1.1 million, respectively, existed on the mortgage servicing right portfolio. For the three months ended September 30, 2021 and 2020, an impairment valuation allowance reversal of $43 thousand and an impairment charge of $166 thousand were included, respectively, in mortgage banking activities on the unaudited condensed consolidated statements of income. For the nine months ended September 30, 2021 and 2020, an impairment valuation allowance reversal of $695 thousand and an impairment charge of $986 thousand, respectively, were included in mortgage banking activities on the unaudited condensed consolidated statements of income. The impairment charges in 2020 resulted from rapidly declining market rates caused by the COVID-19 pandemic. The reversals in the three and nine months ended September 30, 2021 were due to a subsequent increase in market rates.

The following table summarizes assets measured at fair value on a nonrecurring basis at September 30, 2021 and December 31, 2020:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
September 30, 2021
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	776	$	776
Non-owner occupied residential	—		—		69		69
Residential mortgage:
First lien	—		—		677		677
Home equity - lines of credit	—		—		77		77
Total impaired loans	$	—	$	—	$	1,599	$	1,599
Mortgage servicing rights	$	—	$	—	$	3,642	$	3,642
December 31, 2020
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	846	$	846
Non-owner occupied residential	—		—		36		36
Commercial and industrial	—		—		12		12
Residential mortgage:
First lien	—		—		638		638
Home equity - lines of credit	—		—		89		89
Total impaired loans	$	—	$	—	$	1,621	$	1,621
Mortgage servicing rights	$	—	$	—	$	2,745	$	2,745

The following table presents additional qualitative information about assets measured on a nonrecurring basis and for which the Company has utilized Level 3 inputs to determine fair value:

	Fair Value Estimate		Valuation Techniques	Unobservable Input	Range
September 30, 2021
Impaired loans	$	1,599	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	10% - 25% discount
				- Management adjustments for liquidation expenses	6% - 18% discount
Mortgage servicing rights	$	3,642	Discounted cash flows	Weighted average CPR	14.53%
				- Weighted average discount rate	9.04%
December 31, 2020
Impaired loans	$	1,621	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	5% - 25% discount
				- Management adjustments for liquidation expenses	6% - 19% discount
Mortgage servicing rights	$	2,745	Discounted cash flows	Weighted average CPR	18.02%
				- Weighted average discount rate	9.56%

Fair values of financial instruments

The following table presents carrying amounts and estimated fair values of the Company’s financial instruments at September 30, 2021 and December 31, 2020:

	Carrying Amount		Fair Value		Level 1		Level 2		Level 3
September 30, 2021
Financial Assets
Cash and due from banks	$	36,920	$	36,920	$	36,920	$	—	$	—
Interest-bearing deposits with banks	274,495		274,495		274,495		—		—
Restricted investments in bank stocks	7,051		n/a		n/a		n/a		n/a
Investment securities	445,018		445,018		20,228		401,316		23,474
Loans held for sale	6,412		6,412		—		6,412		—
Loans, net of allowance for loan losses	1,919,799		1,917,091		—		—		1,917,091
Derivatives	823		823		—		277		546
Accrued interest receivable	8,015		8,015		—		2,169		5,846
Financial Liabilities
Deposits	2,502,108		2,503,695		—		2,503,695		—
Securities sold under agreements to repurchase	27,595		27,595		—		27,595		—
FHLB advances and other	2,003		2,176		—		2,176		—
Subordinated notes	31,948		32,781		—		32,781		—
Derivatives	272		272		—		272		—
Accrued interest payable	631		631		—		631		—
Off-balance sheet instruments	—		—		—		—		—
December 31, 2020
Financial Assets
Cash and due from banks	$	26,203	$	26,203	$	26,203	$	—	$	—
Interest-bearing deposits with banks	99,055		99,055		99,055		—		—
Restricted investments in bank stocks	10,563		n/a		n/a		n/a		n/a
Investment securities	466,465		466,465		371		434,591		31,503
Loans held for sale	11,734		11,734		—		11,734		—
Loans, net of allowance for loan losses	1,959,539		1,953,860		—		—		1,953,860
Derivatives	1,363		1,363		—		690		673
Accrued interest receivable	8,927		8,927		—		1,529		7,398
Financial Liabilities
Deposits	2,356,880		2,359,317		—		2,359,317		—
Securities sold under agreements to repurchase	19,466		19,466		—		19,466		—
FHLB advances and other	58,045		58,298		—		58,298		—
Subordinated notes	31,903		31,712		—		31,712		—
Derivatives	1,956		1,956		—		1,956		—
Accrued interest payable	238		238		—		238		—
Off-balance sheet instruments	—		—		—		—		—

The methods used to estimate the fair value of financial instruments at September 30, 2021 and December 31, 2020 did not necessarily represent an exit price. In accordance with the Company's adoption of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, the methods utilized to measure the fair value of financial instruments at September 30, 2021 and December 31, 2020 represent an approximation of exit price; however, an actual exit price may differ.

XML

CONTINGENCIES

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

CONTINGENCIES

CONTINGENCIES

The nature of the Company’s business generates a certain amount of litigation involving matters arising out of the ordinary course of business. Except as described below, in the opinion of management, there are no legal proceedings that might have a material effect on the results of operations, liquidity, or the financial position of the Company at this time.

On March 5, 2019, Paul Parshall, a purported individual stockholder of Hamilton, filed, on behalf of himself and all of Hamilton’s stockholders other than the named defendants and their affiliates (the “Purported Class”), a derivative and putative class action complaint in the Circuit Court for Baltimore City, Maryland, captioned Paul Parshall v. Carol Coughlin et. al., naming each Hamilton director, Orrstown, and Hamilton as defendants (the “Action”). The Action alleged, among other things, that Hamilton’s directors breached their fiduciary duties to the Purported Class in connection with the merger, and that the Proxy Statement/Prospectus omitted certain material information regarding the merger. Orrstown was alleged to have aided and abetted the Hamilton directors’ alleged breaches of their fiduciary duties. The Action sought, among other remedies, to enjoin the merger or, in the event the merger was completed, rescission of the merger or rescissory damages; unspecified damages; and costs of the lawsuit, including attorneys’ and experts’ fees. A settlement was reached on the Action in March 2020 which resulted in a payment by the Company of $135 thousand in mootness fees to the defendants in April 2020.

On May 25, 2012, SEPTA filed a putative class action complaint in the U.S. District Court for the Middle District of Pennsylvania against the Company, the Bank and certain current and former directors and officers (collectively, the “Orrstown Defendants”). The complaint alleged, among other things, that (i) in connection with the Company’s Registration Statement on Form S-3 dated February 23, 2010 and its Prospectus Supplement dated March 23, 2010, and (ii) during the purported class period of March 24, 2010 through October 27, 2011, the Company issued materially false and misleading statements regarding the Company’s lending practices and financial results, including misleading statements concerning the stringent nature of the Bank’s credit practices and underwriting standards, the quality of its loan portfolio, and the intended use of the proceeds from the Company’s March 2010 public offering of common stock. The complaint asserted claims under Sections 11, 12(a) and 15 of the Securities Act of 1933, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, and sought class certification, unspecified money damages, interest, costs, fees and equitable or injunctive relief. Under the Private Securities Litigation Reform Act of 1995 (“PSLRA”), the Court appointed SEPTA Lead Plaintiff on August 20, 2012.

On March 4, 2013, SEPTA filed an amended complaint. The amended complaint expanded the list of defendants in the action to include the Company’s former independent registered public accounting firm, Smith Elliott Kearns & Company, LLC (“SEK”), and the underwriters of the Company’s March 2010 public offering of common stock. In addition, among other things, the amended complaint extended the purported 1934 Exchange Act class period from March 15, 2010 through April 5, 2012.

On June 22, 2015, in a 96-page Memorandum, the Court dismissed without prejudice SEPTA’s amended complaint against all defendants, finding that SEPTA failed to state a claim under either the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. On February 8, 2016, the Court granted SEPTA’s motion for leave to amend again and SEPTA filed its second amended complaint that same day.

On December 7, 2016, the Court issued an Order and Memorandum granting in part and denying in part defendants’ motions to dismiss SEPTA’s second amended complaint. The Court granted the motions to dismiss the Securities Act claims against all defendants, and granted the motions to dismiss the Exchange Act Section 10(b) and Rule 10b-5 claims against all defendants except Orrstown Financial Services, Inc., Orrstown Bank, Thomas R. Quinn, Jr., Bradley S. Everly, and Jeffrey W. Embly. The Court also denied the motions to dismiss the Exchange Act Section 20(a) claims against Quinn, Everly, and Embly.

On December 15, 2017, the Orrstown Defendants and SEPTA exchanged expert reports in opposition to and in support of class certification, respectively. On January 15, 2018, the parties exchanged expert rebuttal reports. SEPTA has not yet filed a motion for class certification.

On August 9, 2018, SEPTA filed a motion to compel the production of Confidential Supervisory Information (CSI) of non-parties the Board of Governors of the FRB and the Pennsylvania Department of Banking and Securities, in the possession of Orrstown and third parties. On August 30, 2018, the FRB filed an unopposed motion to intervene in the Action for the purpose of opposing SEPTA’s motion to compel. On February 12, 2019, the Court denied SEPTA’s motion to compel the production of CSI on the ground that SEPTA had failed to exhaust its administrative remedies.

On April 11, 2019, SEPTA filed a motion for leave to file a third amended complaint. The proposed third amended complaint seeks to reassert the Securities Act claims that the Court dismissed as to all defendants on December 7, 2016, when the Court granted in part and denied in part defendants’ motions to dismiss SEPTA’s second amended complaint. The proposed

third amended complaint also seeks to reassert the Exchange Act claims against those defendants that the Court dismissed from the case on December 7, 2016.

On June 13, 2019, Orrstown filed a motion for protective order to stay discovery pending resolution of SEPTA’s motion for leave to file a third amended complaint. On July 17, 2019, the Court entered an Order partially granting Orrstown’s motion for protective order, ruling that all deposition discovery in the case was stayed pending a decision on SEPTA’s motion for leave to file a third amended complaint. Party and non-party document discovery in the case has largely been completed.

On February 14, 2020, the Court issued an Order and Memorandum granting SEPTA’s motion for leave to file a third amended complaint. The third amended complaint is now the operative complaint. It reinstates the Orrstown Defendants, as well as SEK and the underwriter defendants, previously dismissed from the case on December 7, 2016. The third amended complaint also revives the previously dismissed Securities Act claim against the Orrstown Defendants, SEK, and the underwriter defendants. Defendants filed their motions to dismiss the third amended complaint on April 24, 2020. SEPTA’s opposition was filed on July 8, 2020, and Orrstown’s reply brief was filed on August 12, 2020.

Additionally, on February 24, 2020, the Orrstown Defendants, and the underwriter defendants and SEK, separately filed motions under 28 U.S.C. § 1292(b) asking the District Court to certify its February 14, 2020 Order granting leave to file the third amended complaint for interlocutory appeal to the Third Circuit Court of Appeals. The District Court granted those motions on July 17, 2020, and defendants filed their Petition for Permission to Appeal with the Third Circuit on July 27, 2020. The Third Circuit granted permission to appeal the Order pursuant to 28 U.S.C. § 1292(b) on August 13, 2020. Defendants filed their joint Opening Brief in the Third Circuit on November 2, 2020, asking the Court to reverse the district court’s Order. SEPTA filed its responsive brief on December 2, 2020 and defendants filed their reply brief on December 23, 2020. Oral argument was held on February 10, 2021. On September 2, 2021, the Third Circuit affirmed the District Court's February 14, 2020 Order granting SEPTA leave to file a third amended complaint. Defendants' motions to dismiss the third amended complaint are still pending in the District Court.

The Company believes that SEPTA’s allegations and claims against the defendants are without merit, and the Company and intends to defend itself vigorously against those claims. It is not possible at this time to reasonably estimate possible losses, or even a range of reasonably possible losses, in connection with the litigation.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Nature of Operations

Nature of Operations – Orrstown Financial Services, Inc. is a financial holding company that operates Orrstown Bank, a commercial bank providing banking and financial advisory services in Berks, Cumberland, Dauphin, Franklin, Lancaster, Perry and York Counties, Pennsylvania, and in Anne Arundel, Baltimore, Howard and Washington Counties, Maryland, as well as Baltimore City, Maryland. The Company operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services, including checking, savings, time, and money market deposits. The Company also provides fiduciary services, investment advisory, insurance and brokerage services. The Company and the Bank are subject to regulation by certain federal and state agencies and undergo periodic examinations by such regulatory authorities.

Basis of Presentation

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements include the accounts of Orrstown Financial Services, Inc. and its wholly owned subsidiary, the Bank. The Company has prepared these unaudited condensed consolidated financial statements in accordance with GAAP for interim financial information, SEC rules that permit reduced disclosure for interim periods, and Article 10 of Regulation S-X. In the opinion of management, all adjustments (all of which are of a normal recurring nature) that are necessary for a fair statement are reflected in the unaudited condensed consolidated financial statements. The December 31, 2020 consolidated balance sheet information contained in this Quarterly Report on Form 10-Q was derived from the Company's 2020 audited consolidated financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. All significant intercompany transactions and accounts have been eliminated.

The Company's management has evaluated all activity of the Company and concluded that subsequent events are properly reflected in the Company's unaudited condensed consolidated financial statements and notes as required by GAAP.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. The effects of the COVID-19 pandemic may impact material estimates. Material estimates that are particularly susceptible to significant change include the determination of the ALL and those used in valuation methodologies in areas with no observable market, such as loans, deposits, borrowings, goodwill, core deposit and other intangible assets, mortgage servicing rights, other assets and liabilities obtained or assumed in business combinations. Certain prior-year amounts have been reclassified to conform to the current year presentation. These reclassifications did not have a material impact on the Company's consolidated financial condition or results of operations.

Derivatives

Derivatives - FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge.

The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company's objectives in using interest rate derivatives are to add stability to interest income and to manage its exposure to interest rate movements. To accomplish this objective, the Company uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of fixed amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount.

Changes to the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income and are subsequently reclassified into earnings in the period that the hedged transaction affects earnings. The Company discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in accumulated other comprehensive income (loss) are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. Such derivatives were used to hedge the variable cash flows associated with overnight borrowings. During the three and nine months ended September 30, 2021, the Company terminated its interest rate derivative designated as a cash flow hedge.

Derivatives not designated as hedges are not speculative and result from a service the Company provides to certain customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting derivatives that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate derivatives associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer derivatives and the offsetting derivatives are recognized directly in earnings.

Leases

Leases - The Company evaluates its contracts at inception to determine if an arrangement either is a lease or contains one. Operating lease ROU assets are included in other assets and operating lease liabilities in accrued interest payable and other liabilities in the unaudited condensed consolidated balance sheets. The Company had no finance leases at September 30, 2021.

ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company's leases do not provide an implicit rate, so the Company's incremental borrowing rate is used, which approximates its fully collateralized borrowing rate, based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is reevaluated upon lease modification. The operating lease ROU asset also includes any initial direct costs and prepaid lease payments made less any lease incentives. In calculating the present value of lease payments, the Company may include options to extend the lease when it is reasonably certain that it will exercise that option.

In accordance with ASU 2016-02, “Leases (Topic 842)” (“ASU 2016-02”), the Company keeps leases with an initial term of 12 months or less off of the balance sheet. The Company recognizes these lease payments in the unaudited condensed consolidated statements of income on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components and has elected the practical expedient to account for them as a single lease component.

Recent Accounting Pronouncements

Recent Accounting Pronouncements - ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The amendments in this update require an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Organizations will continue to use judgment to determine which loss estimation method is appropriate for their circumstances. Additionally, the amendments in this update amend the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For certain public companies, this update was effective for interim and annual periods beginning after December 15, 2019. The Company delayed the adoption of ASU 2016-13 as noted below.

ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates ("ASU 2019-10"), extended the implementation deadline of ASU 2016-13 for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company meets the requirements to be considered a smaller reporting company under SEC Regulation S-K and SEC Rule 405, and did not adopt ASU 2016-13 on January 1, 2020. The Company is evaluating the impact of the delay for adoption of ASU 2016-13, and is working with a third-party vendor solution to assist with the application of ASU 2016-13 and finalizing the loss estimation models to be used. Once management determines which methods will be utilized, a third party will be contracted to perform a model validation prior to adoption. While the Company anticipates the allowance for loan losses will increase under its current

assumptions, it expects the impact of adopting ASU 2016-13 will be influenced by the composition, characteristics and quality of its loan and securities portfolios, as well as general economic conditions and forecasts at the adoption date. The other provisions of ASU 2019-10 were not applicable to the Company.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). ASU 2020-04 contains optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The optional expedients apply consistently to all contracts or transactions within the scope of this topic, while the optional expedients for hedging relationships can be elected on an individual basis. The Company has formed a cross-functional working group to lead the transition from LIBOR to a planned adoption of an alternate index. The Company currently plans to replace LIBOR with the 30-Day Average SOFR in its loan agreements. The Company is in the process of implementing fallback language for loans that will mature after 2021. The Company expects to adopt the LIBOR transition relief allowed under this standard, and is currently evaluating the potential impact of this guidance on its financial statements.

XML

INVESTMENT SECURITIES (Tables)

9 Months Ended

Sep. 30, 2021

Investments, Debt and Equity Securities [Abstract]

Amortized Cost and Fair Values of AFS Securities

At September 30, 2021 and December 31, 2020, all investment securities were classified as AFS. The following table summarizes amortized cost and fair value of investment securities, and the corresponding amounts of gross unrealized gains and losses recognized in AOCI, at September 30, 2021 and December 31, 2020:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
September 30, 2021
U.S. Treasury securities	$	20,087	$	—	$	256	$	19,831
States and political subdivisions	174,239		8,072		790		181,521
GSE residential MBSs	20,552		80		114		20,518
GSE residential CMOs	69,922		921		656		70,187
Non-agency CMOs	25,929		1		273		25,657
Asset-backed	126,726		457		276		126,907
Other	397		—		—		397
Totals	$	437,852	$	9,531	$	2,365	$	445,018
December 31, 2020
States and political subdivisions	$	104,704	$	9,091	$	1,125	$	112,670
GSE residential MBSs	4,197		96		—		4,293
GSE residential CMOs	56,856		2,226		1,071		58,011
Non-agency CMOs	16,505		413		—		16,918
Private label commercial CMOs	63,941		57		1,762		62,236
Asset-backed	214,425		171		2,630		211,966
Other	371		—		—		371
Totals	$	460,999	$	12,054	$	6,588	$	466,465

Summary of AFS Securities with Unrealized Losses

The following table summarizes investment securities with unrealized losses at September 30, 2021 and December 31, 2020, aggregated by major investment security type and the length of time in a continuous unrealized loss position.

	Less Than 12 Months					12 Months or More					Total
	# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses
September 30, 2021
U.S. Treasury securities	3	$	19,831	$	256	—	$	—	$	—	3	$	19,831	$	256
States and political subdivisions	11	40,666		790		—	—		—		11	40,666		790
GSE residential MBSs	5	17,354		114		—	—		—		5	17,354		114
GSE residential CMOs	7	43,267		656		—	—		—		7	43,267		656
Non-agency CMOs	1	13,257		273		—	—		—		1	13,257		273
Asset-backed	2	19,084		14		3	36,067		262		5	55,151		276
Totals	29	$	153,459	$	2,103	3	$	36,067	$	262	32	$	189,526	$	2,365
December 31, 2020
States and political subdivisions	1	$	9,079	$	1,125	—	$	—	$	—	1	$	9,079	$	1,125
GSE residential CMOs	3	23,954		1,071		—	—		—		3	23,954		1,071
Private label commercial CMOs	1	4,314		685		10	42,403		1,077		11	46,717		1,762
Asset-backed	2	16,921		12		15	183,161		2,618		17	200,082		2,630
Totals	7	$	54,268	$	2,893	25	$	225,564	$	3,695	32	$	279,832	$	6,588

Schedule of Amortized Cost and Fair Values of AFS Securities by Contractual Maturity

The following table summarizes amortized cost and fair value of investment securities by contractual maturity at September 30, 2021. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date are shown separately.

	Amortized Cost		Fair Value
Due in one year or less	$	—	$	—
Due after one year through five years	249		249
Due after five years through ten years	69,999		71,976
Due after ten years	124,475		129,524
CMOs and MBSs	116,403		116,362
Asset-backed	126,726		126,907
Totals	$	437,852	$	445,018

Proceeds From Sale of AFS Securities and Gross Gains and Gross Losses

The following table summarizes proceeds from sales of investment securities and gross gains and gross losses for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Proceeds from sale of investment securities	$	73,319	$	—	$	149,038	$	—
Gross gains	482		—		1,844		—
Gross losses	3		13		1,209		44

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES (Tables)

9 Months Ended

Sep. 30, 2021

Receivables [Abstract]

Summary of Loan Portfolio, Excluding Residential Loans Held for Sale, Broken Out by Classes

The following table presents the loan portfolio by segment and class, excluding residential mortgage LHFS, at September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
Commercial real estate:
Owner occupied	$	196,585	$	174,908
Non-owner occupied	509,703		409,567
Multi-family	112,002		113,635
Non-owner occupied residential	100,088		114,505
Acquisition and development:
1-4 family residential construction	12,246		9,486
Commercial and land development	71,784		51,826
Commercial and industrial (1)	540,205		647,368
Municipal	13,631		20,523
Residential mortgage:
First lien	203,360		244,321
Home equity - term	7,079		10,169
Home equity - lines of credit	154,004		157,021
Installment and other loans	19,077		26,361
Total loans	$	1,939,764	$	1,979,690

(1) This balance includes $259.9 million and $403.3 million of SBA PPP loans, net of deferred fees and costs, at September 30, 2021 and December 31, 2020, respectively.

Loan Portfolio Ratings Based on Internal Risk Rating System

The following table summarizes the Company’s loan portfolio ratings based on its internal risk rating system at September 30, 2021 and December 31, 2020:

	Pass		Special Mention		Non-Impaired Substandard		Impaired - Substandard		Doubtful		PCI Loans		Total
September 30, 2021
Commercial real estate:
Owner occupied	$	176,029	$	8,219	$	6,147	$	3,832	$	—	$	2,358	$	196,585
Non-owner occupied	476,947		32,272		168		—		—		316		509,703
Multi-family	91,726		19,662		614		—		—		—		112,002
Non-owner occupied residential	95,338		2,028		1,344		171		—		1,207		100,088
Acquisition and development:
1-4 family residential construction	12,246		—		—		—		—		—		12,246
Commercial and land development	70,648		636		500		—		—		—		71,784
Commercial and industrial	521,530		7,939		5,505		2,941		—		2,290		540,205
Municipal	13,631		—		—		—		—		—		13,631
Residential mortgage:
First lien	195,717		—		240		2,472		—		4,931		203,360
Home equity - term	7,056		—		—		7		—		16		7,079
Home equity - lines of credit	153,436		21		52		495		—		—		154,004
Installment and other loans	19,002		—		—		37		—		38		19,077
	$	1,833,306	$	70,777	$	14,570	$	9,955	$	—	$	11,156	$	1,939,764
December 31, 2020
Commercial real estate:
Owner occupied	$	148,846	$	12,491	$	7,855	$	3,260	$	—	$	2,456	$	174,908
Non-owner occupied	351,860		57,378		—		—		—		329		409,567
Multi-family	92,769		20,224		642		—		—		—		113,635
Non-owner occupied residential	107,557		3,948		1,422		268		—		1,310		114,505
Acquisition and development:
1-4 family residential construction	9,101		385		—		—		—		—		9,486
Commercial and land development	49,832		655		525		814		—		—		51,826
Commercial and industrial	617,213		17,561		6,118		3,639		—		2,837		647,368
Municipal	20,523		—		—		—		—		—		20,523
Residential mortgage:
First lien	236,381		—		—		2,628		—		5,312		244,321
Home equity - term	10,076		—		64		10		—		19		10,169
Home equity - lines of credit	156,264		95		54		608		—		—		157,021
Installment and other loans	26,283		—		—		17		—		61		26,361
	$	1,826,705	$	112,737	$	16,680	$	11,244	$	—	$	12,324	$	1,979,690

Impaired Loans by Segment and Class

The following table, which excludes accruing PCI loans, summarizes impaired loans by segment and class, segregated by those for which a specific allowance was required and those for which a specific allowance was not required at September 30, 2021 and December 31, 2020. The recorded investment in loans excludes accrued interest receivable due to insignificance. Related allowances established generally pertain to those loans in which loan forbearance agreements were in the process of being negotiated or updated appraisals were pending, and any partial charge-off will be recorded when final information is received.

	Impaired Loans with a Specific Allowance						Impaired Loans with No Specific Allowance
	Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)		Related Allowance		Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)
September 30, 2021
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,832	$	4,923
Non-owner occupied residential	—		—		—		171		383
Commercial and industrial	—		—		—		2,941		3,592
Residential mortgage:
First lien	469		469		29		2,003		3,161
Home equity—term	—		—		—		7		10
Home equity—lines of credit	—		—		—		495		733
Installment and other loans	—		—		—		37		37
	$	469	$	469	$	29	$	9,486	$	12,839
December 31, 2020
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,260	$	4,091
Non-owner occupied residential	—		—		—		268		393
Acquisition and development:
Commercial and land development	—		—		—		814		875
Commercial and industrial	—		—		—		3,639		4,269
Residential mortgage:
First lien	424		508		33		2,204		3,264
Home equity—term	—		—		—		10		13
Home equity—lines of credit	—		—		—		608		832
Installment and other loans	—		—		—		17		18
	$	424	$	508	$	33	$	10,820	$	13,755

Average Recorded Investment in Impaired Loans and Related Interest Income

The following table, which excludes accruing PCI loans, summarizes the average recorded investment in impaired loans and related recognized interest income for the three and nine months ended September 30, 2021 and 2020:

	2021				2020
	Average Impaired Balance		Interest Income Recognized		Average Impaired Balance		Interest Income Recognized
Three Months Ended September 30,
Commercial real estate:
Owner-occupied	$	4,179	$	—	$	4,424	$	—
Non-owner occupied	—		—		102		—
Multi-family	—		—		141		—
Non-owner occupied residential	232		—		433		—
Acquisition and development:
Commercial and land development	—		—		837		—
Commercial and industrial	3,073		—		1,044		—
Residential mortgage:
First lien	2,541		11		3,209		12
Home equity – term	10		—		12		—
Home equity - lines of credit	463		—		645		—
Installment and other loans	24		—		17		—
	$	10,522	$	11	$	10,864	$	12
Nine Months Ended September 30,
Commercial real estate:
Owner occupied	$	3,848	$	1	$	5,033	$	1
Non-owner occupied	—		—		108		—
Multi-family	7		—		259		—
Non-owner occupied residential	252		—		422		—
Acquisition and development:
Commercial and land development	246		—		586		—
Commercial and industrial	3,046		—		1,316		—
Residential mortgage:
First lien	2,575		32		3,050		36
Home equity - term	12		—		12		—
Home equity - lines of credit	547		—		699		1
Installment and other loans	17		—		29		—
	$	10,550	$	33	$	11,514	$	38

Troubled Debt Restructurings

The following table presents impaired loans that are TDRs, with the recorded investment at September 30, 2021 and December 31, 2020:

	September 30, 2021			December 31, 2020
	Number of Contracts	Recorded Investment		Number of Contracts	Recorded Investment
Accruing:
Commercial real estate:
Owner occupied	1	$	26	1	$	28
Residential mortgage:
First lien	8	813		9	898
Home equity - lines of credit	—	—		1	8
	9	839		11	934
Nonaccruing:
Residential mortgage:
First lien	5	291		5	320
	5	291		5	320
	14	$	1,130	16	$	1,254

Loan Portfolio Summarized by Aging Categories of Performing Loans and Nonaccrual Loans

The following table presents the classes of loan portfolio summarized by aging categories of performing loans and nonaccrual loans at September 30, 2021 and December 31, 2020:

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
September 30, 2021
Commercial real estate:
Owner occupied	$	190,183	$	238	$	—	$	—	$	238	$	3,806	$	194,227
Non-owner occupied	509,387		—		—		—		—		—		509,387
Multi-family	112,002		—		—		—		—		—		112,002
Non-owner occupied residential	98,459		—		251		—		251		171		98,881
Acquisition and development:
1-4 family residential construction	12,246		—		—		—		—		—		12,246
Commercial and land development	71,774		10		—		—		10		—		71,784
Commercial and industrial	534,967		7		—		—		7		2,941		537,915
Municipal	13,631		—		—		—		—		—		13,631
Residential mortgage:
First lien	196,076		341		318		35		694		1,659		198,429
Home equity - term	7,041		15		—		—		15		7		7,063
Home equity - lines of credit	153,266		208		35		—		243		495		154,004
Installment and other loans	18,891		70		41		—		111		37		19,039
Subtotal	1,917,923		889		645		35		1,569		9,116		1,928,608
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,358		—		—		—		—		—		2,358
Non-owner occupied	316		—		—		—		—		—		316
Non-owner occupied residential	1,081		—		—		126		126		—		1,207
Commercial and industrial	2,290		—		—		—		—		—		2,290
Residential mortgage:
First lien	4,730		—		—		201		201		—		4,931
Home equity - term	16		—		—		—		—		—		16
Installment and other loans	38		—		—		—		—		—		38
Subtotal	10,829		—		—		327		327		—		11,156
	$	1,928,752	$	889	$	645	$	362	$	1,896	$	9,116	$	1,939,764

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
December 31, 2020
Commercial real estate:
Owner occupied	$	168,262	$	958	$	—	$	—	$	958	$	3,232	$	172,452
Non-owner occupied	409,130		108		—		—		108		—		409,238
Multi-family	113,635		—		—		—		—		—		113,635
Non-owner occupied residential	112,443		484		—		—		484		268		113,195
Acquisition and development:
1-4 family residential construction	9,486		—		—		—		—		—		9,486
Commercial and land development	50,922		32		58		—		90		814		51,826
Commercial and industrial	640,573		9		310		—		319		3,639		644,531
Municipal	19,677		846		—		—		846		—		20,523
Residential mortgage:
First lien	230,903		5,758		535		83		6,376		1,730		239,009
Home equity - term	10,099		40		—		1		41		10		10,150
Home equity - lines of credit	156,153		268		—		—		268		600		157,021
Installment and other loans	26,052		168		49		14		231		17		26,300
Subtotal	1,947,335		8,671		952		98		9,721		10,310		1,967,366
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,456		—		—		—		—		—		2,456
Non-owner occupied	329		—		—		—		—		—		329
Non-owner occupied residential	1,161		—		—		149		149		—		1,310
Commercial and industrial	2,837		—		—		—		—		—		2,837
Residential mortgage:
First lien	4,341		655		9		307		971		—		5,312
Home equity - term	19		—		—		—		—		—		19
Installment and other loans	57		4		—		—		4		—		61
Subtotal	11,200		659		9		456		1,124		—		12,324
	$	1,958,535	$	9,330	$	961	$	554	$	10,845	$	10,310	$	1,979,690

Summary of Activity in the ALL and Ending Loan Balances Individually Evaluated for Impairment Based on Loan Segment

The following table presents the activity in the ALL for the three and nine months ended September 30, 2021 and 2020:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
Three Months Ended
September 30, 2021
Balance, beginning of period	$	11,315	$	1,243	$	3,495	$	29	$	16,082	$	2,863	$	227	$	3,090	$	209	$	19,381
Provision for loan losses	(179)		290		386		(2)		495		(147)		18		(129)		(1)		365
Charge-offs	(89)		—		(55)		—		(144)		—		(20)		(20)		—		(164)
Recoveries	305		8		60		—		373		5		5		10		—		383
Balance, end of period	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
September 30, 2020
Balance, beginning of period	$	9,347	$	1,069	$	2,916	$	75	$	13,407	$	3,552	$	386	$	3,938	$	172	$	17,517
Provision for loan losses	1,520		(219)		963		(19)		2,245		(71)		18		(53)		8		2,200
Charge-offs	(3)		—		(193)		—		(196)		—		(31)		(31)		—		(227)
Recoveries	171		—		45		—		216		6		13		19		—		235
Balance, end of period	$	11,035	$	850	$	3,731	$	56	$	15,672	$	3,487	$	386	$	3,873	$	180	$	19,725
Nine Months Ended
September 30, 2021
Balance, beginning of period	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151
Provision for loan losses	133		418		109		(13)		647		(578)		(69)		(647)		(10)		(10)
Charge-offs	(270)		—		(621)		—		(891)		(92)		(49)		(141)		—		(1,032)
Recoveries	338		9		456		—		803		29		24		53		—		856
Balance, end of period	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
September 30, 2020
Balance, beginning of period	$	7,634	$	959	$	2,356	$	100	$	11,049	$	3,147	$	319	$	3,466	$	140	$	14,655
Provision for loan losses	2,780		(117)		1,875		(44)		4,494		329		162		491		40		5,025
Charge-offs	(3)		—		(689)		—		(692)		(109)		(117)		(226)		—		(918)
Recoveries	624		8		189		—		821		120		22		142		—		963
Balance, end of period	$	11,035	$	850	$	3,731	$	56	$	15,672	$	3,487	$	386	$	3,873	$	180	$	19,725

The following table summarizes the ending loan balance individually evaluated for impairment based upon loan segment, as well as the related ALL loss allocation for each at September 30, 2021 and December 31, 2020. Accruing PCI loans are excluded from loans individually evaluated for impairment.

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
September 30, 2021
Loans allocated by:
Individually evaluated for impairment	$	4,003	$	—	$	2,941	$	—	$	6,944	$	2,974	$	37	$	3,011	$	—	$	9,955
Collectively evaluated for impairment	914,375		84,030		537,264		13,631		1,549,300		361,469		19,040		380,509		—		1,929,809
	$	918,378	$	84,030	$	540,205	$	13,631	$	1,556,244	$	364,443	$	19,077	$	383,520	$	—	$	1,939,764
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	29	$	—	$	29	$	—	$	29
Collectively evaluated for impairment	11,352		1,541		3,886		27		16,806		2,692		230		2,922		208		19,936
	$	11,352	$	1,541	$	3,886	$	27	$	16,806	$	2,721	$	230	$	2,951	$	208	$	19,965
December 31, 2020
Loans allocated by:
Individually evaluated for impairment	$	3,528	$	814	$	3,639	$	—	$	7,981	$	3,246	$	17	$	3,263	$	—	$	11,244
Collectively evaluated for impairment	809,087		60,498		643,729		20,523		1,533,837		408,265		26,344		434,609		—		1,968,446
	$	812,615	$	61,312	$	647,368	$	20,523	$	1,541,818	$	411,511	$	26,361	$	437,872	$	—	$	1,979,690
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	33	$	—	$	33	$	—	$	33
Collectively evaluated for impairment	11,151		1,114		3,942		40		16,247		3,329		324		3,653		218		20,118
	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151

Schedule of Activity for the Accretable Yield of Purchased Impaired Loans

The following table provides activity for the accretable yield of PCI loans for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Accretable yield, beginning of period	$	3,016	$	4,182	$	3,438	$	6,950
Additions (1)	—		—		—		570
Accretion of income	(203)		(546)		(878)		(2,459)
Reclassifications from nonaccretable difference due to improvement in expected cash flows	11		139		128		1,260
Other changes, net (2)	(12)		(231)		124		(2,777)
Accretable yield, end of period	$	2,812	$	3,544	$	2,812	$	3,544

(1) The amount for the nine months ended September 30, 2020 reflects a measurement period adjustment for Hamilton loans that should have been in the PCI pool at the acquisition date.

(2) The amount for the nine months ended September 30, 2020 represents the impact of PCI loans sold during that period

XML

LEASES (Tables)

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

Summary of ROU Assets and Related Lease Liabilities

The following table summarizes the Company's operating leases at September 30, 2021 and December 31, 2020:

	September 30, 2021			December 31, 2020
Operating lease ROU assets	$	9,301		$	8,686
Operating lease ROU liabilities	9,832			9,143
Weighted-average remaining lease term (in years)	16.0			16.8
Weighted-average discount rate	4.2		%	4.3		%

Information Related to Operating Leases

The following table presents information related to the Company's operating leases for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Cash paid for operating lease liabilities	$	331	$	210	$	947	$	847
Operating lease expense	388		421		1,179		1,171

Schedule of Maturities of Lease Liabilities

The following table presents expected future maturities of the Company's lease liabilities as of September 30, 2021:

Remainder of 2021	$	296
2022	926
2023	951
2024	974
2025	991
Thereafter	10,387
	14,525
Less: imputed interest	4,693
Total lease liabilities	$	9,832

XML

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of in Changes in Goodwill

The following table presents changes in goodwill for the nine months ended September 30, 2021 and 2020:

	September 30, 2021		September 30, 2020
Balance, beginning of year	$	18,724	$	19,925
Adjustments to acquired goodwill (1)	—		(1,201)
Balance, end of period	$	18,724	$	18,724

(1) The Company finalized its purchase accounting adjustments associated with Hamilton as of May 1, 2020.

Schedule of Changes in Other Intangible Assets

The following table presents changes in other intangible assets for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Beginning of period	$	4,800	$	6,160	$	5,458	$	7,180
Amortization expense	(314)		(357)		(972)		(1,224)
Impairment	—		—		—		(153)
Balance, end of period	$	4,486	$	5,803	$	4,486	$	5,803

Schedule of Components of Other Intangible Assets

The following table presents the components of other identifiable intangible assets at September 30, 2021 and December 31, 2020:

	September 30, 2021				December 31, 2020
	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
Amortized intangible assets:
Core deposit intangibles	$	8,390	$	3,906	$	8,390	$	2,935
Other customer relationship intangibles	25		23		25		22
Total	$	8,415	$	3,929	$	8,415	$	2,957

Schedule of Estimated Aggregated Amortization Expense

The following table presents future estimated aggregate amortization expense for intangible assets remaining at September 30, 2021:

Remainder of 2021	$	303
2022	1,105
2023	935
2024	766
2025	596
Thereafter	781
	$	4,486

XML

SHARE-BASED COMPENSATION PLANS (Tables)

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Summary of Nonvested Restricted Shares Activity

The table below presents a summary of nonvested restricted shares activity for the nine months ended September 30, 2021:

	Shares	Weighted Average Grant Date Fair Value
Nonvested shares, beginning of year	245,576	$	21.45
Granted	127,847	19.21
Forfeited	(29,388)	19.69
Vested	(78,588)	23.52
Nonvested shares, at period end	265,447	$	19.92

Schedule of Restricted Shares Compensation Expense

The following table presents restricted shares compensation expense, with tax benefit information, and fair value of shares vested, for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Restricted share award expense	$	468	$	434	$	1,380	$	1,607
Restricted share award tax benefit	98		91		316		337
Fair value of shares vested	—		225		1,539		1,314

Schedule of Employee Stock Purchase Plan

The following table presents information for the employee stock purchase plan for the three and nine months ended September 30, 2021 and 2020:

	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Shares purchased	3,271		4,218		8,755		7,831
Weighted average price of shares purchased	$	19.16	$	13.08	$	15.58	$	14.85
Compensation expense recognized	15		3		48		6

XML

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Value of Derivative Instruments

The following table summarizes the fair value of the Company's derivative instruments at September 30, 2021 and December 31, 2020:

	September 30, 2021					December 31, 2020
	Notional Amount		Balance Sheet Location	Fair Value		Notional Amount		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps - balance sheet hedge	$	—		$	—	$	50,000	Other liabilities	$	(1,230)
Total derivatives designated as hedging instruments				$	—				$	(1,230)
Derivatives not designated as hedging instruments:
Interest rate swap - commercial borrower	$	32,462	Other assets	$	277	$	30,673	Other assets	$	690
Interest rate swap - counterparty	32,462		Other liabilities	(269)		30,673		Other liabilities	(726)
Risk participation	15,855		Other liabilities	(3)		—			—
Interest rate lock commitments with customers	22,025		Other assets	546		22,560		Other assets	673
Forward sale commitment	6,198		Other assets	23		10,400		Other liabilities	(61)
Total derivatives not designated as hedging instruments				$	574				$	576

Effect of Derivative Financial Instruments on OCI and Net Income

The following tables summarize the effect of the Company's derivative financial instruments on OCI and net income for the three and nine months ended September 30, 2021 and 2020:

	Amount of (Loss) Gain Recognized in OCI on Derivative				Amount of Gain (Loss) Recognized in OCI on Derivative
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives in cash flow hedging relationships:
Interest rate products	$	(183)	$	208	$	473	$	(1,893)
Total	$	(183)	$	208	$	473	$	(1,893)

	Amount of Loss Reclassified from AOCI into Income				Amount of Loss Reclassified from AOCI into Income				Location of Loss Recognized from AOCI into Income
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives in cash flow hedging relationships:
Interest rate products	$	(581)	$	(114)	$	(757)	$	(239)	Interest expense / Other operating expenses(1)
Total	$	(581)	$	(114)	$	(757)	$	(239)

(1) Includes $514 thousand recorded to other operating expenses due to the loss from the termination of an interest rate swap designated as a cash flow hedge.

	Amount of Gain (Loss) Recognized in Income				Amount of Gain (Loss) Recognized in Income				Location of Gain (Loss) Recognized in Income
	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Derivatives not designated as hedging instruments:
Interest rate products	$	8	$	(4)	$	44	$	(21)	Other operating expenses
Risk participation agreement	1		—		(3)		—		Other operating expenses
Interest rate lock commitments with customers	89		157		(128)		1,040		Mortgage banking activities
Forward sale commitment	1		71		84		(126)		Mortgage banking activities
Total	$	99	$	224	$	(3)	$	893

Summary of Interest Rate Swap Components

The following table is a summary of components for interest rate swaps designated as hedging at September 30, 2021 and December 31, 2020. During the three and nine months ended September 30, 2021, the Company terminated its interest rate derivative of $50.0 million.

	September 30, 2021		December 31, 2020
Weighted average pay rate	—	%	0.77	%
Weighted average receive rate	—	%	0.09	%
Weighted average maturity in years	0.0		4.2

XML

SHAREHOLDERS' EQUITY AND REGULATORY CAPITAL (Tables)

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

Capital Amounts and Ratios

The following table presents capital amounts and ratios at September 30, 2021 and December 31, 2020:

	Actual				For Capital Adequacy Purposes (includes applicable capital conservation buffer)				To Be Well Capitalized Under Prompt Corrective Action Provisions
	Amount		Ratio		Amount		Ratio		Amount		Ratio
September 30, 2021
Total risk-based capital:
Orrstown Financial Services, Inc.	$	291,785	15.6	%	$	195,965	10.5	%	n/a		n/a
Orrstown Bank	273,583		14.7	%	195,899		10.5	%	$	186,570	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	238,492		12.8	%	158,639		8.5	%	n/a		n/a
Orrstown Bank	252,238		13.5	%	158,585		8.5	%	149,256		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	238,492		12.8	%	130,644		7.0	%	n/a		n/a
Orrstown Bank	252,238		13.5	%	130,599		7.0	%	121,271		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	238,492		8.3	%	115,630		4.0	%	n/a		n/a
Orrstown Bank	252,238		8.7	%	115,706		4.0	%	144,633		5.0	%
December 31, 2020
Total risk-based capital:
Orrstown Financial Services, Inc.	$	271,184	15.6	%	$	183,099	10.5	%	n/a		n/a
Orrstown Bank	256,376		14.7	%	183,012		10.5	%	$	174,297	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	217,582		12.5	%	148,223		8.5	%	n/a		n/a
Orrstown Bank	234,677		13.5	%	148,152		8.5	%	139,437		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	217,582		12.5	%	122,066		7.0	%	n/a		n/a
Orrstown Bank	234,677		13.5	%	122,008		7.0	%	113,293		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	217,582		8.1	%	108,063		4.0	%	n/a		n/a
Orrstown Bank	234,677		8.7	%	108,148		4.0	%	135,185		5.0	%

XML

EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Earnings Per Share

The following table presents earnings per share for the three and nine months ended September 30, 2021 and 2020:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net income	$	7,192	$	4,977	$	26,175	$	16,404
Weighted average shares outstanding - basic	10,979		10,941		10,976		10,939
Dilutive effect of share-based compensation	143		84		127		88
Weighted average shares outstanding - diluted	11,122		11,025		11,103		11,027
Per share information:
Basic earnings per share	$	0.66	$	0.45	$	2.38	$	1.50
Diluted earnings per share	0.65		0.45		2.36		1.49

XML

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Contractual or Notional Amounts, Commitments to Fund

The following table presents these contractual, or notional, amounts:

	Contractual or Notional Amount
	September 30, 2021		December 31, 2020
Commitments to fund:
Home equity lines of credit	$	251,607	$	223,216
1-4 family residential construction loans	35,519		28,928
Commercial real estate, construction and land development loans	122,850		60,606
Commercial, industrial and other loans	339,569		268,931
Standby letters of credit	21,423		14,491

XML

FAIR VALUE (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Summary of Assets Measured at Fair Value on Recurring Basis

The following table summarizes assets measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
September 30, 2021
Financial Assets
Investment securities:
U.S. Treasury securities	$	19,831	$	—	$	—	$	19,831
States and political subdivisions	—		171,304		10,217		181,521
GSE residential MBSs	—		20,518		—		20,518
GSE residential CMOs	—		70,187		—		70,187
Nonagency CMOs	—		12,400		13,257		25,657
Asset-backed	—		126,907		—		126,907
Other	397		—		—		397
Loans held for sale	—		6,412		—		6,412
Derivatives	—		277		546		823
Totals	$	20,228	$	408,005	$	24,020	$	452,253
Financial Liabilities
Derivatives	$	—	$	272	$	—	$	272
December 31, 2020
Financial Assets
Investment securities:
States and political subdivisions	$	—	$	103,591	$	9,079	$	112,670
GSE residential MBSs	—		4,293		—		4,293
GSE residential CMOs	—		58,011		—		58,011
Nonagency CMOs	—		—		16,918		16,918
Private label commercial CMOs	—		56,730		5,506		62,236
Asset-backed	—		211,966		—		211,966
Other	371		—		—		371
Loans held for sale	—		11,734		—		11,734
Derivatives	—		690		673		1,363
Totals	$	371	$	447,015	$	32,176	$	479,562
Financial Liabilities
Derivatives	$	—	$	1,956	$	—	$	1,956

Level 3 Fair Value Measurement Activity

The following provides details of the Level 3 fair value measurement activity for the periods ended September 30, 2021 and 2020:

Investment securities:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Balance, beginning of period	$	24,925	$	23,834	$	31,503	$	24,279
Unrealized (loss) gain included in OCI	(964)		200		467		(229)
Principal payments and other	(487)		(142)		(4,951)		(158)
Sales	—		—		(3,545)		—
Balance, end of period	$	23,474	$	23,892	$	23,474	$	23,892

Interest rate lock commitments on residential mortgages:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Balance, beginning of period	$	456	$	986	$	673	$	103
Total gains (losses)
Included in earnings	90		157		(127)		1,040
Balance, end of period	$	546	$	1,143	$	546	$	1,143

Summary of Assets Measured at Fair Value on Nonrecurring Basis

The following table summarizes assets measured at fair value on a nonrecurring basis at September 30, 2021 and December 31, 2020:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
September 30, 2021
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	776	$	776
Non-owner occupied residential	—		—		69		69
Residential mortgage:
First lien	—		—		677		677
Home equity - lines of credit	—		—		77		77
Total impaired loans	$	—	$	—	$	1,599	$	1,599
Mortgage servicing rights	$	—	$	—	$	3,642	$	3,642
December 31, 2020
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	846	$	846
Non-owner occupied residential	—		—		36		36
Commercial and industrial	—		—		12		12
Residential mortgage:
First lien	—		—		638		638
Home equity - lines of credit	—		—		89		89
Total impaired loans	$	—	$	—	$	1,621	$	1,621
Mortgage servicing rights	$	—	$	—	$	2,745	$	2,745

Summary of Additional Qualitative Information

The following table presents additional qualitative information about assets measured on a nonrecurring basis and for which the Company has utilized Level 3 inputs to determine fair value:

	Fair Value Estimate		Valuation Techniques	Unobservable Input	Range
September 30, 2021
Impaired loans	$	1,599	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	10% - 25% discount
				- Management adjustments for liquidation expenses	6% - 18% discount
Mortgage servicing rights	$	3,642	Discounted cash flows	Weighted average CPR	14.53%
				- Weighted average discount rate	9.04%
December 31, 2020
Impaired loans	$	1,621	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	5% - 25% discount
				- Management adjustments for liquidation expenses	6% - 19% discount
Mortgage servicing rights	$	2,745	Discounted cash flows	Weighted average CPR	18.02%
				- Weighted average discount rate	9.56%

Carrying Amounts and Estimated Fair Values of Financial Instruments

The following table presents carrying amounts and estimated fair values of the Company’s financial instruments at September 30, 2021 and December 31, 2020:

	Carrying Amount		Fair Value		Level 1		Level 2		Level 3
September 30, 2021
Financial Assets
Cash and due from banks	$	36,920	$	36,920	$	36,920	$	—	$	—
Interest-bearing deposits with banks	274,495		274,495		274,495		—		—
Restricted investments in bank stocks	7,051		n/a		n/a		n/a		n/a
Investment securities	445,018		445,018		20,228		401,316		23,474
Loans held for sale	6,412		6,412		—		6,412		—
Loans, net of allowance for loan losses	1,919,799		1,917,091		—		—		1,917,091
Derivatives	823		823		—		277		546
Accrued interest receivable	8,015		8,015		—		2,169		5,846
Financial Liabilities
Deposits	2,502,108		2,503,695		—		2,503,695		—
Securities sold under agreements to repurchase	27,595		27,595		—		27,595		—
FHLB advances and other	2,003		2,176		—		2,176		—
Subordinated notes	31,948		32,781		—		32,781		—
Derivatives	272		272		—		272		—
Accrued interest payable	631		631		—		631		—
Off-balance sheet instruments	—		—		—		—		—
December 31, 2020
Financial Assets
Cash and due from banks	$	26,203	$	26,203	$	26,203	$	—	$	—
Interest-bearing deposits with banks	99,055		99,055		99,055		—		—
Restricted investments in bank stocks	10,563		n/a		n/a		n/a		n/a
Investment securities	466,465		466,465		371		434,591		31,503
Loans held for sale	11,734		11,734		—		11,734		—
Loans, net of allowance for loan losses	1,959,539		1,953,860		—		—		1,953,860
Derivatives	1,363		1,363		—		690		673
Accrued interest receivable	8,927		8,927		—		1,529		7,398
Financial Liabilities
Deposits	2,356,880		2,359,317		—		2,359,317		—
Securities sold under agreements to repurchase	19,466		19,466		—		19,466		—
FHLB advances and other	58,045		58,298		—		58,298		—
Subordinated notes	31,903		31,712		—		31,712		—
Derivatives	1,956		1,956		—		1,956		—
Accrued interest payable	238		238		—		238		—
Off-balance sheet instruments	—		—		—		—		—

XML

INVESTMENT SECURITIES - Amortized Cost and Fair Values of AFS Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 437,852	$ 460,999
Gross Unrealized Gains	9,531	12,054
Gross Unrealized Losses	2,365	6,588
Fair Value	445,018	466,465
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	20,087
Gross Unrealized Gains	0
Gross Unrealized Losses	256
Fair Value	19,831
States and political subdivisions
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	174,239	104,704
Gross Unrealized Gains	8,072	9,091
Gross Unrealized Losses	790	1,125
Fair Value	181,521	112,670
GSE residential MBSs
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	20,552	4,197
Gross Unrealized Gains	80	96
Gross Unrealized Losses	114	0
Fair Value	20,518	4,293
GSE residential CMOs
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	69,922	56,856
Gross Unrealized Gains	921	2,226
Gross Unrealized Losses	656	1,071
Fair Value	70,187	58,011
Non-agency CMOs
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	25,929	16,505
Gross Unrealized Gains	1	413
Gross Unrealized Losses	273	0
Fair Value	25,657	16,918
Private label commercial CMOs
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		63,941
Gross Unrealized Gains		57
Gross Unrealized Losses		1,762
Fair Value		62,236
Asset-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	126,726	214,425
Gross Unrealized Gains	457	171
Gross Unrealized Losses	276	2,630
Fair Value	126,907	211,966
Other
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	397	371
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	$ 397	$ 371

XML

INVESTMENT SECURITIES - Summary of AFS Securities with Unrealized Losses (Details) $ in Thousands	Sep. 30, 2021 USD ($) security	Dec. 31, 2020 USD ($) security
Number of Securities
Less Than 12 Months | security	29	7
12 Months or More | security	3	25
Total | security	32	32
Fair Value
Less Than 12 Months	$ 153,459	$ 54,268
12 Months or More	36,067	225,564
Total	189,526	279,832
Unrealized Losses
Less Than 12 Months	2,103	2,893
12 Months or More	262	3,695
Total	$ 2,365	$ 6,588
U.S. Treasury securities
Number of Securities
Less Than 12 Months | security	3
12 Months or More | security	0
Total | security	3
Fair Value
Less Than 12 Months	$ 19,831
12 Months or More	0
Total	19,831
Unrealized Losses
Less Than 12 Months	256
12 Months or More	0
Total	$ 256
States and political subdivisions
Number of Securities
Less Than 12 Months | security	11	1
12 Months or More | security	0	0
Total | security	11	1
Fair Value
Less Than 12 Months	$ 40,666	$ 9,079
12 Months or More	0	0
Total	40,666	9,079
Unrealized Losses
Less Than 12 Months	790	1,125
12 Months or More	0	0
Total	$ 790	$ 1,125
GSE residential MBSs
Number of Securities
Less Than 12 Months | security	5
12 Months or More | security	0
Total | security	5
Fair Value
Less Than 12 Months	$ 17,354
12 Months or More	0
Total	17,354
Unrealized Losses
Less Than 12 Months	114
12 Months or More	0
Total	$ 114
GSE residential CMOs
Number of Securities
Less Than 12 Months | security	7	3
12 Months or More | security	0	0
Total | security	7	3
Fair Value
Less Than 12 Months	$ 43,267	$ 23,954
12 Months or More	0	0
Total	43,267	23,954
Unrealized Losses
Less Than 12 Months	656	1,071
12 Months or More	0	0
Total	$ 656	$ 1,071
Non-agency CMOs
Number of Securities
Less Than 12 Months | security	1
12 Months or More | security	0
Total | security	1
Fair Value
Less Than 12 Months	$ 13,257
12 Months or More	0
Total	13,257
Unrealized Losses
Less Than 12 Months	273
12 Months or More	0
Total	$ 273
Private label commercial CMOs
Number of Securities
Less Than 12 Months | security		1
12 Months or More | security		10
Total | security		11
Fair Value
Less Than 12 Months		$ 4,314
12 Months or More		42,403
Total		46,717
Unrealized Losses
Less Than 12 Months		685
12 Months or More		1,077
Total		$ 1,762
Asset-backed
Number of Securities
Less Than 12 Months | security	2	2
12 Months or More | security	3	15
Total | security	5	17
Fair Value
Less Than 12 Months	$ 19,084	$ 16,921
12 Months or More	36,067	183,161
Total	55,151	200,082
Unrealized Losses
Less Than 12 Months	14	12
12 Months or More	262	2,618
Total	$ 276	$ 2,630

XML

INVESTMENT SECURITIES - Schedule of Amortized Cost and Fair Values of AFS Securities by Contractual Maturity (Details) $ in Thousands	Sep. 30, 2021 USD ($)
Amortized Cost
Due in one year or less	$ 0
Due after one year through five years	249
Due after five years through ten years	69,999
Due after ten years	124,475
CMOs and MBSs	116,403
Asset-backed	126,726
Total Amortized Cost	437,852
Fair Value
Due in one year or less	0
Due after one year through five years	249
Due after five years through ten years	71,976
Due after ten years	129,524
CMOs and MBSs	116,362
Asset-backed	126,907
Total Fair Value	$ 445,018

XML

INVESTMENT SECURITIES - Proceeds from Sales of AFS Securities and Gross Gains and Gross Losses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Proceeds from sale of investment securities	$ 73,319	$ 0	$ 149,038	$ 0
Gross gains	482	0	1,844	0
Gross losses	$ 3	$ 13	$ 1,209	$ 44

XML

INVESTMENT SECURITIES - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($) security	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) security	Sep. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)
Debt Securities, Available-for-sale [Line Items]
Gain on investments	$ 479		$ 635
Loss adjustment on equity securities		$ (13)		$ (44)
Number of investment securities sold | security			18
Investment securities	445,018		$ 445,018		$ 466,465
Proceeds from sale of investment securities	73,319	$ 0	149,038	0
Debt Securities
Debt Securities, Available-for-sale [Line Items]
Investment securities	$ 148,400		148,400
Proceeds from sale of investment securities			149,000	$ 0
Debt Securities | Asset-backed
Debt Securities, Available-for-sale [Line Items]
Number of investment securities sold | security	4
Investment securities	$ 72,800		72,800
Proceeds from sale of investment securities	73,300
Collateral Pledged
Debt Securities, Available-for-sale [Line Items]
Investment securities pledged to secure public funds, fair value	$ 316,000		$ 316,000		$ 398,700

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Narrative (Details)	3 Months Ended		9 Months Ended			18 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) loan note	Dec. 31, 2020 USD ($) loan	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) loan	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Dec. 31, 2019 USD ($)
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans, net	$ 1,939,764,000		$ 1,939,764,000	$ 1,979,690,000		$ 1,939,764,000
Number of PPP loans | loan			3,300	3,200
Interest and fee income on loans	(19,890,000)	$ (21,645,000)	$ (62,724,000)		$ (63,605,000)
SBA, loan guarantee, percentage			100.00%
Amount of loan on which review have been made annually	1,000,000		$ 1,000,000			1,000,000
Amount of loan on which reviews require approval	500,000		$ 500,000			500,000
Loans that are deemed impaired, number of days past due (more than)			90 days
Number of notes split | note			2
Appraisals, required period interval			18 months
Minimum amount on which annual updated appraisals for classified loans is required	250,000		$ 250,000			250,000
Allowance for loan losses	19,965,000	19,725,000	19,965,000	$ 20,151,000	19,725,000	19,965,000	$ 19,381,000	$ 17,517,000	$ 14,655,000
Commercial
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for loan losses	16,806,000	15,672,000	16,806,000	16,247,000	15,672,000	16,806,000	16,082,000	13,407,000	11,049,000
Consumer
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for loan losses	2,951,000	3,873,000	$ 2,951,000	3,686,000	3,873,000	2,951,000	3,090,000	3,938,000	3,466,000
Maximum
Financing Receivable, Allowance for Credit Losses [Line Items]
Percentage of loan-to-value ratio upon loan origination			80.00%
Percentage of loan-to-value ratios of the value of the real estate taken as collateral			90.00%
Percentage of strong loan-to-value (or lower)			70.00%
Commercial and industrial
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans, net	540,205,000		$ 540,205,000	647,368,000		540,205,000
Commercial and industrial | Commercial
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for loan losses	3,886,000	$ 3,731,000	3,886,000	3,942,000	$ 3,731,000	3,886,000	$ 3,495,000	$ 2,916,000	$ 2,356,000
Commercial real estate
Financing Receivable, Allowance for Credit Losses [Line Items]
Decrease in reserve	1,000,000		2,700,000
Allowance for loan losses	0		0			0
SBA | Commercial | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans, net	0		0	15,700,000		$ 0
Number of PPP loans | loan						6,500
PPP loans generated amount	231,700,000		231,700,000	467,700,000		$ 231,700,000
PPP Loan processing fee income				13,500,000
Interest and fee income on loans			$ (8,600,000)
Loan deferral period			180 days
SBA | Commercial | 2021 Payment Deferrals
Financing Receivable, Allowance for Credit Losses [Line Items]
PPP Loan processing fee income			$ 12,300,000
SBA | Consumer | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans, net	317,000		$ 317,000	$ 2,500,000		317,000
Loan deferral period			90 days
SBA | Maximum | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
Fee income amortization period				5 years
SBA | Maximum | Commercial | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
PPP loans generated amount	699,400,000		$ 699,400,000			699,400,000
SBA | Minimum | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
Fee income amortization period				2 years
SBA | Commercial and industrial | SBA PPP Loans
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans, net	$ 259,900,000		$ 259,900,000	$ 403,300,000		$ 259,900,000

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Summary of Loan Portfolio, Excluding Residential Loans Held for Sale (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	$ 1,939,764	$ 1,979,690
Commercial real estate | Owner occupied
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	196,585	174,908
Commercial real estate | Non-owner occupied
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	509,703	409,567
Commercial real estate | Multi-family
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	112,002	113,635
Commercial real estate | Non-owner occupied residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	100,088	114,505
Acquisition and development | 1-4 family residential construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	12,246	9,486
Acquisition and development | Commercial and land development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	71,784	51,826
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	540,205	647,368
Commercial and industrial | SBA | SBA PPP Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	259,900	403,300
Municipal
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	13,631	20,523
Residential mortgage | First lien
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	203,360	244,321
Residential mortgage | Home equity - term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	7,079	10,169
Residential mortgage | Home equity - lines of credit
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	154,004	157,021
Installment and other loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	$ 19,077	$ 26,361

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Company's Loan Portfolio Ratings Based on its Internal Risk Rating System (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable, Recorded Investment [Line Items]
Total loans	$ 1,939,764	$ 1,979,690
Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	196,585	174,908
Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	509,703	409,567
Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	112,002	113,635
Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	100,088	114,505
Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	12,246	9,486
Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	71,784	51,826
Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	540,205	647,368
Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	13,631	20,523
Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	203,360	244,321
Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	7,079	10,169
Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	154,004	157,021
Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	19,077	26,361
Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,833,306	1,826,705
Pass | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	176,029	148,846
Pass | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	476,947	351,860
Pass | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	91,726	92,769
Pass | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	95,338	107,557
Pass | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	12,246	9,101
Pass | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	70,648	49,832
Pass | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	521,530	617,213
Pass | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	13,631	20,523
Pass | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	195,717	236,381
Pass | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	7,056	10,076
Pass | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	153,436	156,264
Pass | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	19,002	26,283
Special Mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	70,777	112,737
Special Mention | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	8,219	12,491
Special Mention | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	32,272	57,378
Special Mention | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	19,662	20,224
Special Mention | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,028	3,948
Special Mention | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	385
Special Mention | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	636	655
Special Mention | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	7,939	17,561
Special Mention | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Special Mention | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Special Mention | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Special Mention | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	21	95
Special Mention | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Non-Impaired Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	14,570	16,680
Non-Impaired Substandard | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	6,147	7,855
Non-Impaired Substandard | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	168	0
Non-Impaired Substandard | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	614	642
Non-Impaired Substandard | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,344	1,422
Non-Impaired Substandard | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Non-Impaired Substandard | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	500	525
Non-Impaired Substandard | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	5,505	6,118
Non-Impaired Substandard | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Non-Impaired Substandard | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	240	0
Non-Impaired Substandard | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	64
Non-Impaired Substandard | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	52	54
Non-Impaired Substandard | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	9,955	11,244
Impaired - Substandard | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	3,832	3,260
Impaired - Substandard | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	171	268
Impaired - Substandard | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	814
Impaired - Substandard | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,941	3,639
Impaired - Substandard | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,472	2,628
Impaired - Substandard | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	7	10
Impaired - Substandard | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	495	608
Impaired - Substandard | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	37	17
Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	11,156	12,324
PCI Loans | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,358	2,456
PCI Loans | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	316	329
PCI Loans | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,207	1,310
PCI Loans | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,290	2,837
PCI Loans | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	4,931	5,312
PCI Loans | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	16	19
PCI Loans | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	$ 38	$ 61

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Impaired Loans by Segment and Class (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	$ 469	$ 424
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	469	508
Impaired Loans with a Specific Allowance, Related Allowance	29	33
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	9,486	10,820
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	12,839	13,755
Commercial real estate | Owner occupied
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	3,832	3,260
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	4,923	4,091
Commercial real estate | Non-owner occupied residential
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	171	268
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	383	393
Acquisition and development | Commercial and land development
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)		0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)		0
Impaired Loans with a Specific Allowance, Related Allowance		0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)		814
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)		875
Commercial and industrial
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	2,941	3,639
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	3,592	4,269
Residential mortgage | First lien
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	469	424
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	469	508
Impaired Loans with a Specific Allowance, Related Allowance	29	33
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	2,003	2,204
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	3,161	3,264
Residential mortgage | Home equity - term
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	7	10
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	10	13
Residential mortgage | Home equity - lines of credit
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	495	608
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	733	832
Installment and other loans
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	37	17
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	$ 37	$ 18

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Average Recorded Investment in Impaired Loans and Related Interest Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	$ 10,522	$ 10,864	$ 10,550	$ 11,514
Interest Income Recognized	11	12	33	38
Commercial real estate | Owner occupied
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	4,179	4,424	3,848	5,033
Interest Income Recognized	0	0	1	1
Commercial real estate | Non-owner occupied
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	0	102	0	108
Interest Income Recognized	0	0	0	0
Commercial real estate | Multi-family
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	0	141	7	259
Interest Income Recognized	0	0	0	0
Commercial real estate | Non-owner occupied residential
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	232	433	252	422
Interest Income Recognized	0	0	0	0
Acquisition and development | Commercial and land development
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	0	837	246	586
Interest Income Recognized	0	0	0	0
Commercial and industrial
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	3,073	1,044	3,046	1,316
Interest Income Recognized	0	0	0	0
Residential mortgage | First lien
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	2,541	3,209	2,575	3,050
Interest Income Recognized	11	12	32	36
Residential mortgage | Home equity - term
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	10	12	12	12
Interest Income Recognized	0	0	0	0
Residential mortgage | Home equity - lines of credit
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	463	645	547	699
Interest Income Recognized	0	0	0	1
Installment and other loans
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	24	17	17	29
Interest Income Recognized	$ 0	$ 0	$ 0	$ 0

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Troubled Debt Restructurings (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2021 USD ($) contract	Sep. 30, 2020 contract	Dec. 31, 2020 USD ($) contract
Financing Receivable, Modifications [Line Items]
Number of Contracts	14		16
Recorded Investment | $	$ 1,130		$ 1,254
Number of new contracts	0	0
Accruing
Financing Receivable, Modifications [Line Items]
Number of Contracts	9		11
Recorded Investment | $	$ 839		$ 934
Accruing | Commercial real estate | Owner occupied
Financing Receivable, Modifications [Line Items]
Number of Contracts	1		1
Recorded Investment | $	$ 26		$ 28
Accruing | Residential mortgage | First lien
Financing Receivable, Modifications [Line Items]
Number of Contracts	8		9
Recorded Investment | $	$ 813		$ 898
Accruing | Residential mortgage | Home equity - lines of credit
Financing Receivable, Modifications [Line Items]
Number of Contracts	0		1
Recorded Investment | $	$ 0		$ 8
Nonaccruing
Financing Receivable, Modifications [Line Items]
Number of Contracts	5		5
Recorded Investment | $	$ 291		$ 320
Nonaccruing | Residential mortgage | First lien
Financing Receivable, Modifications [Line Items]
Number of Contracts	5		5
Recorded Investment | $	$ 291		$ 320

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Loan Portfolio Summarized by Aging Categories of Performing Loans and Nonaccrual Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	$ 362	$ 554
Non- Accrual	9,116	10,310
Loans, net	1,939,764	1,979,690
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	35	98
Non- Accrual	9,116	10,310
Loans, net	1,928,608	1,967,366
Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	327	456
Non- Accrual	0	0
Loans, net	11,156	12,324
Current
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	1,928,752	1,958,535
Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	1,917,923	1,947,335
Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	10,829	11,200
30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	889	9,330
30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	889	8,671
30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	659
60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	645	961
60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	645	952
60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	9
Total Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	1,896	10,845
Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	1,569	9,721
Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	327	1,124
Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	196,585	174,908
Commercial real estate | Owner occupied | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	3,806	3,232
Loans, net	194,227	172,452
Commercial real estate | Owner occupied | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	2,358	2,456
Commercial real estate | Owner occupied | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	190,183	168,262
Commercial real estate | Owner occupied | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	2,358	2,456
Commercial real estate | Owner occupied | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	238	958
Commercial real estate | Owner occupied | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Owner occupied | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Owner occupied | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Owner occupied | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	238	958
Commercial real estate | Owner occupied | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	509,703	409,567
Commercial real estate | Non-owner occupied | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	509,387	409,238
Commercial real estate | Non-owner occupied | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	316	329
Commercial real estate | Non-owner occupied | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	509,387	409,130
Commercial real estate | Non-owner occupied | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	316	329
Commercial real estate | Non-owner occupied | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	108
Commercial real estate | Non-owner occupied | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	108
Commercial real estate | Non-owner occupied | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Multi-family
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	112,002	113,635
Commercial real estate | Multi-family | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	112,002	113,635
Commercial real estate | Multi-family | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	112,002	113,635
Commercial real estate | Multi-family | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Multi-family | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Multi-family | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	100,088	114,505
Commercial real estate | Non-owner occupied residential | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	171	268
Loans, net	98,881	113,195
Commercial real estate | Non-owner occupied residential | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	126	149
Non- Accrual	0	0
Loans, net	1,207	1,310
Commercial real estate | Non-owner occupied residential | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	98,459	112,443
Commercial real estate | Non-owner occupied residential | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	1,081	1,161
Commercial real estate | Non-owner occupied residential | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	484
Commercial real estate | Non-owner occupied residential | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied residential | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	251	0
Commercial real estate | Non-owner occupied residential | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied residential | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	251	484
Commercial real estate | Non-owner occupied residential | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	126	149
Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	12,246	9,486
Acquisition and development | 1-4 family residential construction | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	12,246	9,486
Acquisition and development | 1-4 family residential construction | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	12,246	9,486
Acquisition and development | 1-4 family residential construction | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Acquisition and development | 1-4 family residential construction | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Acquisition and development | 1-4 family residential construction | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	71,784	51,826
Acquisition and development | Commercial and land development | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	814
Loans, net	71,784	51,826
Acquisition and development | Commercial and land development | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	71,774	50,922
Acquisition and development | Commercial and land development | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	10	32
Acquisition and development | Commercial and land development | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	58
Acquisition and development | Commercial and land development | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	10	90
Commercial and industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	540,205	647,368
Commercial and industrial | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	2,941	3,639
Loans, net	537,915	644,531
Commercial and industrial | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	2,290	2,837
Commercial and industrial | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	534,967	640,573
Commercial and industrial | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	2,290	2,837
Commercial and industrial | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	7	9
Commercial and industrial | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial and industrial | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	310
Commercial and industrial | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial and industrial | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	7	319
Commercial and industrial | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Municipal
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	13,631	20,523
Municipal | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	13,631	20,523
Municipal | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	13,631	19,677
Municipal | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	846
Municipal | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Municipal | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	846
Residential mortgage | First lien
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	203,360	244,321
Residential mortgage | First lien | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	35	83
Non- Accrual	1,659	1,730
Loans, net	198,429	239,009
Residential mortgage | First lien | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	201	307
Non- Accrual	0	0
Loans, net	4,931	5,312
Residential mortgage | First lien | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	196,076	230,903
Residential mortgage | First lien | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	4,730	4,341
Residential mortgage | First lien | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	341	5,758
Residential mortgage | First lien | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	655
Residential mortgage | First lien | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	318	535
Residential mortgage | First lien | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	9
Residential mortgage | First lien | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	694	6,376
Residential mortgage | First lien | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	201	971
Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	7,079	10,169
Residential mortgage | Home equity - term | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	1
Non- Accrual	7	10
Loans, net	7,063	10,150
Residential mortgage | Home equity - term | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	16	19
Residential mortgage | Home equity - term | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	7,041	10,099
Residential mortgage | Home equity - term | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	16	19
Residential mortgage | Home equity - term | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	15	40
Residential mortgage | Home equity - term | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Residential mortgage | Home equity - term | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Residential mortgage | Home equity - term | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Residential mortgage | Home equity - term | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	15	41
Residential mortgage | Home equity - term | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	154,004	157,021
Residential mortgage | Home equity - lines of credit | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	495	600
Loans, net	154,004	157,021
Residential mortgage | Home equity - lines of credit | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	153,266	156,153
Residential mortgage | Home equity - lines of credit | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	208	268
Residential mortgage | Home equity - lines of credit | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	35	0
Residential mortgage | Home equity - lines of credit | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	243	268
Installment and other loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	19,077	26,361
Installment and other loans | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	14
Non- Accrual	37	17
Loans, net	19,039	26,300
Installment and other loans | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	38	61
Installment and other loans | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	18,891	26,052
Installment and other loans | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	38	57
Installment and other loans | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	70	168
Installment and other loans | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	4
Installment and other loans | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	41	49
Installment and other loans | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Installment and other loans | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	111	231
Installment and other loans | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	$ 0	$ 4

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Activity in Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Activity in allowance for loan losses
Balance, beginning of period	$ 19,381	$ 17,517	$ 20,151	$ 14,655
Provision for loan losses	365	2,200	(10)	5,025
Charge-offs	(164)	(227)	(1,032)	(918)
Recoveries	383	235	856	963
Balance, end of period	19,965	19,725	19,965	19,725
Unallocated
Activity in allowance for loan losses
Balance, beginning of period	209	172	218	140
Provision for loan losses	(1)	8	(10)	40
Charge-offs	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	208	180	208	180
Commercial
Activity in allowance for loan losses
Balance, beginning of period	16,082	13,407	16,247	11,049
Provision for loan losses	495	2,245	647	4,494
Charge-offs	(144)	(196)	(891)	(692)
Recoveries	373	216	803	821
Balance, end of period	16,806	15,672	16,806	15,672
Commercial | Commercial Real Estate
Activity in allowance for loan losses
Balance, beginning of period	11,315	9,347	11,151	7,634
Provision for loan losses	(179)	1,520	133	2,780
Charge-offs	(89)	(3)	(270)	(3)
Recoveries	305	171	338	624
Balance, end of period	11,352	11,035	11,352	11,035
Commercial | Acquisition and Development
Activity in allowance for loan losses
Balance, beginning of period	1,243	1,069	1,114	959
Provision for loan losses	290	(219)	418	(117)
Charge-offs	0	0	0	0
Recoveries	8	0	9	8
Balance, end of period	1,541	850	1,541	850
Commercial | Commercial and Industrial
Activity in allowance for loan losses
Balance, beginning of period	3,495	2,916	3,942	2,356
Provision for loan losses	386	963	109	1,875
Charge-offs	(55)	(193)	(621)	(689)
Recoveries	60	45	456	189
Balance, end of period	3,886	3,731	3,886	3,731
Commercial | Municipal
Activity in allowance for loan losses
Balance, beginning of period	29	75	40	100
Provision for loan losses	(2)	(19)	(13)	(44)
Charge-offs	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	27	56	27	56
Consumer
Activity in allowance for loan losses
Balance, beginning of period	3,090	3,938	3,686	3,466
Provision for loan losses	(129)	(53)	(647)	491
Charge-offs	(20)	(31)	(141)	(226)
Recoveries	10	19	53	142
Balance, end of period	2,951	3,873	2,951	3,873
Consumer | Residential Mortgage
Activity in allowance for loan losses
Balance, beginning of period	2,863	3,552	3,362	3,147
Provision for loan losses	(147)	(71)	(578)	329
Charge-offs	0	0	(92)	(109)
Recoveries	5	6	29	120
Balance, end of period	2,721	3,487	2,721	3,487
Consumer | Installment and Other
Activity in allowance for loan losses
Balance, beginning of period	227	386	324	319
Provision for loan losses	18	18	(69)	162
Charge-offs	(20)	(31)	(49)	(117)
Recoveries	5	13	24	22
Balance, end of period	$ 230	$ 386	$ 230	$ 386

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Summary of Ending Loan Balances Evaluated for Impairment and Related Allowance for Loan Losses Allocation (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Loans allocated by:
Individually evaluated for impairment	$ 9,955		$ 11,244
Collectively evaluated for impairment	1,929,809		1,968,446
Total Loans	1,939,764		1,979,690
ALL allocated by:
Individually evaluated for impairment	29		33
Collectively evaluated for impairment	19,936		20,118
Total allowance for loan losses	19,965	$ 19,381	20,151	$ 19,725	$ 17,517	$ 14,655
Commercial and Industrial
Loans allocated by:
Total Loans	540,205		647,368
Municipal
Loans allocated by:
Total Loans	13,631		20,523
Installment and Other
Loans allocated by:
Total Loans	19,077		26,361
Commercial
Loans allocated by:
Individually evaluated for impairment	6,944		7,981
Collectively evaluated for impairment	1,549,300		1,533,837
Total Loans	1,556,244		1,541,818
ALL allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	16,806		16,247
Total allowance for loan losses	16,806		16,247
Commercial | Commercial Real Estate
Loans allocated by:
Individually evaluated for impairment	4,003		3,528
Collectively evaluated for impairment	914,375		809,087
Total Loans	918,378		812,615
ALL allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	11,352		11,151
Total allowance for loan losses	11,352		11,151
Commercial | Acquisition and Development
Loans allocated by:
Individually evaluated for impairment	0		814
Collectively evaluated for impairment	84,030		60,498
Total Loans	84,030		61,312
ALL allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	1,541		1,114
Total allowance for loan losses	1,541		1,114
Commercial | Commercial and Industrial
Loans allocated by:
Individually evaluated for impairment	2,941		3,639
Collectively evaluated for impairment	537,264		643,729
Total Loans	540,205		647,368
ALL allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	3,886		3,942
Total allowance for loan losses	3,886		3,942
Commercial | Municipal
Loans allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	13,631		20,523
Total Loans	13,631		20,523
ALL allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	27		40
Total allowance for loan losses	27		40
Consumer
Loans allocated by:
Individually evaluated for impairment	3,011		3,263
Collectively evaluated for impairment	380,509		434,609
Total Loans	383,520		437,872
ALL allocated by:
Individually evaluated for impairment	29		33
Collectively evaluated for impairment	2,922		3,653
Total allowance for loan losses	2,951		3,686
Consumer | Residential Mortgage
Loans allocated by:
Individually evaluated for impairment	2,974		3,246
Collectively evaluated for impairment	361,469		408,265
Total Loans	364,443		411,511
ALL allocated by:
Individually evaluated for impairment	29		33
Collectively evaluated for impairment	2,692		3,329
Total allowance for loan losses	2,721		3,362
Consumer | Installment and Other
Loans allocated by:
Individually evaluated for impairment	37		17
Collectively evaluated for impairment	19,040		26,344
Total Loans	19,077		26,361
ALL allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	230		324
Total allowance for loan losses	230		324
Unallocated
Loans allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	0		0
Total Loans	0		0
ALL allocated by:
Individually evaluated for impairment	0		0
Collectively evaluated for impairment	208		218
Total allowance for loan losses	$ 208		$ 218

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Schedule of Accretable Yield of Purchased Impaired Loans (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Accretable Yield Movement Schedule [Roll Forward]
Accretable yield, beginning of period	$ 3,016	$ 4,182	$ 3,438	$ 6,950
Additions	0	0	0	570
Accretion of income	(203)	(546)	(878)	(2,459)
Reclassifications from nonaccretable difference due to improvement in expected cash flows	11	139	128	1,260
Other changes, net	(12)	(231)	124	(2,777)
Accretable yield, end of period	$ 2,812	$ 3,544	$ 2,812	$ 3,544

XML

LEASES - Narrative (Details)	Sep. 30, 2021
Minimum
Lessee, Lease, Description [Line Items]
Lease terms	7 years
Maximum
Lessee, Lease, Description [Line Items]
Lease terms	32 years

XML

LEASES - Summary of Information Related to Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Leases [Abstract]
Operating lease ROU assets	$ 9,301		$ 9,301		$ 8,686
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets		Other assets		Other assets
Operating lease ROU liabilities	$ 9,832		$ 9,832		$ 9,143
Operating Lease, Liability, Statement of Financial Position [Extensible List]	Other Liabilities		Other Liabilities		Other Liabilities
Weighted-average remaining lease term (in years)	16 years		16 years		16 years 9 months 18 days
Weighted-average discount rate	4.20%		4.20%		4.30%
Cash paid for operating lease liabilities	$ 331	$ 210	$ 947	$ 847
Operating lease expense	$ 388	$ 421	$ 1,179	$ 1,171

XML

LEASES - Schedule of Maturities of Leases Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Remainder of 2021	$ 296
2022	926
2023	951
2024	974
2025	991
Thereafter	10,387
Total payments due	14,525
Less: imputed interest	4,693
Total lease liabilities	$ 9,832	$ 9,143

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Goodwill [Roll Forward]
Balance, beginning of year	$ 18,724	$ 19,925
Adjustments to acquired goodwill	0	(1,201)
Balance, end of period	$ 18,724	$ 18,724

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)		3 Months Ended		9 Months Ended
	Aug. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Impairments	$ 0
Impairment of intangibles		$ 0	$ 0	$ 0	$ 153,000
Customer Lists
Finite-Lived Intangible Assets [Line Items]
Impairment of intangibles			$ 0	$ 0

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Finite-lived Intangible Assets [Roll Forward]
Beginning of period	$ 4,800	$ 6,160	$ 5,458	$ 7,180
Amortization expense	(314)	(357)	(972)	(1,224)
Impairment	0	0	0	(153)
Balance, end of period	$ 4,486	$ 5,803	$ 4,486	$ 5,803

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Other Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 8,415	$ 8,415
Accumulated Amortization	3,929	2,957
Core deposit intangibles
Finite-Lived Intangible Assets [Line Items]
Gross Amount	8,390	8,390
Accumulated Amortization	3,906	2,935
Other customer relationship intangibles
Finite-Lived Intangible Assets [Line Items]
Gross Amount	25	25
Accumulated Amortization	$ 23	$ 22

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Aggregate Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]
Remainder of 2021	$ 303
2022	1,105
2023	935
2024	766
2025	596
Thereafter	781
Total	$ 4,486	$ 4,800	$ 5,458	$ 5,803	$ 6,160	$ 7,180

XML

SHARE-BASED COMPENSATION PLANS - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense, recognition period	1 year 9 months 18 days
Orrstown 2011 Incentive Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved to be issued (in shares)	881,920
Number of shares available to be issued under employee stock purchase plan (in shares)	258,020
Orrstown 2011 Incentive Stock Plan | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 2.6	$ 2.0
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved to be issued (in shares)	350,000
Number of shares available to be issued under employee stock purchase plan (in shares)	151,480
Maximum shares that can be purchased, as percentage of annual salary	10.00%
Percentage of value of the shares on the semi-annual offering	95.00%

XML

SHARE-BASED COMPENSATION PLANS - Summary of Nonvested Restricted Shares Activity (Details) - Orrstown 2011 Incentive Stock Plan - Restricted Stock	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Shares
Nonvested shares, beginning of year (in shares) | shares	245,576
Granted (in shares) | shares	127,847
Forfeited (in shares) | shares	(29,388)
Vested (in usd per share) | shares	(78,588)
Nonvested shares, at period end (in shares) | shares	265,447
Weighted Average Grant Date Fair Value
Nonvested shares, beginning of year (in usd per share) | $ / shares	$ 21.45
Granted (in usd per share) | $ / shares	19.21
Forfeited (in usd per share) | $ / shares	19.69
Vested (in usd per share) | $ / shares	23.52
Nonvested shares, at period end (in usd per share) | $ / shares	$ 19.92

XML

SHARE-BASED COMPENSATION PLANS - Schedule of Restricted Shares Compensation Expense (Details) - Orrstown 2011 Incentive Stock Plan - Restricted Stock - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted share award expense	$ 468	$ 434	$ 1,380	$ 1,607
Restricted share award tax benefit	98	91	316	337
Fair value of shares vested	$ 0	$ 225	$ 1,539	$ 1,314

XML

SHARE-BASED COMPENSATION PLANS - Schedule of Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plan - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
Shares purchased (in shares)	3,271	4,218	8,755	7,831
Weighted average price of shares purchased (in usd per share)	$ 19.16	$ 13.08	$ 15.58	$ 14.85
Compensation expense recognized	$ 15	$ 3	$ 48	$ 6

XML

DERIVATIVES FINANCIAL INSTRUMENTS - Narrative (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2021 USD ($) bank customer	Sep. 30, 2021 USD ($) bank customer	Dec. 31, 2020 USD ($) bank
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Third-party broker | bank	11	11
Cash collateral held by counterparty for derivatives	$ 0	$ 0	$ 1,700,000
Interest rate derivative
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of derivatives | bank			1
Interest rate derivative | Designated as hedging instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative	50,000,000	50,000,000
Reclassification of realized losses from AOCI		(398,000)
Derivative, notional amount			$ 50,000,000
Interest rate derivative | Derivatives not designated as hedging instruments:
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	$ 64,900,000	$ 64,900,000	61,300,000
Number of customers | customer	11	11
Interest rate derivative | Derivatives not designated as hedging instruments: | Other Liabilities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative	$ 32,462,000	$ 32,462,000	30,673,000
Interest rate derivative | Derivatives not designated as hedging instruments: | Agent Bank
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Upfront fee from derivative	53,000
Interest rate derivative | Derivatives not designated as hedging instruments: | Agent Bank | Other Liabilities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative	$ 15,900,000	$ 15,900,000	$ 0

XML

DERIVATIVE FINANCIAL INSTRUMENTS - Summary of Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Derivatives designated as hedging instruments:
Fair Value
Total derivatives	$ 0	$ (1,230)
Derivatives designated as hedging instruments: | Interest rate swap
Notional Amount
Derivative liabilities	50,000
Derivatives designated as hedging instruments: | Other Liabilities | Interest rate swaps - balance sheet hedge
Notional Amount
Derivative liabilities	0	50,000
Fair Value
Derivative liabilities	0	(1,230)
Derivatives not designated as hedging instruments:
Fair Value
Total derivatives	574	576
Derivatives not designated as hedging instruments: | Other Liabilities | Interest rate swap
Notional Amount
Derivative liabilities	32,462	30,673
Fair Value
Derivative liabilities	(269)	(726)
Derivatives not designated as hedging instruments: | Other Liabilities | Risk participation agreement
Notional Amount
Derivative liabilities	15,855	0
Fair Value
Derivative liabilities	(3)	0
Derivatives not designated as hedging instruments: | Other Liabilities | Forward sale commitment
Notional Amount
Derivative liabilities		10,400
Derivative asset	6,198
Fair Value
Derivative liabilities		(61)
Derivative asset	23
Derivatives not designated as hedging instruments: | Other assets | Interest rate swap
Notional Amount
Derivative asset	32,462	30,673
Fair Value
Derivative asset	277	690
Derivatives not designated as hedging instruments: | Other assets | Interest rate lock commitments with customers
Notional Amount
Derivative asset	22,025	22,560
Fair Value
Derivative asset	$ 546	$ 673

XML

DERIVATIVES FINANCIAL INSTRUMENTS - Effect of Derivative Financial Instruments on OCI and Net Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivative	$ (183)	$ 208	$ 473	$ (1,893)
Amount of Loss Reclassified from AOCI into Income	(581)	(114)	(757)	(239)
Interest expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Loss Reclassified from AOCI into Income	(581)	(114)	(757)	(239)
Mortgage banking activities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	99	224	(3)	893
Interest rate products
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivative	(183)	208	473	(1,893)
Interest rate products | Interest expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Loss Reclassified from AOCI into Income	(581)	(114)	(757)	(239)
Interest rate products | Other operating expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Loss Reclassified from AOCI into Income	514
Amount of Gain (Loss) Recognized in Income	8	(4)	44	(21)
Risk participation agreement | Other operating expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	1	0	(3)	0
Interest rate lock commitments with customers | Mortgage banking activities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	89	157	(128)	1,040
Forward sale commitment | Mortgage banking activities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	$ 1	$ 71	$ 84	$ (126)

XML

DERIVATIVES FINANCIAL INSTRUMENTS - Summary of Interest Rate Swap Components (Details) - Interest Rate Swap	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Weighted average pay rate	0.00%	0.77%
Weighted average receive rate	0.00%	0.09%
Weighted average maturity in years	0 years	4 years 2 months 12 days

XML

SHAREHOLDERS’ EQUITY AND REGULATORY CAPITAL - Schedule of Actual and Required Capital Amounts and Ratios (Detail) $ in Thousands	Sep. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)
Orrstown Financial Services, Inc.
Total risk-based capital:
Actual, Amount	$ 291,785	$ 271,184
Actual, Ratio	0.156	0.156
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 195,965	$ 183,099
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.105	0.105
Tier 1 risk-based capital:
Actual, Amount	$ 238,492	$ 217,582
Actual, Ratio	0.128	0.125
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 158,639	$ 148,223
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.085	0.085
Tier 1 common equity risk-based capital:
Actual, Amount	$ 238,492	$ 217,582
Actual, Ratio	12.80%	12.50%
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 130,644	$ 122,066
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	7.00%	7.00%
Tier 1 leverage capital:
Actual, Amount	$ 238,492	$ 217,582
Actual, Ratio	0.083	0.081
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 115,630	$ 108,063
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.040	0.040
Orrstown Bank
Total risk-based capital:
Actual, Amount	$ 273,583	$ 256,376
Actual, Ratio	0.147	0.147
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 195,899	$ 183,012
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.105	0.105
To Be Well Capitalized Under Prompt Corrective Action Regulations, Amount	$ 186,570	$ 174,297
To Be Well Capitalized Under Prompt Corrective Action Regulations, Ratio	0.100	0.100
Tier 1 risk-based capital:
Actual, Amount	$ 252,238	$ 234,677
Actual, Ratio	0.135	0.135
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 158,585	$ 148,152
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.085	0.085
To Be Well Capitalized Under Prompt Corrective Action Regulations, Amount	$ 149,256	$ 139,437
To Be Well Capitalized Under Prompt Corrective Action Regulations, Ratio	0.080	0.080
Tier 1 common equity risk-based capital:
Actual, Amount	$ 252,238	$ 234,677
Actual, Ratio	13.50%	13.50%
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 130,599	$ 122,008
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	7.00%	7.00%
To Be Well Capitalized Under Prompt Corrective Action Regulations, Amount	$ 121,271	$ 113,293
To Be Well Capitalized Under Prompt Corrective Action Regulations, Ratio	6.50%	6.50%
Tier 1 leverage capital:
Actual, Amount	$ 252,238	$ 234,677
Actual, Ratio	0.087	0.087
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 115,706	$ 108,148
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.040	0.040
To Be Well Capitalized Under Prompt Corrective Action Regulations, Amount	$ 144,633	$ 135,185
To Be Well Capitalized Under Prompt Corrective Action Regulations, Ratio	0.050	0.050

XML

SHAREHOLDERS' EQUITY AND REGULATORY CAPITAL - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		9 Months Ended
	Oct. 18, 2021	Sep. 30, 2021	Apr. 19, 2021	Sep. 30, 2015
Equity, Class of Treasury Stock [Line Items]
Number of shares authorized to be repurchased (in shares)				416,000
Acquisition of treasury stock (in shares)		201,518
Acquisition of treasury stock		$ 3.7
Acquisition of treasury stock (in usd per share)		$ 18.26
Stock repurchase program, additional number of shares authorized to be repurchased			562,000
Stock repurchase program, shares available for future repurchase		776,482
Stock repurchase program percentage of outstanding shares of common stock available for future purchase		7.00%
Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Dividends declared per share (in usd per share)	$ 0.19
Maximum
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program authorized, maximum percentage of outstanding shares of common stock				5.00%

XML

EARNINGS PER SHARE - Calculation of Basic and Diluted Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Net income	$ 7,192	$ 4,977	$ 26,175	$ 16,404
Weighted average shares outstanding - basic (in shares)	10,979	10,941	10,976	10,939
Dilutive effect of share-based compensation (in shares)	143	84	127	88
Weighted average shares outstanding - diluted (in shares)	11,122	11,025	11,103	11,027
Per share information:
Basic earnings per share (in usd per share)	$ 0.66	$ 0.45	$ 2.38	$ 1.50
Diluted earnings per share (in usd per share)	$ 0.65	$ 0.45	$ 2.36	$ 1.49

XML

EARNINGS PER SHARE - Narrative (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Average outstanding options excluded from diluted earnings per share (in shares)	0	6,110	0	21,479

XML

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Reserve for off-balance sheet credit exposures	$ 1,400	$ 1,500
Home equity lines of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	251,607	223,216
1-4 family residential construction loans
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	35,519	28,928
Commercial real estate, construction and land development loans
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	122,850	60,606
Commercial, industrial and other loans
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	339,569	268,931
Standby letters of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	$ 21,423	$ 14,491

XML

FAIR VALUE - Narrative (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($) security	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) security bank	Sep. 30, 2020 USD ($)	Dec. 31, 2020 USD ($) security
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of investment securities sold | security			18
Fair value option, aggregate fair value exceeded principle amount	$ 151		$ 151
Increase (decrease) in fair value			150,652	$ 147,647
Impairment reserve (recovery) for mortgage servicing rights	372		372		$ 1,100
Impairment charges (reversal)	$ 43	$ 166	(695)	$ 986
Interest rate lock commitments on residential mortgages
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Increase (decrease) in fair value			$ 26
Level 3 | Municipal Bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of investment securities | security	1		1
Level 3 | Collateralized Mortgage Obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of investment securities | security	1		1		3
Number of investment securities sold | security			1
Number of investment securities called | bank			1
Level 3 | Measurement Input, Pull Through | Interest rate lock commitments on residential mortgages
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Asset, measurement input (percent)	0.89		0.89
Level 3 | Measurement Input, Pull Through Increase (Decrease) | Interest rate lock commitments on residential mortgages
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Asset, measurement input (percent)	0.05		0.05

XML

FAIR VALUE - Summary of Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financial Assets
Investment securities	$ 445,018	$ 466,465
U.S. Treasury securities
Financial Assets
Investment securities	19,831
States and political subdivisions
Financial Assets
Investment securities	181,521	112,670
GSE residential MBSs
Financial Assets
Investment securities	20,518	4,293
GSE residential CMOs
Financial Assets
Investment securities	70,187	58,011
Non-agency CMOs
Financial Assets
Investment securities	25,657	16,918
Asset-backed
Financial Assets
Investment securities	126,907	211,966
Other
Financial Assets
Investment securities	397	371
Fair Value, Measurements, Recurring
Financial Assets
Loans held for sale	6,412	11,734
Totals	452,253	479,562
Financial Liabilities
Derivatives	272	1,956
Fair Value, Measurements, Recurring | Derivatives
Financial Assets
Derivatives	823	1,363
Fair Value, Measurements, Recurring | U.S. Treasury securities
Financial Assets
Investment securities	19,831
Fair Value, Measurements, Recurring | States and political subdivisions
Financial Assets
Investment securities	181,521	112,670
Fair Value, Measurements, Recurring | GSE residential MBSs
Financial Assets
Investment securities	20,518	4,293
Fair Value, Measurements, Recurring | GSE residential CMOs
Financial Assets
Investment securities	70,187	58,011
Fair Value, Measurements, Recurring | Non-agency CMOs
Financial Assets
Investment securities	25,657	16,918
Fair Value, Measurements, Recurring | Private label commercial CMOs
Financial Assets
Investment securities		62,236
Fair Value, Measurements, Recurring | Asset-backed
Financial Assets
Investment securities	126,907	211,966
Fair Value, Measurements, Recurring | Other
Financial Assets
Investment securities	397	371
Fair Value, Measurements, Recurring | Level 1
Financial Assets
Loans held for sale	0	0
Totals	20,228	371
Financial Liabilities
Derivatives	0	0
Fair Value, Measurements, Recurring | Level 1 | Derivatives
Financial Assets
Derivatives	0	0
Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury securities
Financial Assets
Investment securities	19,831
Fair Value, Measurements, Recurring | Level 1 | States and political subdivisions
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | GSE residential MBSs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | GSE residential CMOs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Non-agency CMOs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Private label commercial CMOs
Financial Assets
Investment securities		0
Fair Value, Measurements, Recurring | Level 1 | Asset-backed
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Other
Financial Assets
Investment securities	397	371
Fair Value, Measurements, Recurring | Level 2
Financial Assets
Loans held for sale	6,412	11,734
Totals	408,005	447,015
Financial Liabilities
Derivatives	272	1,956
Fair Value, Measurements, Recurring | Level 2 | Derivatives
Financial Assets
Derivatives	277	690
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury securities
Financial Assets
Investment securities	0
Fair Value, Measurements, Recurring | Level 2 | States and political subdivisions
Financial Assets
Investment securities	171,304	103,591
Fair Value, Measurements, Recurring | Level 2 | GSE residential MBSs
Financial Assets
Investment securities	20,518	4,293
Fair Value, Measurements, Recurring | Level 2 | GSE residential CMOs
Financial Assets
Investment securities	70,187	58,011
Fair Value, Measurements, Recurring | Level 2 | Non-agency CMOs
Financial Assets
Investment securities	12,400	0
Fair Value, Measurements, Recurring | Level 2 | Private label commercial CMOs
Financial Assets
Investment securities		56,730
Fair Value, Measurements, Recurring | Level 2 | Asset-backed
Financial Assets
Investment securities	126,907	211,966
Fair Value, Measurements, Recurring | Level 2 | Other
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3
Financial Assets
Loans held for sale	0	0
Totals	24,020	32,176
Financial Liabilities
Derivatives	0	0
Fair Value, Measurements, Recurring | Level 3 | Derivatives
Financial Assets
Derivatives	546	673
Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury securities
Financial Assets
Investment securities	0
Fair Value, Measurements, Recurring | Level 3 | States and political subdivisions
Financial Assets
Investment securities	10,217	9,079
Fair Value, Measurements, Recurring | Level 3 | GSE residential MBSs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3 | GSE residential CMOs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Non-agency CMOs
Financial Assets
Investment securities	13,257	16,918
Fair Value, Measurements, Recurring | Level 3 | Private label commercial CMOs
Financial Assets
Investment securities		5,506
Fair Value, Measurements, Recurring | Level 3 | Asset-backed
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Other
Financial Assets
Investment securities	$ 0	$ 0

XML

FAIR VALUE - Level 3 Fair Value Measurement Activity (Details) - Level 3 - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Interest rate lock commitments on residential mortgages
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	$ 456	$ 986	$ 673	$ 103
Included in earnings	90	157	(127)	1,040
Balance, end of period	546	1,143	546	1,143
Collateralized Mortgage Obligations
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	24,925	23,834	31,503	24,279
Unrealized (loss) gain included in OCI	(964)	200	467	(229)
Principal payments and other	(487)	(142)	(4,951)	(158)
Sales	0	0	(3,545)	0
Balance, end of period	$ 23,474	$ 23,892	$ 23,474	$ 23,892

XML

FAIR VALUE - Summary of Assets Measured at Fair Value on Nonrecurring Basis (Details) - Fair Value, Measurements, Nonrecurring - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	$ 1,599	$ 1,621
Mortgage servicing rights	3,642	2,745
Commercial real estate | Owner occupied
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	776	846
Commercial real estate | Non-owner occupied residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	69	36
Commercial and industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans		12
Residential mortgage | First lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	677	638
Residential mortgage | Home equity - lines of credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	77	89
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Mortgage servicing rights	0	0
Level 1 | Commercial real estate | Owner occupied
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 1 | Commercial real estate | Non-owner occupied residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 1 | Commercial and industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans		0
Level 1 | Residential mortgage | First lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 1 | Residential mortgage | Home equity - lines of credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Mortgage servicing rights	0	0
Level 2 | Commercial real estate | Owner occupied
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 2 | Commercial real estate | Non-owner occupied residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 2 | Commercial and industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans		0
Level 2 | Residential mortgage | First lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 2 | Residential mortgage | Home equity - lines of credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	1,599	1,621
Mortgage servicing rights	3,642	2,745
Level 3 | Commercial real estate | Owner occupied
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	776	846
Level 3 | Commercial real estate | Non-owner occupied residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	69	36
Level 3 | Commercial and industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans		12
Level 3 | Residential mortgage | First lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	677	638
Level 3 | Residential mortgage | Home equity - lines of credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	$ 77	$ 89

XML

FAIR VALUE - Summary of Additional Qualitative Information (Details) - Fair Value, Measurements, Nonrecurring $ in Thousands	Sep. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)
Impaired loans | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)		0.06
Impaired loans | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)		0.19
Impaired loans | Discount Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.06
Impaired loans | Discount Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.18
Impaired loans | Appraisal of collateral
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Estimate	$ 1,599	$ 1,621
Impaired loans | Appraisal of collateral | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)		0.05
Impaired loans | Appraisal of collateral | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)		0.25
Impaired loans | Appraisal of collateral | Discount Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.10
Impaired loans | Appraisal of collateral | Discount Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.25
Mortgage servicing rights | Discounted cash flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Estimate	$ 3,642	$ 2,745
Mortgage servicing rights | Discounted cash flow | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.0904	0.0956
Mortgage servicing rights | Discounted cash flow | Constant Prepayment Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.1453	0.1802

XML

FAIR VALUE - Financial Instruments at Carrying Amounts and Estimated Fair Values (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financial Assets
Interest-bearing deposits with banks	$ 274,495	$ 99,055
Restricted investments in bank stocks	7,051	10,563
Investment securities	445,018	466,465
Financial Liabilities
Securities sold under agreements to repurchase	27,595	19,466
Carrying Amount
Financial Assets
Cash and due from banks	36,920	26,203
Interest-bearing deposits with banks	274,495	99,055
Restricted investments in bank stocks	7,051	10,563
Investment securities	445,018	466,465
Loans held for sale	6,412	11,734
Loans, net of allowance for loan losses	1,919,799	1,959,539
Accrued interest receivable	8,015	8,927
Financial Liabilities
Deposits	2,502,108	2,356,880
Securities sold under agreements to repurchase	27,595	19,466
FHLB advances and other	2,003	58,045
Subordinated notes	31,948	31,903
Accrued interest payable	631	238
Off-balance sheet instruments	0	0
Carrying Amount | Derivatives
Financial Assets
Derivatives	823	1,363
Financial Liabilities
Derivatives	272	1,956
Fair Value
Financial Liabilities
Off-balance sheet instruments	0	0
Fair Value | Fair Value, Inputs, Level 1, 2 and 3
Financial Assets
Cash and due from banks	36,920	26,203
Interest-bearing deposits with banks	274,495	99,055
Investment securities	445,018	466,465
Loans held for sale	6,412	11,734
Loans, net of allowance for loan losses	1,917,091	1,953,860
Accrued interest receivable	8,015	8,927
Financial Liabilities
Deposits	2,503,695	2,359,317
Securities sold under agreements to repurchase	27,595	19,466
FHLB advances and other	2,176	58,298
Subordinated notes	32,781	31,712
Accrued interest payable	631	238
Fair Value | Fair Value, Inputs, Level 1, 2 and 3 | Derivatives
Financial Assets
Derivatives	823	1,363
Financial Liabilities
Derivatives	272	1,956
Fair Value | Level 1
Financial Assets
Cash and due from banks	36,920	26,203
Interest-bearing deposits with banks	274,495	99,055
Investment securities	20,228	371
Loans held for sale	0	0
Loans, net of allowance for loan losses	0	0
Accrued interest receivable	0	0
Financial Liabilities
Deposits	0	0
Securities sold under agreements to repurchase	0	0
FHLB advances and other	0	0
Subordinated notes	0	0
Accrued interest payable	0	0
Off-balance sheet instruments	0	0
Fair Value | Level 1 | Derivatives
Financial Assets
Derivatives	0	0
Financial Liabilities
Derivatives	0	0
Fair Value | Level 2
Financial Assets
Cash and due from banks	0	0
Interest-bearing deposits with banks	0	0
Investment securities	401,316	434,591
Loans held for sale	6,412	11,734
Loans, net of allowance for loan losses	0	0
Accrued interest receivable	2,169	1,529
Financial Liabilities
Deposits	2,503,695	2,359,317
Securities sold under agreements to repurchase	27,595	19,466
FHLB advances and other	2,176	58,298
Subordinated notes	32,781	31,712
Accrued interest payable	631	238
Off-balance sheet instruments	0	0
Fair Value | Level 2 | Derivatives
Financial Assets
Derivatives	277	690
Financial Liabilities
Derivatives	272	1,956
Fair Value | Level 3
Financial Assets
Cash and due from banks	0	0
Interest-bearing deposits with banks	0	0
Investment securities	23,474	31,503
Loans held for sale	0	0
Loans, net of allowance for loan losses	1,917,091	1,953,860
Accrued interest receivable	5,846	7,398
Financial Liabilities
Deposits	0	0
Securities sold under agreements to repurchase	0	0
FHLB advances and other	0	0
Subordinated notes	0	0
Accrued interest payable	0	0
Off-balance sheet instruments	0	0
Fair Value | Level 3 | Derivatives
Financial Assets
Derivatives	546	673
Financial Liabilities
Derivatives	$ 0	$ 0

XML

CONTINGENCIES (Details) $ in Thousands	1 Months Ended
	Apr. 30, 2020 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Litigation settlement fees paid	$ 135